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Abstract
GPI8 is a Clan CD, family C13 cysteine protease and the catalytic core of the GPI: 
protein transamidase (GPIT) complex. GPI8 catalyses the addition of pre-formed 
glycosylphosphatidylinositol (GPI) anchors to the C-terminus region of GPI-anchored 
proteins. The GPIT complex has been well characterised in higher eukaryotes, and 
contains at least 4 components. In the parasitic protozoon Leishmania mexicana GPI8 
is non-essential. AgpiS mutants lack GPI-anchored GP63 from the cell surface.
Site-directed mutagenesis of L. mexicana GPI8, followed by expression in the à^gpiS 
cell line, identified the active site cysteine (C216) and histidine (H174) residues. The 
amino acid C94 was also identified as a functionally important residue. Mutation of the 
amino acid H65 had no detectable effect on GPI8 activity. Re-expression of GPI8^^^^  ^
within WT cells had a dominant negative effect on the processing and trafficking of 
GP63 to the cell surface. This indicates that GPI8 is part of a larger complex within L. 
mexicana. Attempts to identify other components of the GPIT complex, by epitope 
tagging, or the production of a GPI-anchored GFP were unsuccessful.
The àgpiS cell line was used to study the effect that a GPI-anchor deficiency has on the 
processing and trafficking of a GPI-protein. Non-GPI-anchored GP63 was secreted 
from the AgpiS cell line, and this secreted form was not processed in the same way as 
in WT cells. In AgpiS non-GPI-anchored GP63 was glycosylated and secreted without 
further processing from the cell with a Un of 120 minutes. Loss in GPI anchoring did 
not result in the intracellular retention of GP63 as found in mammalian cells. N-glycans 
were shown to be important for the secretion of GP63 in the absence of a GPI anchor. 
In WT cells the majority of GP63 was rapidly glycosylated, GPI-anchored and 
trafficked to the surface with defined processing intemiediates. WT cells secreted 2 
isoforms of GP63 into the medium with different kinetics. The 65s isofoiTn was not 
GPI-anchored, while the 63s isoform retained its anchor. It is suggested that anchored 
and unanchored GP63 are trafficked via 2 different pathways in Leishmania mexicana', 
a classical pathway whereby GP63 is N-glycosylated, GPI-anchored and then 
undergoes further modification during transport to the cell surface; or a direct secretion 
pathway whereby non-anchored GP63 is secreted from the cell without modification.
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Chapter 1
Chapter 1 
General Introduction
1.1 Trypanosomatids
1.1.1 Introduction
The trypanosomatids are parasitic protozoa, many of which cause a range of parasitic 
diseases in mammals. These diseases have a severe social and economic impact on the 
areas of the world in which they are prevalent. Species of trypanosomatids include 
Trypanosoma brucei spread by the tsetse fly and Leishmania spread by the sandfly. 
Sub-species of T. brucei cause the serious wasting diseases known as nagana in cattle, 
or African sleeping sickness in humans, which often leads to death if untreated. African 
trypanosomes are endemic in 36 countries across Central and West Africa. Leishmania 
species cause a variety of diseases, which can lead to severe disfigurement or death. 
Leishmania has a worldwide distribution encompassing Southern Europe, Asia and 
Africa (old world) and North and South America (new world). Leishmania is a 
diamorphic parasite, with a lifecycle which alternates between the sandfly vector and 
mammalian hosts, which includes humans (Handman, 1999; Handman, 2001).
1.1.2 Leishmaniasis
There aie approximately 20 human infective species and sub-species of Leishmania 
which are the causative agent of a variety of human diseases collectively known as the 
leishmaniases. The varying clinical manifestations of the disease can be divided into 
four categories (Handman, 2001).
Visceral leishmaniasis also known as kala azar, is the most serious condition, and can 
cause 100% mortality if left untreated. It is characterised by iiTegular bouts of fever, 
swelling of the spleen and liver, weight loss and anaemia. 90% of cases of visceral 
leishmaniasis occur in Bangladesh, Brazil, India and Sudan.
Species; L. donovani, L. tropica.
Cutaneous leishmaniasis is the most common form of the disease, and causes skin 
lesions and ulcers which self heal. The disease can cause a large number of lesions
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(over 200), usually on exposed areas such as the face, arms and legs, and can cause 
permanent disability and severe disfigurement.
Species; L. major, L. mexicana, L. tropica, L. aethiopica.
Mucotaneous leishmaniasis initially produces skin ulcers, which spread to the mucose 
membranes of the nose mouth and throat. Here it can cause massive tissue destruction, 
leading to dreadful facial disfigurement and disability.
Species; L. braziliensis.
Diffuse cutaneous leishmaniasis produces chronic skin lesions, which do not heal, and 
are difficult to treat.
Species; L. mexicana, L. aethiopica.
In general the extent of disease progression depends on the species initiating infection, 
however the general health and immunological competence of the infected individual 
also effects the success of infection.
Leishmaniases infections occur in 88 countries world wide, most of which are 
developing countries, and 350 million people are at risk from infection. Figures from 
the World Health Organisation estimate that 12 million people are infected, and 2 
million new cases are estimated to occur annually (WHO, Leishmaniasis control home 
page: http://www.who.int/ctd/html/leis.html). Epidemics of both visceral and cutaneous 
leishmaniasis occur frequently. An epidemic of visceral leishmaniasis in Sudan in the 
1990s was estimated to have killed 100,000 people (McGregor, 1998). At present an 
epidemic of cutaneous leishmaniasis in Afghanistan is estimated to have infected
200,000 people (WHO website). In recent years there has been an increase in both the 
number of cases and the geographic spread of the disease. This is thought to be in part 
due to co-infection with HIV. In southern Europe 1.5% to 9% of AIDS suffers also 
suffer from newly acquired or reactivated visceral leishmaniasis (Alvar et al., 1997).
The prevention of infection is an important aspect in the control of the disease. 
Strategies include the control of the sandfly vector by the spraying of insecticides, and 
the control of the reservoir host. Large scale programmes are often difficult to 
implement in developing countries, or inappropriate in the countryside areas where the 
disease is prevalent. No vaccine is at present available (Handman, 2001). In many 
developing countries a common method of protection from cutaneous leishmaniasis, is
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the deliberate infection of babies, providing immunisation and preventing the 
occurrence of disfiguring scars on the face.
Treatment of the disease relies on the use of chemotherapeutic agents. Many of the 
drugs currently in use are in themselves toxic, producing an array of unwanted side 
effects. They also require intravenous delivery, and are prohibitively expensive for use 
in developing countries. In recent years there has also be an increase in parasite drug 
resistance (Bryceson, 2001). Traditionally treatment has required a long, high dosage 
course of treatment with toxic, pentavalent antimony based drugs, such as sodium 
stibogluconate, or meglumine antimonate. Increased di'ug resistance to antimonials, has 
resulted in the use of amphotericin B, which inhibits the biosynthesis of ergosterols, 
and therefore leads to the membrane permeability of the parasite. Amphotericin B is 
toxic and in some cases can lead to death. Pentamidine is also used, but has 
increasingly been found to be ineffective, due to parasite drug resistance, and causes a 
number of serious side effects including diabetes, and death (Sundar, 2001). More 
recently miltefosine has been developed as an anti-leishmanial, and affects cell 
signalling pathways and membrane synthesis. The drug has the advantage of being 
taken orally (Fischer et al., 2001). The rapid increase in parasite drug resistance means 
that the development of further new effective drugs is essential to allow the use of 
effective multi-drug regimes. The urgent need for the development of an effective 
vaccine or isolation of new drug targets, are important factors in the study of this 
parasite.
1.1.3 The lifecycle of Leishmania
The lifecycle of Leishmania is diamorphic, cycling between the sandfly vector and the 
vertebrate host (Figure 1.1). Leishmania have three distinct morphological forms. In the 
gut of the insect host, Phlebotomus female sandflies, they exist as flagellated procyclic 
promastigotes. The protozoa are attached to the gut wall and rapidly divide by binary 
fission. From the gut they migrate to the sandfly mouthparts. Here they undergo a 
morphological change to become metacyclic promastigotes, that is, motile, non­
dividing and infective to the mammalian host.
Infection of the mammalian host occurs from an infected sandfly bite, metacyclic 
promastigotes are injected directly into the bloodstream. Activation of the alternative
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complement pathway results in the phagocytosis of the protozoa by macrophages 
(Brittingham and Mosser, 1996). Inside the macrophage, the phagolysosome fuses with 
lysosomes to form parasitophorous vacuoles. The protozoa differentiate into their third 
morphological form, non-motile dividing amastigotes. Amastigote numbers rapidly 
increase until the macrophage undergoes an oxidative burst, releasing the amastigotes 
directly into the bloodstream to infect other macrophages. This process continues, until 
a sandfly takes up infected macrophages during a bloodmeal. The amastigotes emerge 
from the macrophage and differentiate to the procyclic promastigote form within the 
insect gut.
1.2 Surface Molecules
The Leishmania lifecycle is complex, requiring the parasite to adapt rapidly to the 
different conditions within the insect gut and mouthparts, and the macrophage within 
the mammalian host. The parasite must also evade the mammalian immune response, 
while exploiting its opsonic properties. The architecture of the parasite’s surface coat is 
particularly important in maintaining the organism’s survival. GPI-anchored proteins 
and glycoconjugates cover the cell surface of trypanosomatids, and these are thought to 
play a key role in parasite survival. The major cell surface GPI glycoconjugates of 
Leishmania fall into three distinct classes; glycosylphosphatidylinositol (GPI) anchored 
proteins, lipophosphoglycans (LPG), and glycoinositolphospholipids (GIPLs) (Figure 
1.2).
1.2.1 GPI-anchored proteins
Outer surface proteins are attached to the membrane either by transmembrane domains, 
or modification with a glycosylphosphatidylinositol (GPI) anchor, whereby proteins are 
anchored to the membrane via covalent linkage to phosphatidylinositol (PI). The 
structure of the GPI anchor was first described for the variant surface glycoprotein 
(VSG), of T. brucei (Ferguson et al., 1985; Ferguson et al., 1988). Since then over 200 
examples of GPI-anchored proteins have been identified in eukaryotes, and analyses of 
the known GPI anchor structures demonstrate that they each have a conserved core 
structure, which is further modified in a protein and speeies specific manner (Ferguson, 
1999). The conserved GPI core structure is comprised of the protein linked at the C- 
terminal end via ethanolamine phosphate (EtN-P) to the glycan backbone; M anal-
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2Manal-6Manai-4GlcNH2. The glycan backbone is linked to the inositol ring of 
phosphatidylinositol (PI) (Figure 1.2) (McConville and Ferguson, 1993). Variations 
from this core include: i) The substitution of the tetrasaccharide backbone with 
elaborate side chains, an example being the Variable Surface Glycoprotein (VSG) of T. 
brucei, which has highly variable and complex additions, ii) Addition of the fatty acid 
palmitate to the inositol ring, this is particularly true of mammalian GPI anchors, iii) 
Lipid moieties aic highly variable, and yeast anchors commonly contain ceramide. iv) 
Higher eukaryotes have additional EtN-P residues on the mannose backbone (Reviewed 
(McConville and Ferguson, 1993).
In Leishmania the major GPI-anchored proteins include GP63 (also known as major 
surface protease (MSP) or leishmanolysin) (Bouvier et a l, 1985), and GP46, also 
referred to as promastigote surface antigen 2 (PSA2) (Murray et al., 1989). The 
structure of the GPI anchor of GP63 is the same as the generalised core structure 
described above, and is not modified further (Schneider et a l, 1990). GP63 is described 
in more detail in section 1.3.
GP46 is abundant on the cell surface of all species of Leishmania promastigotes, with 
the exception of L. braziliensis (McMahon-Pratt et al., 1992). GP46 is encoded by a 
polymorphic multigene family (Symons et a l, 1994). Its function is unknown but has 
been shown to contain leucine rich 24 amino acid repeats (Lohman et a l, 1990). GP46 
is down-regulated in amastigotes, as assessed by mRNA levels (Handman et a l, 1995), 
Similarly the protein level of GP63 is also greatly decreased in amastigotes (Bahr et a l, 
1993). In L. chagasi the mRNA levels of both GP46 and GP63 show a 30 fold increase 
as the promastigotes enter the infective stationary phase (Myung et a l, 2002).
1.2.2 Proteophosphoglycans (PPG).
Proteophosphoglycans (PPGs) are a group of proteins which are modified by
phosphoglycans. The proteins consist of a polypeptide backbone consisting of serine/
alanine/ proline repeat domains, the serine residues are extensively modified by
complex, and highly variable phosphoglycan side chains, which can extend to up to 30
sugar residues in length (IIg, 2000b). The PPG molecules include secreted acid
phosphatase, a non-filamentous proteophosphoglycan, and a filamentous
proteophosphogl yean. A GPI-anchored form of PPG has also been identified, which is
5
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present on the cell surface of both L. major promastigotes and amastigotes (IIg et ah, 
1999). The precise function of PPGs is not known, but they are thought to be involved 
in macrophage interaction and invasion, and the formation of parasitophorous vacuoles 
(Piani et al., 1999; Both et al., 2002). Study of a L. mexicana mutant cell line, Alpg2, 
showed that these cells lacked both PPG and LPG from the cell surface, but were still 
able to invade macrophage and infect mice (Ilg et al., 2001).
1.2.3 Lipophosphoglycans (LPG)
The surface coat of promastigotes is dominated by LPGs, which are complex 
carbohydrates attached to the cell membrane via a GPI anchor. LPGs are highly 
variable, but the basic structure includes an extended phosphoglycan chain, made up of 
phosphosaccharide repeats and a terminating cap structure, and a GPI anchor. This 
anchor is structurally distinct from the protein-linked GPI anchor, and contains a 
lysoalkyl-PI. The LPG anchor contains the common GPI-protein anchor motif M anal- 
4GlcN-PI, but a second mannose residue is linked via a a l-3  bond instead of the a i-4  
bond present in the GPI protein anchor. The second mannose residue is linked to a 
galactosefuronose residue, which in turn is linked to two galactose residues. The final 
galactose residue is linked to the phosphosaccharide repeat unit. The mannose residues 
are often modified with an additional side chain (McConville and Ferguson, 1993).
LPGs are present on the surface of Leishmania promastigotes at a level of 5x10^ 
molecules per cell (McConville and Blackwell, 1991). LPGs are also present on the 
surface of amastigotes, though at a vastly reduced level, and in a modified foim 
(Moody et al., 1993). During the lifecycle the length of the phosphoglycan chains 
alters, for example, the differentiation of L. major procyclic promastigotes to 
metacyclic promastigotes corresponds with the doubling in length of the phosphoglycan 
chain, resulting in an increase in thickness of the glycocalyx (McConville et al., 1992).
LPGs act as a ligand for the attachment of procyclic promastigotes to the midgut wall 
of the sandfly vector, and may also protect promastigotes from the digestive enzymes 
within the gut (Sacks et al., 1994; Sacks et al., 2000). LPGs are also thought to confer 
resistance to complement mediated lysis, and facilitate uptake of the parasite into 
macrophages via interaction with complement receptors (Puentes et al., 1990).
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Leishmania strains with mutations in the LPG biosynthetic pathway have been used to 
assess the requirements for LPG in Leishmania infections. An L. major LPG minus 
strain showed decreased virulence within the sandfly vector, mammalian macrophage, 
and mouse (Sacks et al., 2000; Spath et a l, 2000). However similar studies with an L. 
mexicana LPG minus strain, demonstrated that the mutants replicated normally in 
macrophage and were able to infect mice (Ilg, 2000a). It is suggested that this disparity 
in the requirement for LPG reflects the divergence between different Leishmania 
species (Turco et al., 2001).
1.2.4 Glycoinositolphospholipids (GIPLs)
The GIPLs are free GPI anchor structures which are abundant in both promastigote and 
amastigote lifecycle stages. The GIPLs have a variety of structures: Type 1 GIPLs have 
the same glycan core structure as the GPI protein anchor. Type 2 GIPLs have the same 
core structure as the LPG anchor. Hybrid-Type share similarities in common with each 
(Figure 1.2, panel B) (McConville and Ferguson, 1993). The GIPLs may also be 
modified with distinct lipid moieties, ethanolamine phosphates, and glyeans 
(McConville et al., 1993; Ralton and McConville, 1998).
The GIPLs are abundant in both promastigote, and amastigote lifecycle stages and are 
present on the cell surface at an estimated 10^  molecules per cell (McConville and 
Blackwell, 1991). As the most dominant molecule on the amastigote cell surface they 
are thought to act as a protective glycocalyx within the parasitophorous vacuole 
(Winter et al., 1994). A L. amazonensis strain expressing Phospholipase C from an 
episome, was demonstrated to have a decreased number of GIPLs present in the 
amastigote form. This strain showed decreased virulence in hamster infections, and in 
in vitro macrophage infections differentiation of promastigotes into amastigotes 
resulted in growth arrest (Mensa-Wilmot et al., 1999). Dolicholphosphate-Man 
synthase (DPMS) is an enzyme required for the formation of Dolicholphosphate-Man 
(Dol-p-Man) which is directly utilised in the biosynthesis of glycoconjugates. A L. 
mexicana Adpms cell line deficient in this enzyme, was unable to express GIPLs, LPGs 
or GPI anchored proteins on the cell surface (Garami et al., 2001). However this cell 
line was still able to infect macrophage and mice, though with reduced virulence.
Chapter 1
Phosphomannose mutase (PMM) is an enzyme required for the activation of mannose, 
and is one of the first enzymes in the mannose activation pathway. An L. mexicana 
Apmm cell line was unable to express any detectable mannose containing GIPLs, LPGs, 
GPI-anchored proteins, or PPG on the cell surface. This Apmm cell line was avirulent, 
as it failed to infect macrophages or mice (Garami et a l, 2001). It has therefore been 
suggested that whilst all classes of glycoconjugates are important virulence factors in 
Leishmania, a certain amount of redundancy exists. Cell lines defective in only one or 
two classes of surface expressed glycoconjugates are still infective to mice. It is only 
the loss of all classes of glycoconjugates from the cell surface which results in an 
avirulent phenotype (Garami et al., 2001).
The characterisation of biosynthesis intermediates from GPI anchors, LPGs and GIPLs 
suggests that the LPG and protein anchors appear to shai’e a set of common early 
intermediates. They may share a common early biosynthesis pathway which diverges at 
the point of the addition of the second mannose residue (Ralton and McConville, 1998). 
GIPLs however share no common intermediates and utilise an alternate PI species. 
GIPL biosynthesis also seems to occur at a higher rate than either LPG, or protein 
anchor biosynthesis. The presence of three individual pathways for glycoconjugate 
biosynthesis would allow the independent regulation of expression of the different 
molecules at different lifecycle stages (Ralton and McConville, 1998). The biosynthetic 
pathway of GPI protein anchors is described in section 1.4.
It can be seen that during the different lifecycle stages the Leishmania surface coat 
undergoes a series of changes. The promastigote form is dominated by GIPLS, LPGs, 
and GPI-anchored proteins, whilst the amastigote form sees a down regulation of both 
LPGs and GPI-anchored proteins, but retains the GIPL layer. These surface 
glycoconjugates are considered to be extremely important for parasite virulence.
1.3 GP63
1.3.1 Genetics and stage regulated expression
The major GPI-anchored protein of Leishmania promastigotes is the 63kDa protein, 
GP63 (Bouvier et al., 1985; Russell and Wilhelm, 1986). It is estimated to be 1% of the 
total protein in the cell, and is present at 5x10^ molecules per pai'asite (Medina-Acosta
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et al., 1989; Bahr et al., 1993). GP63 is also present in the amastigote stage of the 
lifecycle (Medina-Acosta et al., 1989; Frommel et al., 1990), though at a reduced level. 
In L. major amastigotes GP63 proteolytic activity has been estimated to represent less 
than 1% of that detected in promastigote cells (Schneider et al., 1992). Labelling of 
total L. mexicana cell lysates suggests that GP63 expression in amastigotes is 10% of 
that found in promastigotes (Medina-Acosta et al., 1989; Bahr et al., 1993). Both 
mRNA and protein levels increase four hours after the onset of differentiation of 
amastigotes into promastigotes, demonstrating stage regulated expression (Schneider et 
a l, 1992).
In all species of Leishmania studied, GP63 is encoded by a series of multi-copy, 
tandemly repeated genes (Button et a l, 1989; Webb et a l, 1991; Medina-Acosta et a l,
1993). The genomic organisation of the seven genes encoding GP63 in L. major has 
been well characterised (Button et a l, 1989; Joshi et a l, 1998; Voth et a l, 1998). Five 
homologous 1.8 kb genes (genes 1-5) are present in a tandem array, each separated by a
1.3 kb intergenic region. Gene 6 is 8 kb downstream from gene 5, and is less highly 
conserved. Gene 7 is 1.7 kb downstream from gene 6 (Voth et a l, 1998; Joshi et al, 
1998). The genes are regulated stage specifically. Genes 1-5 are expressed exclusively 
in promastigote stage parasites, gene 6 is expressed throughout the life cycle, and gene 
7 is expressed only in stationary-phase promastigotes, and amastigotes (Joshi et a l, 
1998; Voth et a l, 1998). Genes 1-5 are highly conserved (Button et a l, 1989), and 
encode for proteins which are GPI-anchored (Schneider et a l, 1990). The predicted 
protein for L. major Gene 6 is less well conserved in its C-terminal GPI signal 
attachment site than the GPI-anchored proteins encoded by genes 1-5 (Voth et al, 
1998). It was speculated that this protein may have a transmembrane domain and not be 
GPI-anchored. Expression of gene 6 in L. donovani, radio-labelling with myristic acid, 
and immune-precipitation with a L. major specific GP63 antibody demonstrated that 
the protein was GPI-anchored (Voth et a l, 1998). Sequence analysis suggests that gene 
7 is identical to gene 1, which encodes a GPI-anchored protein (Voth et a l, 1998).
The genomic organisation of GP63 in L. mexicana has been shown to be more complex 
(Medina-Acosta et a l, 1993). GP63 is encoded by an estimated 11 genes, at a single 
chromosomal locus. These are grouped into three sub-classes based on restriction site
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polymorphism (Cl, C2, and C3). Four GP63 C2 genes are upstream from a cluster of 
five Cl genes. A single C3 gene is 3’ to the Cl cluster. Northern blotting with class- 
specific probes demonstrated that the Cl subclass is expressed in amastigotes, and at a 
lower level in promastigotes. C2 and C3 are expressed at high levels in promastigotes 
only (Medina-Acosta et ah, 1993). The predicted protein sequence for a clone from the 
Cl subclass showed considerable variation from L. major GP63 encoded by gene 1. 
The L. mexicana sequence has nine potential N-glycosylation sites, compared to three 
sites predicted in L. major GP63. The C-temiinus of the L. mexicana Cl GP63 is 
extended and does not appear to contain sequence compatible with GPI anchor 
addition. Therefore this L. mexicana amastigote form of GP63 is predicted to be non 
GPI-anchored (Medina-Acosta et a l, 1993). Microscopy and labelling studies on L. 
mexicana suggest that only a small sub-population of the detectable amastigote GP63 is 
GPI-anchored, the remainder is found intracellular!y (Medina-Acosta et a l, 1989; Bahr 
et a l, 1993). Cleavage of GPI anchors from proteins with phosphatidylinositol-specific 
phospholipase C (PIPLC) produces a carbohydrate epitope on the C-terminus of the 
protein, which is recognisable by the cross-reacting determinant (CRD) antibody. The 
antibody can therefore be used for determining if soluble proteins have previously been 
GPI-anchored. Soluble L. mexicana promastigote GP63 is recognised by the CRD 
antibody, while soluble amastigote GP63 is not. This provides further evidence that the 
amastigote foim of GP63 in L. mexicana is not GPI-anchored (Ilg et a l, 1993). 
Electron-microscopy localised the intracellular soluble GP63 to lysosomes (Bahr et a l,
1993).
In L. chagasi, GP63 (termed msp for major surface protease) is encoded by more than 
18 genes located in a 80kb cluster (Roberts et a l, 1993). These are divided into three 
classes and named according to the lifecycle stage in which they are expressed: 
logarithmic (mspL), stationary (mspS) and constitutive (mspC) (Roberts et a l, 1993). 
They are categorised by unique sequences present in the 3’ untranslated regions (UTR) 
(Ramamoorthy et a l, 1992). The genes are organised such that four tandem stationary 
phase genes (mspS2, mspSl, mspS3, and mspS5) are followed by 12 or more 
logarithmic genes, one constitutive!y expressed gene, and a stationary phase gene 
(mspS4) (Roberts et al., 1993).
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Regulation of the stage-specific expression of GP63 is thought to be post- 
transcriptional (Ramamoorthy et al,, 1995). In L. major the coding and intergenic 
regions of genes 1-7 are conserved, but the 3’UTR are divergent (Voth et al., 1998). 
Expression of the marker gene Thymidine Kinase (TK) from a plasmid, could be 
regulated to specific stages of the L. mexicana lifecycle by cloning in different L. major 
GP63 intergenic regions 3’ to the gene. The 3’ UTR from L. major GP63 gene 3 
resulted in TK RNA and protein expression in promastigote cells only. The 3’UTR 
from L. major GP63 gene 6 resulted in TK RNA and protein expression in both 
lifecycle stages. This suggests that stage-specific expression of GP63 is regulated by 
the 3’UTR (Kelly et a l, 2001).
Mechanisms for controlling the stage-regulated expression of GP63 have been 
examined in detail in L. chagasi. Genes from all classes of GP63 are constitutively 
transcribed in L. chagasi, suggesting that the stage-regulated expression of the proteins 
is controlled post-transcriptionally (Ramamoorthy et a l, 1995). A construct was 
produced in which the entire 3’UTR of an mspS gene, including the intergenic region 
(IR) and the region 5’ of the downstream gene, was placed downstream of the reporter 
gene. The reporter protein was expressed in a growth-specific manner similar to that of 
the mspS class of GP63 (Ramamoorthy et a l, 1995). This demonstrated that regulatory 
sequences were present in this region. Sequence analysis identified an ORF within this 
region, termed mag (msp associated gene), and it was demonstrated that elements were 
required from each of the 3’UTR, IR, and mag to regulate GP63 expression (McCoy et 
a l, 1998). Comparison of sequences of the 3’UTR from the genes encoding GP63 
(class mspS), and a second stage regulated protein PSA (GP46) identified common 
segments (Myung et a l, 2002). The systematic deletion of these segments within the 
mspS 3’UTR, and the effects of these deletions on the expression of a reporter protein, 
was used to identify regulatory elements within this region. However, the complex 
nature of the regulation suggested that a more detailed analysis of the 3’UTR was 
required (Myung et a l, 2002).
In general, the multiple genes encoding GPI-anchored forms of GP63 aie highly 
conserved both within and between species, and the protein has several domains 
characteristic of a GPI-anchored metalloproteinase (Button and McMaster, 1988). The
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domain structure of GPI-anchored GP63 can be summarised: an ER-signal direction 
sequence is present at the amino terminal end, and is adjacent to a regulatory pro­
region, a GPI anchor addition site and a hydrophobic tail are present at the COOH- 
terminal end. These three domains are cleaved off at different times during the 
trafficking and processing of the protein (Button and McMaster, 1988; McMaster et al.,
1994).
1,3.2 Metalloproteinase activity.
L. major GP63 has been characterised as a zinc metalloproteinase, associating with one 
atom of zinc per molecule of GP63 (Bouvier et al., 1989). It is active in a neutral to 
alkaline pH range (pH 7-10), and is site specific in its proteolytic activity, cleaving on 
the amino side of serine and threonine. It shows significant inhibition with the chelator 
I-10 phenanthroline (Ip et al., 1990). The amastigote L. mexicana GP63 has a pH 
optimum which has been shifted to the acidic range (pH 5.5-6) (Ilg et a l, 1993), which 
is consistent with a lysosomal location. The protein sequence of L. major GP63 shows 
sequence identity to other zinc metalloproteinases, such as thermolysin, at the proposed 
active site, HEXXH. The histidine residues act as the zinc-binding domain, and the 
glutamic acid is the catalytic active site residue (Bouvier et a l, 1989; McMaster et al,
1994). Site-directed mutagenesis produced an inactive protein confirming glutamic acid 
as the catalytic active-site residue (McMaster et a l, 1994; Macdonald et a l, 1995; 
McGwire and Chang, 1996). The crystal structure of promastigote L. major GP63 has 
been solved, and the N-terminal domain is similar in structure to that of the catalytic 
modules of other zinc proteases (Schlagenhauf et a l, 1998).
Metalloproteinases are synthesised in an inactive form, and activated by a ‘cysteine 
switch’ mechanism (Springman et a l, 1990). Latency is maintained by obstruction of 
the active site by the protein’s regulatory pro-region. A cysteine residue within the pro­
region binds to the zinc atom in the catalytic active site, disruption of this complex 
results in an active enzyme. A recombinant form of GP63 (reGP63) lacking its GPI 
signal was expressed and secreted using a baculovirus expression system (Button et a l, 
1993). This recombinant protein was latent, and was of the predicted size of the mature 
protein and pro-region. It was activated by treatment with HgCL (Button et a l, 1993). 
HgClz activates latent metalloproteinases by disrupting the cysteine-zinc complex
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(Springman et aL, 1990; Grant et al., 1992). A non-GPI-anchored form of GP63 was 
expressed and secreted from Cos-7 cells, and this protein was also shown to be inactive 
(McMaster et aL, 1994; Macdonald et ah, 1995). Activation of this protein 
corresponded with a decrease in protein size, sequencing of the different-sized protein 
intermediates showed this size decrease was a result of the partial loss of the pro­
region. The activation of the protein coiTesponded to the loss of Cys48 from the pro­
region, and pro-region removal is therefore involved in GP63 activation, which is 
similar to the situation found in higher eukaryotes (Macdonald et aL, 1995). Incubation 
of latent reGP63 with previously activated enzyme did not activate the latent reGP63, 
suggesting the activation mechanism was not autocatalytic (Macdonald et a l, 1995). 
The Cos-7 transient expression system was also used to produce two recombinant 
forms of GP63, which were membrane-associated. GPI-GP63 retained the protein’s 
GPI-anchor attachment signal whilst a second GP63 was engineered to contain a trans­
membrane domain (Macdonald et at., 1995). Both membrane-associated proteins were 
active on the surface of Cos-7 cells, compared to the secreted form of GP63 that was 
inactive. Activation was not thought to be directly linked with the GPI-anchor addition 
pathway, but was speculated to be mediated by enzymes localised in a membrane 
trafficking pathway (Macdonald et a l, 1995).
Activation of secreted and GPI-anchored foims of GP63 was also examined directly in 
Leishmania (McGwire and Chang, 1996). A strain of L. amazonensis, described as 
GP63 deficient, was obtained by continuous growth of promastigotes in vitro for 3 
years (Kink and Chang, 1988). The strain was found to have decreased virulence, a 
decrease in glycosyltransferase activity, and had three fold less GP63 expression and 
activity when compared to virulent cells. This ‘GP63-deficient’ strain was transfected 
with a plasmid construct containing a L. major GP63 mutated at the anchor addition 
site. The mutated GP63 was shown to exit from the cell into the medium as two sized 
forms, 65kDa, and 63kDa. Cell lysates from cells expressing the mutated form of 
GP63, or the L. major WT GPI-anchored form, were treated with PI-PLC, and western 
blotted with the CRD antibody. The CRD antibody detected the L. major WT protein 
but no CRD epitope was detected in the proteins mutated at the anchor addition site. 
This demonstrated that the mutated GP63 protein did not receive a GPI anchor 
(McGwire and Chang, 1996). GP63 is a protease, and in its active form digests gelatin.
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Assessment of gelatinolytic activity can be used to assess GP63 activation. The 
secreted forms of GP63 had gelatinolytic activity, suggesting these proteins were active 
(McGwire and Chang, 1996). This result contrasts with the results found using the 
Baculovirus and Cos-7 expression systems (Button et al., 1993; McMaster et al., 1994; 
Macdonald et al., 1995), It was suggested that GPI-anchoring does not affect the 
activation and catalytic activity of GP63 (McGwire and Chang, 1996).
1.3.3 Glycosylation
N-linked glycans are complex structures, in which the basic core structure is 
synthesised by a glycan biosynthetic pathway. The core is added to the protein by the 
oligo-saccharide transferase (OST) during translocation of the protein into the ER 
(Johnson and van Waes, 1999). Further modifications and additions to the glycan occur 
as the glycosylated protein moves through the ER and Golgi apparatus, a process which 
has been well studied in higher eukaryotes (Dwek, 1996). Tunicamycin is an inhibitor 
of UDP-GlcN Ac : dolichol phosphate GlcNac-l-P transferase (GPT), the first enzyme in 
the glycan biosynthetic pathway, and therefore is an inhibitor of N-linked glycan 
formation.
L. major GP63 has three potential N-linked glycosylation sites as identified from 
sequence analysis (Button et al., 1989), each of which has been demonstrated by 
mutagenesis studies to be N-glycosylated (McGwire and Chang, 1996). Four major 
different oligosaccharide structures were identified from L. mexicana amazonensis 
GP63, and these were all of the biantennary oligomannose form (Olafson et al., 1990).
The glycosylation of GP63 was further examined by using recombinant forms of L.
major GP63 expressed in Chinese hamster ovary (CHO) cells (Morrison et al., 2000).
GP63 was either expressed as a GPI-anchored form, or modified for secretion, by
truncation of the C-terminus. The glycan structures of both forms of protein were
similar, complex biantennary types. However, differences were observed in the profiles
of the glycans on the GPI-anchored GP63, compared with the secreted form, and these
were shown to be due to differences in glycan modification. Pulse-chase labelling
suggested that the dynamics of the secretion and membrane pathways were similar,
both proteins were detected extracellularly after 60 minutes, and both proteins became
resistant to EndoH treatment after 40 and 60 minutes. EndoH sensitivity is a marker for
14
Chapter 1
proteins passing through the Golgi. Processing of glycans in the medial compartment of 
the Golgi confers EndoH resistance, whilst unprocessed glycans remain sensitive. 
Alteration of recombinant GP63 for secretion in mammalian cells affects its glycan 
modifications. Differences in modifications to the N-linked glycans were considered to 
be most likely due to changes in protein conformation, and therefore the proteins 
accessibility to glycosyl-transferases (Monison et a l, 2000).
Growth of wild type L. major, and L. mexicana promastigotes in medium containing 
tunicamycin resulted in the production of a smaller-sized GP63 protein (Funk et a l,
1994). This non-glycosylated protein was demonstrated by biotinylation and PI-PLC 
treatment to be present on the cell surface, it was also shown to be active. N-linked 
glycans were therefore concluded not to be essential for either targeting of GP63 to the 
cell surface, or its activity. Mutational studies altering each of the three N-glycosylation 
sites, either individually or as a group, also suggested that loss of N-glycosylation did 
not prevent either surface expression of GP63 or its activity (McGwire and Chang, 
1996). Tunicamycin treatment has also been examined in relation to the secreted 
protein acid phosphatase in L. donovani promastigotes. While the inhibitor affected the 
size of the protein it did not affect its secretion from the cell (Bates and Dwyer, 1987). 
However, the activity of the acid phosphatase was reduced (Lovelace and Gottlieb, 
1987).
1,3.4 Function.
GP63 is classified as a protein with neutral metalloproteinase activity for a range of 
substrates. It is suggested that GP63, expressed abundantly in promastigotes, provides 
protection from hydrolytic enzymes in the insect gut. (Alexander et a l, 1999). In 
metacyclic promastigotes GP63 expression is upregulated and is thought to contribute 
to the survival of the parasite in the vertebrate bloodstream by possible inhibition of 
complement mediated lysis, and increasing opsonisation (Brittingham and Mosser, 
1996). It has also been shown that expression of GP63 on the surface of mammalian 
cells converts those cells into efficient activators of complement, and the complement 
is opsonic and enhances binding to the complement receptor CRl of the macrophage 
complement receptor system (Brittingham et a l, 1995).
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Deletion of six of the seven L. major GP63 genes (genes 1-6) resulted in a mutant cell 
line with increased sensitivity to complement mediated lysis (Joshi et a l, 1998). A later 
study examined a strain where all seven L. major GP63 genes had been deleted, and 
compared this with WT L. major, and a deletion strain re-expressing GP63 gene-1 from 
a plasmid (Joshi et a l, 2002). Within the sandfly vector there was no phenotypic 
differences between the three strains. The GP63 deletion mutant was more sensitive to 
complement mediated lysis than WT cells, and whilst still able to infect mice, lesion 
development was significantly delayed in comparison to WT cells. Once the disease 
had been established the rate of lesion progression for WT and GP63 mutant strains 
was similar. The GP63 Gene-1 re-expressing cell line had an intermediate phenotype, 
infectivity and complement insensitivity were not completely restored to WT levels, 
possibly due to inappropriate gene regulation from the plasmid (Joshi et a l, 2002). In a 
different study an L. mexicana mutant cell line, AgpiS, which lacks GPI-anchored GP63 
from the cell surface, was able to infect macrophage and differentiate and replicate at 
levels comparable to WT cells. The cell line was also able to infect mice, although 
wild-type L. mexicana amastigotes produced larger lesions which formed more rapidly 
than those caused by the mutant parasites (Hi!ley et a l, 2000). Therefore, whilst GP63 
plays an important role in pathogenesis, it does not appear to be essential (Hi 1 ley et a l, 
2000; Joshi et a l, 2002).
1.4 GPI biosynthetic pathway
GPI protein anchors are synthesised within the endoplasmic reticulum by a series of 
additions of sugars and other molecules to phosphatidylinositol (PI), the final step 
being the linkage of the complete anchor to a protein with a GPI-anchor attachment 
signal sequence. A core region of the GPI anchor is well conserved between higher and 
lower eukaryotes, but this is modified by different side chains in different organisms 
and cell types (McConville and Ferguson, 1993; Ferguson, 1999).
GPI biosynthesis was first characterised using a trypanosome cell free system. 
Introduction of radiolabelled substrates to permeabalised cells or membranes allowed 
the identification of GPI intermediates (Masterson et a l, 1989). Subsequently cell free 
systems were developed for a variety of mammalian cell types (Hirose et a l, 1992) and 
Leishmania (Smith et a l, 1997b). The highly conserved GPI backbone suggested that
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the biosynthesis of GPI anchors was also highly conserved between species (Ferguson, 
1999).
The genes involved in the GPI biosynthetic pathway have been most clearly defined in 
mammalian and yeast cells. The methods used for identifying the genes encoding the 
enzymes involved in the pathway include the generation and characterisation of panels 
of GPI deficient mutant cell lines (Stevens and Raetz, 1991; Sugiyama et aL, 1991), 
complementation with cDNA (Inoue et aL, 1993), and the use of cell-free assay 
systems. A large number of GPI-deficient cell lines have been isolated and while GPI- 
anchored proteins are not essential in mammalian cells in culture, GPI-anchor deficient 
mice were embryonic lethal (Kawagoe et aL, 1996).
The GPI anchor is essential in yeast, possibly due to the requirement for the 
transportation and incorporation of GPI proteins into the cell wall (De Sampaïo et aL, 
1999). Temperature sensitive mutants have been produced in which GPI anchoring is 
abolished when yeast cells are grown at 31°C (Leidich et aL, 1994; Benghezal et aL, 
1995). Screening of mutagenized cells labelled with [^H]inositol at 37°C allowed the 
identification of cell lines which were unable to incorporate [^H]inositol. These cell 
lines were further analysed by incubation of washed membranes with a labelled 
substrate, and tested for the synthesis of GPI anchor intermediates to identify at which 
point in the GPI biosynthetic pathway the cells were defective. The genetic 
complementation of these cell lines allowed the isolation of the genes involved (Leidich 
et a l, 1994). GPI inhibitors, such as YW3548, which blocks the addition of 
ethanolamine phosphate (EtN-P) to the first mannose residue in yeast and mammalian 
cells, have also been used (Siitterlin et a l, 1998).
The genes involved in GPI biosynthesis have been less well characterised in protozoa. 
In T, brucei the production of viable GPI biosynthesis deletion mutants has proved 
difficult, suggesting an essential role for GPI-anchored proteins in T. brucei. However 
in a recent study a T. brucei GPI biosynthesis mutant, with a disruption in the gene 
GPIIO, was produced. Procyclic cells were viable but only when cultured in non­
adherent flasks (Nagamune et a l, 2000). In L. mexicana GPI biosynthesis mutants are 
viable (Hilley et a l, 2000). The GPI biosynthetic pathway is described with respect to
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mammalian and yeast cells, and where known the T. brucei and Leishmania 
homologues are included. Figure 1.3 provides a summary of the mammalian GPI 
biosynthetic pathway, and a list of all homologues identified in mammalian, yeast and 
trypanosomatids is given in Table 1.1.
1.4.1 Step 1; Transfer of N-acetylglucosaminyl to phosphatidylinositol
The first step of the pathway is the transfer of N-acetylglucosaminyl (GIcNAc) from a 
donor, UDP-GlcNAc, to a phosophatidylinositol (PI) to form GlcNAc-PI (Masterson et 
a i, 1989). The enzyme involved in this reaction is GPI-GlcNAc transferase, and in 
mammalian cells this enzyme is a complex of at least 5 proteins, PIG-A, PIG-C, PIG-H, 
GPU and PIG-P (PIG refers to phosphatidylinositol glycan) (Watanabe et aL, 2000).
Assessment of a panel of mammalian cell lines (murine T-cell lymphoma cells), in 
which the GPI-anchored protein Thy-1 was synthesized but not expressed on the cell 
surface, identified 3 complementation classes (A, C and H), which were unable to 
transfer GlcNAc to the PI acceptor (Stevens and Raetz, 1991; Sugiyama et aL, 1991). 
The human PIG-A gene was cloned by complementation of mammalian class A cell 
line (Miyata et al., 1993). The protein has a small lumenal domain thought to be 
required to target the protein to the ER, and a large cytoplasmic domain (Watanabe et 
al., 1996). Mutation of this gene is responsible for the disease paroxysmal nocturnal 
hemoglobinuria, characterised by abnormal blood cell populations due to a deficiency 
in complement regulating GPI-anchored molecules (Takeda et al., 1993).
The yeast homologue of PIG-A, GPI3 was identified in S. cerevisiae by 
complementation of a temperature sensitive mutant, defective in the synthesis of 
GlcNAc-PI (Leidich et al., 1995; Vossen et al., 1995). Both PIG-A and GPI3 have 
homology to bacterial GlcNAc transferases (Kawagoe et al., 1994; Vossen et al., 
1995), and photo-crosslinking experiments demonstrated that GPI3 could be directly 
crosslinked to a UDP-GlcNAc analogue (Kostova et al., 2000). GPI3 and PIG-A are 
thought to be the catalytic components in the yeast and human forms of the GPI- 
GlcNAc transferase.
The gene encoding human PIG-H was cloned by complementation of the H class 
mutant cell line deficient in the ability to synthesize the first intermediate in the GPI
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pathway (Kamitani et ah, 1993). PIG A and PIG-H directly associate with each other as 
demonstrated by co-precipitation experiments, though neither is required to target the 
other to the ER (Watanabe et a l, 1996). The ORF YNL038w of S. cerevisiae was 
identified as encoding the yeast homologue of human PIG-H, and was designated 
GPI15 (Yan et ah, 2001). Disruption of the gene was lethal, however a temperature 
sensitive mutant cell line showed that the formation of GlcNAc-PI in membranes 
from cells depleted of GPU 5 expression was less than in membranes from cells 
expressing GPU5, The foimation of GPI intermediates in whole cells was also shown 
to decrease when GPI 15 expression was depleted. This demonstrated that GPI 15 was a 
component of the yeast GPI-GlcNAc transferase (Yan et ah, 2001).
GPU was identified in S, cerevisiae by the production, isolation and analysis of a 
temperature sensitive mutant cell line (Leidich et a l, 1994), and complementation with 
a S. cerevisiae genomic library (Leidich and Orlean, 1996). Membranes from the 
temperature sensitive cell line grown at 37°C showed decreased ability to convert 
UDP[^'^C]GlcNAc to [^"^C]GlcNAc-PI, showing the defect was at the first step of the 
GPI biosynthetic pathway (Leidich et ah, 1994). Production of a Agpil haploid cell 
line, in which a large portion of the GPU gene was deleted, was still viable at 25°C, 
though it was non-viable at 37°C. At 25°C ^H inositol was still incorporated into GPI- 
anchored proteins. This suggested that GPU was a non-essential protein within the 
GPI-GlcNAc transferase enzyme complex (Leidich and Orlean, 1996).
The mammalian hGPll gene was identified by homology to the yeast GPU (Watanabe 
et ah, 1998; Tiede et ah, 1998). Co-precipitation of a tagged form of GPU with each of 
the proteins PIG-A, PIG-H, and PIG-C demonstrated that in mammalian cells GPU 
directly interacts with each of these proteins. PIG-A, PIG-H, PIG-C and GPU could be 
co-precipitated together, suggesting that the four proteins interact as a complex 
(Watanabe et a l, 1998). GPU was disrupted in a mouse cell line, and in these cells 
PIG-A and PIG-H were easily detected as a complex, but a complex of PIG-A, PIG-H, 
and PIG-C was not detected (Hong et ah, 1999a). GPU is thought to be a membrane 
protein with 4 membrane spanning domains (Leidich and Orlean, 1996; Watanabe et 
ah, 1998). It is thought that GPU stabilises the GlcNAc-transferase enzyme complex 
linking PIG-A and PIG-H with PIG-C (Hong et ah, 1999a).
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The gene encoding the S. cerevisiae GPI2 protein was isolated by complementation of a 
temperature sensitive mutant cell line using a yeast genomic library (Leidich et a l,
1995). The mutant cell line was shown to be defective in the first step of the GPI 
biosynthetic pathway, as membranes from cells grown at 37°C were unable to convert 
UDP[14c]gicNAc to [^"^C]GlcNAc-PL Analysis of the predicted protein sequence 
encoded by GPI2 suggested that it was a membrane protein with at least 2 potential 
membrane spanning domains (Leidich and Orlean, 1996). The gene encoding the 
human PIG-C gene was isolated by complementation of the C class mutant cell line 
(Inoue et a l, 1996). PIG-C is an ER membrane protein with 20% identity to the yeast 
GPI2 protein (Inoue et a l, 1996).
The human GlcNAC transferase complex was isolated by affinity purification from 
cells expressing tagged foims of PIG-A. SDS-PAGE revealed the complex was made 
up of 6 different proteins, one of which was revealed by N-terminal sequencing of the 
protein to be novel (Watanabe et a l, 2000). The cDNA for this protein, tenued PIG-P 
was cloned, and used to complement a cell line deficient in GlcNAc transferase 
activity, such that GPI-anchored proteins were restored to the cell surface. (Watanabe et 
a l, 2000). A tagged form of PIG-P could be used to co-precipitate PIG-A and GPI-1, 
but not PIG-H or PIG-C when co-expressed. These experiments demonstrated that PIG- 
P was an essential component of the GlcNAc Transferase complex, and directly 
associated with PIG-A and GPI-1 (Watanabe et a l, 2000). Analysis of the predicted 
protein sequence of PIG-P suggests that it has 2 membrane domains, however it has no 
homology to other proteins with specific functions. Database analysis suggested that 
homologues of PIG-P also exist in mice, and S. cerevisiae (Watanabe et a l, 2000).
Analysis of the GlcNAc transferase complex from human cell lines also identified the 
protein DPM2, which is a component of the dolichol-phosphate-mannose (Dol-P-Man) 
synthase (Watanabe et a l, 2000). Dol-P-Man synthase is made up of three components 
DPMI, DPM2, and DPM3, however analysis of the GlcNAc transferase complex by 
western blotting or co-precipitation demonstrated that DPM2 but not DPMI or DPM3 
associates with GlcNAc Transferase (Watanabe et a l, 2000). Co-expression of DPM2 
individually with each of the GlcNAc transferase complex members, followed by co­
precipitation showed that DPM2 interacts with the GlcNAc transferase by direct
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association with PIG-A, PIG-C and GPU (Watanabe et a l, 2000). The CHO Lecl5 cell 
line, which was defective in DPM2 (Maeda et a l, 1998), was analysed for GlcNAc 
transferase activity, and compared with the cell line re-expressing DPM2. Microsomes 
from both cell lines had GlcNAc transferase activity, as assessed by the conversion of 
UDP-GlcNAc to GlcNAc-PI and GlcN-PI, however in the mutant cell line re­
expressing DPM2 the efficiency of this conversion was three-fold higher. DPM2 is not 
an essential component of the GlcNAc transferase, however it does appear to enhance 
activity and it was speculated that DPM2 may regulate GlcNAc transferase activity 
(Watanabe et a l, 2000).
1.4.2 Step 2: Deacetylation of GlcNAc-PI
The second step of the pathway is the deacetylation of GlcNAc-PI to form 
glucosaminyl-PI (GlcN-PI) catalysed by GlcNAc-PI deacetylase (Doering et a l, 1989; 
Milne et a l, 1994). Chinese hamster ovary (CHO) cells were mutagenised and a cell 
line was identified which did not express GPI-anchored proteins on the cell surface. 
Membranes from this cell line converted UDP-[6-^H]GlcNAc to GlcNAc-PI, but not 
GlcN-PI demonstrating that the cell line was defective in GlcNAc-PI deacetylation. A 
gene, termed PIG-L, was identified by complemetation of the mutant cell line using a 
rat cDNA library. Analysis of the predicted protein sequence suggests that the protein 
has an amino terminal hydrophobic domain thought to attach the protein to the ER 
membrane (Nakamura et a l, 1997).
A yeast homologue, GPI 12, was identified based on sequence homology to the 
mammalian gene PIG-L (Watanabe et a l, 1999). Expression of the S. cerevisiae GPI 12 
protein in the class L mutant CHO cells was able to restore GPI anchoring to these 
cells, demonstrating that GPU2 is the functional homologue of mammalian PIG-L. 
Attempts to produce an S. cerevisiae Agpil2 cell line were unsuccessful suggesting that 
GPI12 is an essential gene in yeast (Watanabe et a l, 1999).
The T. brucei GlcNAc-PI deacetylase was partially purified and characterised using a
series of substrate analogues (Milne et a l, 1994). T. brucei and L. major GPII2
homologues were cloned through homology to the S. cerevisiae and mammalian
sequences, and each was shown to restore GPI anchoring when expressed in the class L
mutant CHO cells (Chang et a l, 2002). Attempts to produce a T. brucei AgpiI2 mutant
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cell line were unsuccessful suggesting GPI 12 is an essential protein in T. brucei. 
However a TbGPIll conditional mutant was produced in which TbGPIll expression 
was controlled by induction with tetracycline. Membranes from the inducible cell line 
grown without tetracycline for 4 hours converted UDP[^H] GlcNAc to [^H]GlcNAc-PI, 
but showed a considerably lower conversion to the GPI intermediate [^H]GlcN-PI 
compared to WT membranes. This demonstrated that TbGPI12 encoded for a protein 
involved in GlcNAc-PI deacetylation (Chang et al., 2002). Comparison of the human 
and trypanosome enzymes show some differences in substrate specificity, suggesting 
this enzyme is a potential drug target (Sharma et al., 1997; Sharma et al., 1999a).
1.4.3 Step 3: Inositol acylation
The third step in the mammalian pathway is inositol acylation, where a fatty acid is 
added to the inositol residue. This occurs prior to mannose addition in both mammalian 
cells and yeast. Cell lines deficient in the mannose donor mannose-P-dolichol (MPD) 
accumulate GlcN-acyl-PI (Costello and Orlean, 1992; Urakaze et al., 1992). Use of 
synthetic analogues demonstrated that acylation was not obligatory for mannose 
addition to occur, however acylation increased the efficiency of mannosylation 
(Doerrler et al., 1996). The genes encoding the GlcN-PI acyl transferase have not been 
identified. Acylation of the inositol confers PI-specific phospholipase C (PI-PLC) 
resistance to the GPI inteimediate (PI-PLC is an enzyme which cleaves the phosphate 
lipid bond between the lipid component and inositol of GPI anchors).
The GPI biosynthetic pathway of T. brucei varies at this point from the mammalian 
pathway, as there is no requirement for the acylation of GlcN-PI for mannosylation to 
occur (Smith et a l, 1997a). Inositol acylation occurs only after the addition of the first 
mannose to GlcN-PI. All subsequent GPI intermediates exist as both inositol acylated 
and non-acylated forms. It is suggested that the inositol acylation of T. brucei GPI 
intermediates is required for the addition of ethanolamine, whilst inositol déacylation is 
required for fatty acid remodelling (Güther and Ferguson, 1995; Smith et a l, 1997a). A 
GPI inositol deacylase (GPIdeAc) has recently been cloned from T. brucei by 
exploiting the enzymes sensitivity to the inhibitor DFP, and using [^HjDFP to identify 
the enzyme from trypanosome membranes (Güther et a l, 2001). The protein was 
predicted to be an ER lumenal glycoprotein. A GPIdeAc null mutant was produced.
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The cells retained inositol deacylase activity, though at a reduced level, and the cells 
also showed an accumulation of inositol acylated GPI intermediates. This suggested the 
protein identified was an inositol deacylase but that other inositol deacylases were also 
present in the cells (Güther et al., 2001). GPI intennediates from Leishmania are not 
inositol acylated (Smith et a l, 1997a).
1.4.4 Step 4: Mannose addition by mannosyltransferase I (MTI).
The three mannoses in the GPI core are linked to the backbone by different bonds, and 
therefore addition of each of the three mannose residues, contributed by dolichol 
phosphate-mannose (Dol-P-Man), is in three independent steps catalysed by different 
Dol-P-Man-dependent mannosyltransferases GPI-MTÏ, GPI-MTII and GPI-MTIII. 
Addition of the first mannose to the backbone forms Man-GlcN-acyl-PL The substrate 
specificity of this step in the pathway differs between mammalian cells, trypanosomes 
and Leishmania and this is attributed to the varying acylation of the inositol ring (Smith 
e ta l, 1997b).
A mammalian cell line, termed class M, was generated, defective in the addition of the 
first mannose to the GPI backbone, as demonstrated by the accumulation of the GlcN- 
acyl-PI intermediate (Maeda et a l, 2001). Complementation of the cell line with a rat 
cDNA library identified the mammalian PIG-M gene. Tagged foims of PIG-M were 
purified, and Man-GlcN-acyl-PI was generated when GlcN-acyl-PI and Dol-P-Man 
were incubated with the purified protein, indicating PIG-M had GPI-MTI activity. 
Analysis of the predicted protein sequence suggests that PIG-M may have up to 10 
transmembrane domains. PIG-M also had a functionally important DXD motif, 
predicted to be a binding domain, positioned between the first and second 
transmembrane domains. DXD was predicted to be on the opposite side of the ER 
membrane from the N-terminal hydrophillic region. Tagging of the N-terminal of PIG- 
M and subsequent immunofluorescence microscopy demonstrated that the N-teiminus 
was accessible to antibodies after permeabilization of the plasma membrane, and did 
not require the additional peimeabilization of the ER membrane. The N-terminus was 
present on the cytoplasmic side of the ER membrane, and the functional domain of 
PIG-M was predicted to be in the ER lumen (Maeda et a l, 2001). S. cerevisiae, human
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and T. brucei homologues were cloned through homology to the predicted rat PIG-M 
protein sequence (Maeda et a l, 2001).
Tagged forms of PIG-A, PIG-H and PIG-L have been demonstrated by microscopy and 
cell fractionation to localise to the ER (Watanabe et aL, 1996; Nakamura et aL, 1997). 
Microsomes prepared from the PIG-A, PIG-H and PIG-L mammalian mutant cell lines 
complemented with tagged forms of PIG-A, PIG-H, or PIG-L were exposed to 
Proteinase K digestion. An endogenous ER lumen protein, protein-disulfide isomerase 
(PDI) was protected from digestion, whilst PIG-A, PIG-H and PIG-L were not, 
suggesting a location on the cytosolic face of the ER for these proteins (Watanabe et 
al., 1996; Nakamura et al., 1997). GlcNAc-PI and GlcN-PI were susceptible to the PI- 
PLC treatment of intact microsomes prepared from mammalian cells and 
trypanosomes, suggesting these GPI inteitnediates were also present on the cytosolic 
face of the ER (Vidugiriene and Menon, 1993; Vidugiriene and Menon, 1994).
The first and second steps of GPI biosynthesis occur on the cytosolic face of the ER, 
whilst mannosylation of the GPI backbone occurs in the lumen of the ER (Maeda et a l, 
2001). Subsequent steps in the pathway also occur in the ER lumen (Takahashi et al., 
1996; Hong et al., 1999b; Ohishi et al., 2000). The GPI intermediate is flipped from the 
cytosolic to the lumenal face of the ER at an undefined point in the pathway (Nakamura 
et a l, 1997). It is not clear if PIG-M, with its multiple transmembrane domains acts as 
the putative ‘flippase’ (Maeda et a l, 2001).
1.4.5 Step 5; Addition of ethanolamine phosphate to mannose
In mammalian, and yeast cells ethanolamine phosphate (EtN-P) is added to the first and 
second mannose residues of the GPI core. The modification of the mannose backbone 
by the addition of various side chains is one of the ways the conserved backbone of GPI 
anchors varies in different types of eukaryotes. Neither trypanosomes or Leishmania 
GPIs are modified with ethanolamine on the first and second mannose residues.
Yeast and mammalian GPI protein anchors are modified with EtN-P at position two of 
the first mannose. A yeast mcd4 temperature sensitive mutant was shown to be 
defective in GPI anchoring (Gaynor et a l, 1999). MCD4 is homologous to a second 
yeast gene GPI7, responsible for the transfer of EtN-P to the second mannose
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(Benachour et a l, 1999). Radiolabelling experiments on a temperature sensitive gpi7 
mutant cell line demonstrated that these cells accumulated a GPI anchor intermediate, 
termed M4, which lacked an EtN-P on the second mannose residue (Benachour et aL, 
1999)
The mammalian gene PIG-N was cloned by homology to the yeast gene MCD4 (Hong 
et a l, 1999b). A mutant cell line was produced which was demonstrated to be deficient 
in the enzyme responsible for the transfer of EtN-P to the first mannose residue of the 
GPI intermediate, as a synthetic substrate analogue, GlcN-PI(C8), could be converted 
to ManGlcN-acylPI(C8) but no further. This demonstrated that PIG-N is responsible for 
the modification of Manl with EtN-P. The PIG-N knock out cell line was still able to 
synthesise GPI intermediates with three mannose residue, and with EtN-P additions to 
mannose 2 and 3. PIG-N is specific for the addition of EtN-P to mannose 1 only, but 
this modification is not essential for the biosynthesis of the GPI anchor, though there is 
a reduction in the level of GPI-anchored protein (Hong et a l, 1999b). Sequence 
analysis suggests a GP17 homologue is also present in humans (Benachour et a l, 
1999).
1.4.6 Step 6: Transfer of mannose 2 and 3
Two further Mannose residues are transfeiTed to the GPI core structure, the mannose 
transferase (GPI-MTII) responsible for the addition of the second mannose has not been 
identified. PIG-B, which is associated with the addition of the third mannose has been 
identified in mammalian cells (Takahashi et a l, 1996). The Human PIG-B gene was 
cloned by complementation of a mutant cell line which accumulated a GPI precursor 
(M2) containing only 2 of the 3 mannose residues. The protein was shown to be an ER 
transmembrane protein with a small cytoplasmic domain, which was not required for 
activity, and a large lumenal domain (Takahashi et a l, 1996). GPIIO was identified in 
S. cerevisiae by homology to PIG-B (Siitterlin et a l, 1998). The gene was essential, 
however a conditional mutant was produced in which GPIIO was expressed under the 
control of the GALl/10 promoter. When GPIIO expression was prevented, inositol was 
no longer incorporated into proteins and the GPI intermediate Man2-GlcN(acyl)PI 
accumulated. GPIIO could be replaced by PIG-B demonstrating that PIG-B is the 
functional homologue of GPIIO (Siitterlin et a l, 1998).
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GPIIO from T. brucei was cloned by homology to PIG-B, and was able to restore GPI 
anchoring in the mammalian PIG-B defective cell line, and rescue yeast gpilO mutants 
(Nagamune et a l, 2000). Production of a AgpilO cell line in bloodstream form 
trypanosomes was not possible suggesting that GPIIO is essential in these cells. In 
procyclic cells double knockouts were produced when the cells were grown in non­
adherent flasks. It was speculated that loss of the GPI protein procyclin resulted in the 
cells having an abnormally adhérant surface. Labelling of the Agpil0 cell membranes 
with GDP-[^H]mannose demonstrated that the cell line was not able to synthesise the 
complete GPI anchor precursor (PPl), and accumulated precursors containing only 2 
mannose residues (M2). [^H]EP procyclin could not be detected in cells labelled with 
[^H]myrstic acid, which is incorporated into GPI anchors, and EP procyclin could not 
be detected on the surface of the AgpilO cells. This demonstrated that GPI biosynthesis 
was disrupted in this cell line at the point of the addition of the third mannose to the 
GPI intermediate (Nagamune et a l, 2000).
1.4.7 Step 7: Transfer of EtN-P to the final mannose
The next step in the GPI biosynthetic pathway is the addition of EtN-P to the third 
mannose residue to produce a fully formed GPI anchor. The mutant murine thymoma 
cell line of complementation class F, accumulated the GPI anchor intermediate M3, 
which is an immediate precursor of the mature anchor. Complementation of the class F 
mutant cell line identified the human gene PIG-F (Inoue et a l, 1993). A second gene 
PIG-O involved in the transfer of EtN-P to the third mannose residue was identified by 
homology to the yeast EtN-P transferases GPI7, MCD4 and YLL031c (GPU 3) (Hong 
et a l, 2000). Tagged fonns of PIG-O and PIG-F could be co-precipitated 
demonstrating that they directly associate. A PIG-O deletion cell line was produced, in 
which the surface expression of a GPI-anchored protein was drastically decreased but 
not eliminated. Labelling experiments also demonstrated that while the PIG-F and PIG- 
O deletion cell lines both accumulated a major GPI anchor intermediate predicted to 
contain three mannose residues, each cell line also accumulated a different set of minor 
intermediates (Hong et a l, 2000). The predicted protein sequence of PIG-F was 
hydrophobic and it is thought to be a membrane protein (Inoue et a l, 1993). It was 
suggested that PIG-F, is not a catalytic component of the enzyme, but interacts with 
PIG-O and a third component to form the active enzyme. PIG-F and the third
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component still retain some EtN-P transferase activity in the PIG-O deletion cell line 
(Hong et al., 2000).
Sequence analysis suggested that yeast has a homologue of PIG-F, (Hong et aL, 2000). 
The S. cerevisiae gene YLLOSlc was identified by homology to MCD4 and GPU as a 
potential EtN-P transferase. Production of deletion mutant was not possible suggesting 
the gene was essential, however a conditional mutant was produced in which YLLOSlc 
was expressed under the control of an inducible promoter (Flury et al., 2000). A tagged 
version of the protein was shown to have an ER location, and the high level of N- 
glycosylation was interpreted as suggesting the protein had a large luminal domain, 
despite the apparent degradation of the tagged protein when microsomes were exposed 
to Proteinase-K. YLLOSlc depleted cells also showed a decrease in the maturation of 
the GPI-anchored protein Gas Ip, a phenotype associated with loss of GPI anchor 
addition to the protein (Doering and Schekman, 1996). Microsomes from the YLLOSlc 
depleted cells cell line made less of the complete GPI anchor precursor compared to 
WT microsomes, and instead accumulated a lipid teiTned 031b which was characterised 
as containing four mannose residues, but lacked EtN-P on Man3. This suggested that 
the cells were unable to attach EtN-P to the third mannose, and were therefore unable to 
attach the anchor precursor to the protein (Flury et al., 2000).
1.4.8 Step 8: Addition of the complete anchor to an awaiting protein.
GPI anchor addition mechanism
The final step of the GPI anchor biosynthetic pathway is the removal of the 
hydrophobic CO OH terminal of a protein and replacement with a GPI anchor. The 
mechanism for this addition has been the subject of much study. The rapidity of this 
GPI-anchor addition mechanism following translation of a protein destined to be GPI- 
anchored was first demonstrated in two separate studies in T. brucei (Bangs et al., 
1985; Ferguson et al., 1986). Following the pulse-labelling of cells with methionine 
for 2 minutes, VSG could be immune-precipitated with both a VSG or CRD antibody, 
which detects the carbohydrate epitope which remains on a protein subsequent to 
cleavage of the GPI anchor. This suggested that a GPI anchor had been transfeiTed to 
the protein. ^H-myristate was also shown to be rapidly incorporated into VSG during 
pulse-chase labelling experiments, and it was concluded from these data that the GPI
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anchor was added to an awaiting protein within 2 minutes of the proteins translation 
(Bangs et aL, 1985; Ferguson et aL, 1986). The rapidity of this modification indicated 
that the added anchor was pre-formed and added in its entirety to the awaiting protein 
(Bangs et aL, 1985). Addition of exogenous GPIs to a cell free system in T. brucei, 
confirmed that pre-formed GPI anchors were added to endogenous protein acceptors. 
This occurred even when membranes were incubated with protein synthesis inhibitors, 
indicating that ongoing protein synthesis was not required for GPI anchor attachment 
(Mayor et aL, 1991), Anchor addition did not occur outwith a very nan'ow detergent 
concentration, suggesting that anchor addition required proper membrane integrity, and 
that the transamidase enzyme was membrane associated (Mayor et aL, 1991).
The mechanism by which a pre-foimed GPI anchor is linked to an awaiting protein was 
determined by a range of studies, many of which utilized cell free systems (Mayor et 
aL, 1991; Kodukula et aL, 1991; Sharma et aL, 1999b). These cell-free systems utilised 
washed membranes with endogenous GPI anchors, anchor accepting proteins, and 
transamidase activity. Alternatively the systems allowed the addition of the different 
components of the anchor addition reaction, such as m vitro translated anchor addition 
proteins modified to act as reporter proteins for different steps of the reaction. These 
systems allowed close regulation of the GPI-anchor addition reaction, and also 
eliminated the requirement to purify the enzyme involved in the reaction, which at that 
time had not been identified.
The precise mechanism for GPI anchor addition was thought to proceed by either of 
two methods, a transamidation reaction, or a 2-step reaction involving protein cleavage 
and anchor additon (Ferguson and Williams, 1988). The transamidation mechanism 
involves the cleavage of the carboxy-terminal extension of the protein and formation of 
an amide bond with the ethanolamine of the GPI in a single reaction. Alternatively 
cleavage of the protein by a signal peptidase may occur, followed by addition of the 
anchor by a transferase. A T. brucei cell free system was used to demonstrate that the 
anchor addition reaction did not require an exogenous energy source (Mayor et aL, 
1991). In the absence of ATP and GTP the GPI anchor was still transferred to VSG. 
The lack of an energy requirement for the transfer reaction was consistent with a 
transamidation mechanism (Mayor et aL, 1991).
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A cell free system utilizing the rough microsomal membranes (RM) of mammalian 
cells was developed (Bailey et aL, 1989), and was able to process an in vitro translated 
reporter protein specially modified to allow examination of the GPI anchor addition 
mechanism (Kodukula et aL, 1991). The reporter protein was adapted from the 
mammalian GPI-anchored protein placental alkaline phosphatase (PLAP), and 
contained the ER signal peptide, and the COOH terminal GPI addition sequence. The 
protein, miniPLAP, was 60% smaller than PLAP and glycosylation sites were absent. 
The sequential processing of four isofoi*ms of the protein could be monitored by size, or 
by antibodies raised against epitopes from the NHa terminal end, COOH terminal end, 
or site of GPI anchor addition. PreprominiPLAP was the unprocessed non-GPI- 
anchored form, promini PLAP lacked the ER signal, and was not GPI-anchored. GPI- 
miniPLAP was the GPI-anchored form, and free miniPLAP was the processed form 
lacking the ER signal, COOH hydrophobic domain and GPI anchor. PreprominiPLAP 
was transcribed in vitro, and translated using rabbit reticulocyte lysate. RMs were then 
added to this lysate.
Use of the miniPLAP system demonstated that there was a requirement for ATP during 
maturation of the GPI-anchored protein (Amthauer et aL, 1992), this was contradictory 
to previous findings (Mayor et aL, 1991). Subsequent investigation indicated that ATP 
hydrolysis was required to dissociate the pro form of the protein from the molecular 
chaperone, BiP, prior to transamidation (Amthauer et aL, 1993). It was proposed that 
BiP facilitates proper folding of the protein, or stabilises the proprotein until 
recognition by the transamidase occurs (Amthauer et aL, 1993). ER derived 
microsomes depleted of soluble lumenal components, such as BiP, were unable to 
process preprominiPLAP to miniPLAP, however when the lumenal content was 
removed after translocation of the prominiPLAP processing did occur (Vidugiriene and 
Menon, 1995). An energy dependent chaperone-mediated maturation step occurs prior 
to the energy independent transamidation reaction (Amthauer et aL, 1993; Vidugiriene 
and Menon, 1995).
Growth of cells mammalian cells in Brefeldin A, which disrupts the trans-Golgi 
network, failed to prevent GPI-anchor addition (Amthauer et aL, 1993), whilst a yeast 
mutant with a block in the secretory pathway between the ER and Golgi still added GPI
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anchors to awaiting proteins (Conzelmann et al,, 1988). These results, together with the 
use of ER derived micosomes to reconstitute transamidase activity (Vidugiriene and 
Menon, 1995), indicated an ER membrane associated location for the GPI: protein 
transamidase (GPIT) (Conzelmann et aL, 1988; Amthauer et aL, 1993; Vidugiriene and 
Menon, 1995).
Use of the miniPLAP system demonstrated that in a cell free environment both GPI 
linked miniPLAP, and cell free mini PLAP could be synthesized (Maxwell et aL, 
1995a). The production of free miniPLAP, lacking both a GPI anchor, and the COOH 
terminal sequence, was incompatible with a transamidation reaction. However in a 
previous study utilizing microsomes derived from a cell line which was unable to 
produce GPI anchors, no free miniPLAP was seen, leading to the conclusion that GPI 
anchors were required for the cleavage of the proteins GPI signal in vivo (Kodukula et 
aL, 1992). This was consistent with transamidation. From both sets of data it was 
concluded that a transamidation reaction does occur, with a complex forming between 
the GPI anchor, transamidase and prominiPLAP. This complex leads to the formation 
of a highly reactive carbonyl group on the protein which is susceptible to nucleophillic 
attack. This nucleophile is usually the ethanolamine group on the GPI anchor, resulting 
in a GPI-anchored protein. However in the cell free system another abundant 
nucleophile, such as water, could interact with the protein-transamidase intermediate in 
a competing reaction, resulting in the foimation of free miniPLAP (Maxwell et aL, 
1995a). This model suggested that the introduction of stronger nucleophiles could 
replace GPIs within the cell free system (Maxwell et aL, 1995a). This hypothesis was 
proved with the demonstration that enzyme catalysed cleavage of the GPI signal 
peptide occuiTed in the presence of hydrazine and hydroxylamine, even in the absence 
of an energy source and in GPI-deficient cells (Maxwell et aL, 1995b; Ramalingam et 
aL, 1996). The products foimed were presumed to be miniPLAP-hydrazide and 
miniPLAP-hydroxamate, however due to the low abundance of these products they 
were not characterized. This set of experiments provided convincing evidence that the 
enzyme involved in GPI anchor addition was a transamidase.
A cell free assay using washed membranes from T. brucei procyclic cells expressing 
VSG was used to further clarify the transamidation mechanism (Sharma et aL, 1999b).
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Hydrazine was used to release membrane associated GPI-VSG, but not transmembrane 
VSG. This release occuiTed in the absence of GPI biosynthesis and in an early 
compartment of the secretory pathway. Pro-VSG was therefore the substrate for the 
hydrazine mediated release. A biotin-linked hydrazine demonstrated directly that 
biotin-hydrazine was incorporated into VSG, and this incorporation was at the C~ 
terminal, as indicated by the lack of susceptibility of VSG-hydrazide to 
carboxypeptidases. Previous studies had not been able to show directly that hydrazine 
was incorporated at the C-terminus of pro-proteins (Maxwell et aL, 1995b). Hydrazine 
replaced the GPI moiety in the transamidation reaction. Sulfhydryl alkylating reagents 
were shown to inhibit the transamidation reaction, suggesting that the transamidase 
contains a catalytically important cysteine residue (Sharma et aL, 1999b).
A GPI: protein transamidase (GPIT) reaction mechanism was proposed (Figure 1.4 A). 
The carbonyl group at the site of GPI anchor attachment on the awaiting GPI-anchored 
protein, is activated by a sulfhydryl group in the transamidase. An enzyme-substrate 
complex foims, and the C-terminal signal sequence is cleaved from the protein. The 
complex undergoes nucleophilic attack by the free amine on the EtN-P residue on the 
GPI anchor, and this results in protein linked to the GPI anchor by an amide bond, and 
restoration of the active sulfhydryl site in the transamidase (Sharma et aL, 1999b).
GPIT complex members.
The genes encoding the members of the GPIT have been identified in yeast and 
mammalian cells, and the enzyme appears to be a complex of at least 4 members. In 
yeast these are termed GAAl, GPI8, GPI16 and GP117. GAAl was identified by 
complementation of a temperature sensitive mutant cell line, which synthesised the 
complete GPI anchor precursor, but was unable to incorporate it onto the GPI-anchored 
protein Gas Ip. The GAAl protein was characterised as containing 6 membrane 
spanning domains (Hamburger et aL, 1995). The mammalian GAAl was cloned by 
homology to the yeast protein, and had 28% identity at the amino acid level (Hiroi et 
aL, 1998).
GP18 was identified by the complementation of a second defective yeast cell line, and
the gene encoded a protein with a predicted N-terminal ER signal sequence and a C-
terminal transmembrane domain (Benghezal et aL, 1996). Treatment of microsomes
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with Proteinase K and cellular fractionation demonstrated that the protein had an ER 
lumen location (Benghezal et aL, 1996). Studies on mammalian cells identified a 
human K562 cell line with a mutation in GPI anchoring (termed complementation class 
K) (Mohney et aL, 1994). A later study demonstrated, using a cell free system, that 
these cells were defective at the point of anchor addition to awaiting proteins (Chen et 
aL, 1996). The human GPI8 gene was cloned by homology to the yeast protein, and 
was able to restore GPI anchoring in the class K cells (Yu et aL, 1997). The GPI8 
protein showed a significant homology to a family of plant endopeptidases, some of 
which have transamidase activity, and GPI8 was predicted to be the catalytic sub-unit 
of the GPIT complex (Benghezal et aL, 1996).
The yeast protein GPU 6 was identified as a third member of the GPIT complex by co- 
immune-precipitation of the complex, and was predicted to be N-glycosylated with a 
single C-temiinal transmembrane domain (Fraering et aL, 2001). A mammalian 
homologue, PIG-T, was identified by a similar method (Ohishi et aL, 2001). This study 
also isolated a fourth member of the mammalian GPIT complex, termed PIG-S, and 
cloned a yeast homologue termed GPU 7.
The GPIT complex of trypanosomatids has been less well characterised. The gene 
encoding GPI8 from L. mexicana was identified through homology to the yeast GPI8 
protein (Hilley et aL, 2000). A GPIS deletion strain (AgpiS) was produced, 
demonstrating that the protein was not essential in L. mexicana promastigotes grown in 
culture. Immunofluorescence demonstrated that the GPI-anchored protein GP63 was 
lost from the cells surface, while re-expression of the GPI8 protein within the AgpiS 
cell line restored GP63. The AgpiS cells accumulated protein anchor precursors. A 
histidine tagged form of the Leishmania GPI8 protein was used in the trypanasome cell 
free system and was able to restore GPI anchoring, after GPIT activity had been 
removed by a high pH wash (Sharma et aL, 2000). A T. brucei GPI8 homologue has 
also recently been identified (Kang et aL, 2002; Lillico et aL, 2003). L. mexicana and T. 
brucei GPI8 have no transmembrane domain as predicted from the gene sequences, and 
appear to be soluble homologues of the yeast and mammalian enzymes (Hilley et aL, 
2000; Kang et aL, 2002; Lillico et aL, 2003)
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Recent studies have attempted to define the function of each of the identified complex 
members within the GPIT enzyme. The role of GPI8 as the catalytic sub-unit of the 
enzyme has been characterised in some detail. These results are described more fully, 
and discussed in relation to the situation in Leishmania and the trypanosomatids in 
section 3.5.
1.4,9 The GPI-anchor addition site
Proteins destined to be GPI-anchored show little sequence homology at the C-teiTninal 
end, however all proteins possess 2 common features; a GPI attachment signal, and a 
hydrophobic domain at the C-teiTninus (Ferguson and Williams, 1988) (Figure 1.4 B). 
The hydrophobic domain has been shown to be necessary for anchor attachment. A 
model system studied the mammalian GPI-anchored protein decay accelerating factor 
(DAF), transiently expressed from a vector in COS (CVl origin-deficient SV-40) cells 
(Caras et aL, 1989). Deletion or shortening of the 17 amino acid hydrophobic domain 
prevented GPI-anchor addition to DAF, whilst fusion of this domain to a secreted 
protein did not result in anchor addition (Caras et aL, 1989). Replacement of the 17 
amino acid domain with a random hydrophobic sequence, or attachment of the non­
anchored protein hGH (human growth factor) at the C-terminal end of DAF, such that 
the hydrophobic domain and associated attachment sequence were positioned in the 
middle of a large hydrophilic fusion protein, both resulted in the efficient GPI 
anchoring of DAF (Cai'as and Weddell, 1989; Caras, 1991). It was concluded from 
these experiments that the C-terminal hydrophobic domain was essential but not 
sufficient for anchor addition, and that the function of the domain was not due to the 
precise sequence, but its hydrophobic properties.
The amino acid at the site of GPI anchor attachment has undergone much study, and 
has been termed the co residue (Gerber et aL, 1992). The GPI anchor is attached to the 
protein on the C-terminal side of the co residue. Site directed mutagenesis studies 
showed that the only requirement for the co residue was that it had a small side chain 
(Asparagine, serine, glycine, alanine, aspartic acid, and cystiene). (Micanovic et aL, 
1990; Moran et aL, 1991; Nuoffer et aL, 1993).
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The CO site of the human protein Decay accelerating factor (DAF) was identified as 
serine^^ ,^ 12 residues N-terminal to the C-teiminal hydrophobic domain. Attachment of 
the DAF hydrophobic domain to the C-terminal end of the non-GPI-anchored receptor 
protein LDL was insufficient to produce a GPI-anchored fusion protein. Subsequent 
addition of both a serine and glycine residue 12 or 9 amino acids N-terminal to the 
hydrophobic domain did produce a GPI-anchored protein. Addition of only a serine 
residue, or addition of the serine and glycine residues at other positions failed to 
produce a GPI-anchored protein (Moran and Caras, 1991). This suggested that the only 
requirement for GPI anchor addition was an anchor addition site consisting of a pair of 
small amino acid residues positioned 9-12 residues N-terminal of a hydrophobic 
domain.
Site directed mutagenesis studies using preprominiPLAP expressed in a cell free 
system (Kodukula et aL, 1991) examined the residues C-terminal to the o) residue (co+l 
and CO+2) (Gerber et aL, 1992). GPI-anchor addition occurred when the co+l site was 
any residue with the exception of proline. The co+2 site was more limited, in that 
anchor addition only occurred when alanine or glycine were in this position, a small 
amount of processing also occuiTed with serine (Gerber et aL, 1992). These results 
were repeated when WT PLAP was expressed in intact cells. The addition of threonine 
or valine at the co+2 site also resulted in some processing but at a reduced level 
(Kodukula et aL, 1993). It was suggested that the co, and co+2 residues were highly 
predictive of the point of GPI anchor addition (Kodukula et aL, 1993). These results 
appeared to contradict the findings from the DAF system, whereby only 2 small 
residues were required at the co, and co+l sites (Moran and Caras, 1991). A study on the 
S, cerevisiae GPI-anchored protein Gas Ip also indicated that the co and co+2 site were 
important in determining GPI anchor addition, however it was also suggested that the 
residues tolerated at each position (co, co+l, and co+2) were dependent on which 
residues were present at the other two sites (Nuoffer et aL, 1993). A predictive model 
was developed based on the co and co+2 sites (Udenfriend and Kodukula, 1995), whilst 
a later model was developed using a computer based analysis of GPI-anchored proteins, 
which identified conserved sequence properties from co-11 to co+5 (Eisenhaber et aL,
1998).
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Analysis of miniPLAP and a fusion protein consisting of the mature domain of 
miniPLAP fused to the C-terminus of the GPI-anchored protein the urokinase receptor, 
allowed a direct comparison of mutations on different GPI anchor signals (Aceto et aL, 
1999). This demonstrated that the requirements for the anchor addition domain in 
different proteins is highly variable, influenced partly by the residue at the co+4 
position. In some cases a second cleavage site was utilized (Aceto et aL, 1999).
Sequence analysis of GPI-anchored proteins suggest that some differences exist 
between the mammalian and protozoan GPI attachment site. Protozoa favour different 
amino acids at the co and 0)+2 site compared to mammalian proteins. The expression of 
VSG (variant 117) in COS cells resulted in inefficient GPI anchoring, as assessed by 
surface expression and ethanolamine labeling (Moran and Caras, 1994). The production 
and expression of VSG-DAF fusion proteins in COS cells suggested that this failure 
was due to the VSG GPI signal functioning poorly in mammalian cells. Addition of the 
DAF 0) site and C-terminal end to VSG or human Growth Hormone (hGH) using this 
expression system resulted in GPI-anchored protein, whilst addition of the VSG m site 
and C-terminal to hGH did not (Moran and Caras, 1994). Replacement of the DAF C- 
terminal hydrophobic domain with that of VSG resulted in the production of GPI- 
anchored DAF, indicating the hydrophobic domain did not influence differences in 
GPI-anchoring between mammalian and human cells. It was suggested that the defect 
in anchor addition was due to the different requirements at the anchor addition site 
between protozoan and mammalian cells (Moran and Caras, 1994). However a later 
study converted the predicted GPI-anchor attachment site of porcine membrane 
dipeptidase (MDP) to that found in VSG (variant 117) and expressed the protein in 
COS cells (White et aL, 2000). The mutated forni of MDP was GPI-anchored on the 
cell surface, suggesting that the VSG anchor addition site was viable in the mammalian 
system, and that the requirements at the anchor addition site between mammalian and 
protozoan cells were not as variable as suggested (White et aL, 2000).
An extensive study mutating the co, co+2, co+3, co+4, co+5, co+7 and co+8 positions of 
VSG 117 by site directed mutagenesis, and analysis of the mutated proteins by 
expression in T. brucei did not prevent GPI-anchor addition (Bohme and Cross, 2002). 
This suggested that the GPI-anchor addition site of VSG was not as conserved as had
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been previously predicted, though it was also considered possible that after mutation an 
alternate addition site was utilised (Bohme and Cross, 2002). The variability in anchor 
addition requirements between individual proteins (Moran and Caras, 1994; Aceto et 
aLj 1999; White et al., 2000), and the ability to utilise secondary anchor addition sites 
in the event of mutation (Aceto et a i, 1999), suggested that anchor addition 
requirements are extremely complex and may be specific for the particular protein 
studied (White et a l, 2000).
1.5 Processing and trafficking of GFI-anchored proteins
The processing and trafficking of GPI-anchored proteins to the cell surface in higher 
eukaryotes is thought to follow a broadly defined, highly organised pathway. Proteins 
are trafficked into the ER where differentiated domains exist for processes such as 
protein folding, lipid metabolism, and membrane transport, and are then transported to 
the Golgi body, for further processing. The mature protein enters the trans-GoIgi 
network (TGN), where it is sorted and packaged for export to the cell membrane or 
secretion (Lippincott-Schwaitz et a l, 2000). Secretory transport in trypanosomatids is 
less well defined, but is thought to follow the general pathway found in higher 
eukaryotes, though all endocytosis and exocytosis to the cell surface occurs via the 
flagellar pocket (Clayton et a l, 1995; Overath et a l, 1997; McConville et a l, 2002b).
Ultrastructural studies of high pressure frozen L. mexicana cells show the intracellular 
distribution of GPI-anchored proteins and give a detailed picture of the intracellular 
architecture of these cells (Weise et a l, 2000). Organelles involved in the trafficking of 
secreted molecules are clustered at the anterior end of the cell close to the flagellar 
pocket. An ER region with an intense budding pattern is located close to the cisternal 
face of the Golgi, and these budding vesicles appear to form the new cisternae on the 
cis-face of the Golgi apparatus (Weise et a l, 2000). The area between the ER and Golgi 
appeal's less complicated than that found in mammalian cells, with no regions which 
could be interpreted as an ER-Golgi intermediate compartment (ERGIC) found in 
mammalian cells (Weise et a l, 2000). Flattened vesicles bud from the trans-face of the 
Golgi, and these can be equated with the trans-Golgi network (TGN) present in 
mammalian cells. The flattened vesicles appear to be in transit between the Golgi, and 
large translucent vesicles, which in turn appear to connect with the flagellar pocket and
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tubular clusters. These large vesicles contained biotinylated material and it was 
speculated that these structures are involved in the sorting and recycling of endosomes, 
similar to the system found in mammalian cells (Weise et aL, 2000).
The enzyme dolichol-phosphate mannose synthase (DPMS), catalyses the synthesis of 
dolichol phosphate mannose, a mannose donor required for GPI biosynthesis, on the 
cytosolic face of the ER (Ilgoutz et al., 1999b). Production of a functionally active GPP 
tagged form of this enzyme was produced in order to identify sub-compartments of the 
ER important in GPI, LPG, and GIPL biosynthesis (Ilgoutz et al., 1999a). The chimera 
localised to a stable tubular compartment, which extended from the flagellar pocket 
toward the posterior end of the cell (Ilgoutz et a l, 1999a). This multivesicular tubule 
(MVT) was also identified by electron microscopy and was flanked by microtubules 
and contained a variety of different sized vesicles (Weise et a l, 2000). Labelling of the 
MVT with surface biotinylated GP63, and antibodies directed against phosphoglycan 
structures which are formed post ER suggested that the structure was not an ER 
compartment but was a post-Golgi compartment (Weise et a l, 2000). Subcellular 
fractionation suggested that the MVT may contain cysteine proteases, and it was also 
observed that the MVT was labelled with the endocytic marker PM 4-64, but that this 
compound was not chased any further (Mullin et a l, 2001). This suggested that the 
MVT is a late lysosomal compartment. (Weise et a l, 2000; Mullin et a l, 2001). 
Disruption of the MVT with the inhibitor Balfomycin (which specifically perturbs 
lysosome/ endosome function), did not effect the trafficking of GPI-anchored GP63 to 
the cell surface, and it was concluded that the MVT was not a compartment in the 
secretory pathway (Mullin et a l, 2001).
Ultrastructural studies suggest that the secretory pathway of the trypanosomatids is 
broadly similar to that found in mammalian cells. The processes involved in this 
pathway are briefly described in relation to mammalian cells, and related to the 
enzymes and pathways so far identified in trypanosomatids.
1.5.1 Traiislocation and ER Processing
Proteins destined to enter the secretory pathway have an N-terminal ER signal direction
sequence. This signal binds to the signal receptor protein (SRP) during synthesis of the
protein, forming a ribosome/ nascent protein/ SRP complex. The complex targets to the
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SRP receptor on the membrane of the ER adjacent to the translocon. Transfer of 
secreted proteins from the ribosome into the ER occurs via the translocon. The 
translocon has an ER membrane spanning aqueous pore, which in mammalian cells has 
the core components of translocon associated membrane protein (TRAM), and a sec61 
complex (Johnson and van Waes, 1999). Removal of the signal peptide by signal 
peptidase (SP), and N-glycosylation by the oligosaccharide transferase (OST) both 
occur as the protein is translocated into the ER lumen.
N-linked glyeans are complex structures, the basic core structure of which is 
synthesised by a glycan biosynthetic pathway, this core is then added to the protein by 
the OST during translocation of the protein into the ER (Johnson and van Waes, 1999). 
Further modifications and additions to the glycan can occur as the glycosylated protein 
moves through the ER and Golgi apparatus (Dwek, 1996). The OST is considered to be 
an integral part of the translocon, though direct interaction between it and other 
translocon sub-units has not been demonstrated (Reviewed by Johnson and van Waes, 
1999).
Little is known about the translocon in trypanosomatids. A mammalian signal sequence 
has been used to control the secretion of interferon-gamma in L. major. The protein was 
processed and secreted from the cells, suggesting that the translocation machinery is 
similar in both Leishmania and higher eukaryotes (Tobin and Wirth, 1993). VSG could 
not be imported into canine pancreas microsomes, unless its signal peptide was 
replaced with a yeast signal. GP63 was not imported into the microsomes, unless its 
signal peptide was altered by replacing 9 amino acids with those from Autographa 
califomica. This suggests some diversity in the ER signal peptide exists between 
species (Al-Qahtani et al., 1998).
The molecular chaperone, BiP, is a ubiquitous protein within the ER lumen of
mammalian cells, and appears to have multiple functions. It is associated with the
translocation of proteins across the ER membrane, assists in the folding of protein by
reversibly binding to polypeptide chains, and may be responsible for blocking the
translocon pore to prevent retrotranslocation (Reviewed in Johnson and van Waes,
1999). A homologue has been identified in T. brucei, the predicted protein sequence of
which has 64% identity with rat BiP (Bangs et al., 1993). The protein has an ER
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retention signal, and immunofluorescence microscopy demonstrated that the protein 
localised to the ER. A BiP homologue has not yet been identified in Leishmania, 
however, the BiP antibody specific to T. brucei also identifies an ER located protein in 
L. donovani (Debrabant et aL, 2002).
In higher eukaryotes a variety of quality control mechanisms exists in the ER, which 
prevent the continued trafficking of misfolded proteins. ER associated degradation 
(ERAD) retrotranslocates misfolded proteins to the cytosol, where they are degraded in 
proteasomes. A build up of misfolded proteins in the ER triggers the unfolded protein 
response (UPR) (Ng et aL, 2000). The calnexin calreticulin pathway modulates the 
forward trafficking of glycoproteins (Parodi, 2000; Ellgaard and Helenius, 2001). N- 
glycosylation occurs as proteins are translocated to the ER lumen. The subsequent 
trimming of these N-glycans by Glucosidase I and II (GI and GII) allows the interaction 
of the glycosylated protein with the lectins calnexin or calreticulin. This association 
exposes the folding protein to ERp57 a molecular chaperone. The interaction is 
terminated by the removal of glucose from the glycan by GII and the protein is 
trafficked to the Golgi. If the protein is not in its correct confoimation glucose is 
reattached to the protein by UDP-Glc:glycoprotein glucosyltransferase (GT), tagging it 
for reinteraction with the calnexin/ calreticulin cycle, and retaining the protein within 
the ER.
The mechanisms of quality control within the ER of trypanosomatids, are at present 
poorly defined. GII and GT activity has been detected in trypanosome cells (Parodi et 
aL, 1983; Bosch et aL, 1988; Trombetta et aL, 1989). Homologues of calreticulin have 
been identified in L. donovani and T. cruzi, the predicted proteins of which have the 
same characteristic domains identified in calreticulin homologues from higher 
eukaryotes (Joshi et aL, 1996; Labriola et aL, 1999). Over expression of the calreticulin 
P-domain in L. donovani, resulted in the reduction of secretion of acid phosphatase, and 
its intracellular retention (Debrabant et aL, 2002). This suggests that a similar quality 
control system to the calnexin/ calreticulin cycle of mammalian cells exists in 
trypanosomatids.
The ER of mammalian cells is an array of interconnecting membranes and cisternae
organised into localised sub-domains specialised for different functions such as protein
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folding, lipid metabolism and membrane transport (Lippincott-Schwartz et aL, 2000), 
Fractionation of thyoma cells demonstrated that some of the enzymes associated with 
GPI biosynthesis are confined to a sub-domain of the ER (Vidugiriene et aL, 1999). 
The trypanosomatid ER has been less well defined, though ultrastructural studies 
suggest that the ER of these organisms is similarly organised into distinct 
compaitments (Weise et aL, 2000). The presence of distinct GPI biosynthetic pathways 
for the production of GIPL and GPI protein anchors and LPGs in L. mexicana, suggests 
that some compartmentalisation of the ER must occur (Ralton and McConville, 1998; 
Ilgoutz etaL, 1999b).
1.5.2 ER to Golgi transport
In mammalian cells the trafficking of secretory proteins from the ER to and through the 
Golgi is thought to occur by a generalised model (Lippincott-Schwartz et aL, 2000). 
Transport vesicles form in the ER, which traffic cargo proteins possibly via ERGIC 
whereby the vesicles fuse to form Golgi cisternae. ER/ Golgi intermediates were 
originally thought to be stable compartments (Lotti et aL, 1992), but it has since been 
suggested they are transient transport vehicles (Lippincott-Schwartz et aL, 2000).
In mammalian cells the small GTPase, Rab2, is associated with ER to Golgi transport, 
and the maturation of ER-Golgi intermediates (Tisdale and Balch, 1996). A homologue 
of Rab2 has been identified in T. brucei (Field et aL, 1999). Over-expression of 
TbRab2 in T. brucei resulted in a decrease in the level of procyclin synthesis, which is 
the major GPI-anchored surface protein of procyclic cells, and is thus the major cargo 
in the secretory pathway. Over-expression also resulted in the disruption of the ER by 
excess vacuolisation. Fluorescence microscopy suggested that TbRab2 co-localised 
with BiP, though in an incomplete fashion, whilst expression of TbRab2 in COS cells 
suggested the protein targeted to the ERGIC (Field et aL, 1999). It was suggested that 
ER/ Golgi intermediates may foim in T. brucei (Field et aL, 1999). Electron 
microscopy on high pressure frozen cells was unable to identify complex ERGIC like 
structures in Leishmania, though the area of ER directly opposite the Golgi appeared to 
be highly specialised with cisternal like extensions and budding (Weise et aL, 2000). 
This specialised area of the ER was termed the transitional ER (tER).
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1.5.3 Progression through the Golgi
The Golgi apparatus is organised as a series of stacks of cisternae, which appear to be 
polarised between the cis and trans faces. The method of transport through the Golgi is 
unclear but is thought to occur either by cisternal maturation, or by vesicular trafficking 
between stable compartments (Glick and Malhotra, 1998). Cargo proteins are 
transported through the Golgi to the TGN, here COPII/ clatherin coated vesicles form 
and continue anteriograde transport of the cargo proteins from the cell. Retrograde 
transport of resident Golgi proteins maintains polarity of the Golgi apparatus, and 
recycles proteins back to the ER (Glick and Malhotra, 1998). COPII (coat protein 
complex II) vesicles are involved in the anteriograde transport of proteins from the ER 
to the Golgi. The COPII coat consists of five proteins, the small GTPase Sarlp, and the 
heterodimers Sec23/24p and Sec 13/3 Ip. COPI vesicles are involved in retrograde 
transport whereby proteins are recycled from the cis-Golgi to ER. The COPI coat 
consists of a GTPase (Arf Ip and/ or ARF2p) and a ‘coatmer’ (consisting of seven sub 
units) (Springer et ah, 1999).
Brefeldin A (BFA) inhibits secretion by disruption of the Golgi body. It does this by 
inhibiting some of the proteins (GEFs) involved in the activation of the ADP- 
ribosylation factors (ARF) (Donaldson et aL, 1992). The ARF proteins are involved in 
the assembly of COPI vesicles responsible for the retrograde transport from the cis- 
Golgi to the ER (Roth, 1999). Inhibition of retrograde transport leads to the collapse of 
the Golgi and its redistribution into the ER. Yeast cells are insensitive to BFA due to 
the impermeability of the cells. However in permeable mutant strains BFA blocks 
secretion and affects Golgi moiphology, by inhibition of the GEF proteins Geal, Gea2 
and Sec7 (Peyroche et aL, 1999), In mammalian cells BFA causes the collapse of the 
Golgi complex however only one of the mammalian GEFs identified is sensitive to 
BFA (Chardin and McCormick, 1999). Treatment of T. cruzi epimastigotes with BFA 
also dismpted the ultrastructure of the Golgi apparatus by causing an increase in the 
number and size of the cisternae (Engel et aL, 1998).
1.5.4 Trans-Golgi network to flagellar pocket
The TGN of mammalian cells is responsible for the sorting and packaging of transport 
intermediates. From the TGN proteins are trafficked to both the cell surface, and a
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variety of compartments in the endosomal system. The complex mechanisms involved 
in the regulation of these pathways and sorting processes are at present only partially 
understood (Keller and Simons, 1997; Lippincott-Schwartz et aL, 2000). The trans- 
cistemae of the Golgi apparatus is speculated to be functionally equivalent to the TGN 
in trypanosomatids (McConville et aL, 2002b). Electron microscopy demonstrated that 
in L. mexicana this region undergoes the budding of different sized vesicles, and is 
closely associated with tubular clusters and larger vesicles (Weise et aL, 2000). The 
GRIP domain, which is a targeting domain specific for the mammalian TGN, was also 
identified on a T, brucei protein. This TbGRIP domain could be used to localise GFP to 
both the TGN of mammalian cells, and the trans-face of the Golgi apparatus in L. 
mexicana (McConville et aL, 2002a).
All endocytosis and exocytosis in trypanosomatids occurs via the flagellar pocket 
(Overath et aL, 1997). In T. brucei the density of VSG at the flagellar pocket was 
shown to be approximately 50 times higher than the density in the ER (Grunfelder et 
aL, 2002). Incubation of cells at 20°C inhibits intracellular transport between the trans- 
Golgi and cell surface. Transport of VSG to the surface of T. brucei cells was prevented 
by this treatment, and VSG was shown to have accumulated in the region of the trans- 
Golgi (Duszenko et aL, 1988). Immunogold labelling and electron microscopy 
demonstrated that L. mexicana GP63 was trafficked via large translucent vesicles, and 
tubule clusters, both of which appeared to associate directly with both the trans-Golgi, 
and flagellar pocket (Weise et aL, 2000).
1.5.5 GPI anchors and secretion
GPI anchors have been implicated in the correct forward transport of GPI-anchored 
proteins from the cell. Addition of a GPI anchor signal peptide to human growth 
hormone (hGH), which is normally secreted, resulted in the protein being targeted to 
the cell membrane. Mutation of the fusion proteins anchor addition site resulted in the 
uncleaved and unanchored protein accumulating intracellularly in a post-ER 
compartment (Moran and Caras, 1992), where it appeared to aggregate and was then 
degraded (Field et aL, 1994).
Inositol starvation of yeast cells prevented GPI-anchor modification of the protein
Gas Ip, and proper processing. The immature protein accumulated intracellularly
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(Doering and Schekman, 1996). The yeast GPI-anchored protein Gas Ip has been 
shown to associate with COPII vesicles in its transport from the ER, and loss of the GPI 
anchor inhibits this (Doering and Schekman, 1996). Mutation of Ret Ip, a protein which 
is a coat component of COPII vesicles, also blocks GPI-protein transport from the ER 
(Siitterlin et ah, 1997). Retention of GPI-proteins in the ER may be due to the 
requirement of GPI anchor for foi-ward transport, or instead, a result of the uncleaved 
GPI signal peptide acting as a strong retention signal.
Studies in T. brucei used a reporter system, based on a truncated foim of VSG lacking 
the C-terminal GPI-signal peptide (VSGAgpi), expressed in procyclic cells. This 
protein was exported from the cell with greatly reduced kinetics, compared with the 
rate wtVSG reached the cell surface. The procyclin GPI-signal peptide, restored anchor 
addition and transport efficiency (Bangs et aL, 1997). VSGAgpi was shown to 
accumulate in the ER, and was demonstrated to be correctly folded and dimerised. The 
truncated protein lacked the hydrophobic C-teiminal GPI-signal, previously suggested 
to be responsible for ER retention. It was suggested that the GPI anchor is necessary for 
the forward transport of some GPI-anchored proteins (McDowell et aL, 1998). In 
Leishmania GP63 mutated at the GPI-anchor addition site and expressed in a GP63 
deficient cell line was demonstrated to be secreted from the cell, however the kinetics 
of secretion was not shown (McGwire and Chang, 1996).
1.6 Aims.
The extent of GPI-anchoring in the trypanosomatid protozoa demonstrates that this is 
an important process in these organisms. The production of a viable L. mexicana cell 
line deficient in GPI biosynthesis, suggest that Leishmania is an ideal organism in 
which to study GPI-anchor addition and biosynthesis. Recent research also indicates 
that there may be some significant differences between the GPIT complex in 
trypanosomatid protozoa and higher eukaryotes. The cloning of the GPI8 homologue 
from L. mexicana, and the generation of a AgpiS mutant cell line provided a useful tool 
for the study of GPI anchor addition in this organism. The AgpiS cell line also provided 
a method of comparing the trafficking of GPI-anchored, and unanchored proteins 
through the cell, and assessing the significance of the GPI anchor in this process.
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This study had 3 aims:
1. The characterisation of GPI8 and the GPIT complex by the determination of the 
active site residues of GPI8, the production of active site mutants and the examination 
of the role of GPI8 as part of a larger complex.
2. Characterisation of the trafficking of GPI-anchored proteins, and comparison with 
the situation in cells with a defect in GPI anchor addition.
3. Identification of novel genes associated with GPI anchor biosynthesis and 
trafficking, and the development of a novel screening method for the isolation of 
biosynthesis and trafficking mutants.
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Sandfly Vector Mammalian host
Metacyclic Promastigotes
-Mammalian infective
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Figure 1.1: The lifecycle of Leishmania
The lifecycle is described in detail in section 1.1.3. Images were taken from web site; 
http://www-medlib.med.utah.edu/parasitology/image.html
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Figure 1.2: Structure of glycoconjugates in Leishmania
Panel A) Schematic of the glycocoiijugates present on the surface of Leishmania
promastigote cells.
Panel B) Structure of the GPI molecules present in Leishmania.
The GPI-anchor of GP63 is shown as an example of the common core structure 
present on GPI-anchored proteins. M3, GIPL-A, iM4, are shown as examples of 
Type 1, Type 2, and Hybrid Type GIPLs. The generic shucture of the LPG anchor 
is shown.
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Figure 1.3: The GPI biosynthetic pathway of mammalian cells
Key
Phosphatidylinositol (PI)
1
Mannose
Ethanolamine phosphate (EtN-P)
d ' N - Acety Iglucosamine CO GPI-anchor addition site
0 Glucosamine \ Acyl chain
Step IrGlcNAc Transferase
Transfer of N-Acetylglucosaminyl (GlcNAc) from UDP-GlcNAc to a 
phosphatidylinositol (PI)
Step 2: GlcNAc-PI Deacetylase 
GlcNAc-PI is N-deacetylated to form GlcN-PI 
Step3: Inositol-Acyltransferase 
An acyl chain is attached to the inositol ring.
Step4: Mannosyltransferase (GPI-MTI)
A mannose residue is transferred from dolichol phosphate mannose (dol-P-man) to the 
backbone.
StepS: EtN-P Transferase
Addition of EtN-P to the first and second mannose residues (higher eukaryotes only). 
Step6: GPI-MTII and GPI-MTIII
Two mannose residues are transferred from dol-p-man to the backbone in two 
independent reactions.
Step?: EtN-P Transferase 
Addition of EtN-P to the final mannose 
StepS: GPIT
The complete anchor is attached at the co site of the awaiting GPI anchored protein, by 
the EtN-P residue on the GPI anchor, catalysed by the GPIT complex
48
M) C
I W O
49
STEP Mammalian Yeast Trypanosomes
T. brucei Leishmania
1 PIG A GPI3
1 PIG-C GPI2
1 PIG-H GPI15
1 hGPIl GPU
1 PIG-P
1 DPM2 DPM2
2 PIG-L GPÏ12 TbGPI12 GPI12
3 (GPIdeAc)
4 PIG-M PIG-M PIG-M
5a PIG-N MCD4 N/A N/A
5b hGPI-7 GPI7 N/A N/A
6 PIG-B GPIIO TbGPIlO
7 PIG-F G PIll
7 PIG-O GPI13 (PIG-O)
8 hGPI-8 GPI8 GPI8 GPI8
8 hGAAl GAAl
8 PIG-S GPI16
8 PIG-T GPI17
Table 1.1: Summary of proteins involved in GPI biosynthesis
Summaiy of proteins so far identified involved in GPI biosynthesis. The 
protein homologues found in mammalian, yeast and trypanosomes cells are 
listed. The step in the pathway with which each protein is associated is 
numbered according to the system used in the legend of figure 3,3, and can be 
directly related to the text in section 1.4.
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Figure 1.4: GPI anchor addition
A). The mechanism of GPI anchor addition. The carbonyl group at the o) site on 
the awaiting protein, is activated by a sulfhydryl group on the transamidase. An 
enzyme-substrate complex forms. The C-terminal end is cleaved from the protein. 
The complex undergoes nucleophilic attack by the amino group of the EtN-P residue 
present on the GPI anchor. The protein is linked to the GPI anchor by an amide 
bond, the GPIT enzyme has its active sulfhydryl residue restored (after Sharma et aL, 
1999).
B). Summary of the structure of the C-terminal end of a GPI anchored protein.
Hydrophobic, and linker regions are indicated as are the residues surrounding the 
point of GPI anchor addition (co site). The peptide sequence is that of L. mexicana 
GP63.
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Chapter 2 
Materials and Methods
2.1 Bacteriology methods
2.1.1 Bacterial strains
XL 1-Blue MRF’, Stratagene.
2.1.2 Bacterial culture and long term storage
Cells were plated on LB-agar plates with appropriate antibiotics and incubated at 37°C 
overnight. A single colony was picked using a sterile toothpick and used to inoculate 
10ml of LB broth containing appropriate antibiotics. The culture was grown overnight 
at 37°C in a rotary incubator (220rpm). The overnight culture was then either used 
directly for small-scale plasmid preps, or 1ml used to inoculate larger cultures. For long 
term storage 0.5ml of the overnight culture was mixed with an equal volume of 2% 
peptone/ 40% glycerol. Cells were stored at -80°C.
2.1.3 Preparation of heat shock competent cells
A 5ml overnight culture of cells was diluted 1/100 in 50ml of LB-broth and incubated 
at 37°C in a rotary incubator until an OD^oo of 0.6 was reached. The culture was 
incubated on ice for 10 minutes, and harvested by centrifugation at 2000rpm for 15 
minutes at 4°C. Cells were resuspended in 16ml of cold RFl, incubated on ice for 15 
minutes, and pelleted by centrifugation at 1800 rpm, 4°C for 15 minutes. Cells were 
resuspended in 4 mis cold RF2, incubated on ice for Ihour, divided in to 200pl aliquots 
snap-frozen on dry-ice/ ethanol and stored at -80°C,
2.2 Leishmania mexicana methods
2.2.1 Leishmania mexicana cell lines and culture methods
The wild type L. mexicana cell line used throughout this study was Leishmania 
mexicana mexicana (MNYC/BZ/M379). AgpiS was derived from this cell line by Dr. 
Jim Hilley (Hilley et a l, 2000).
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L, mexicana wild-type and AgpiS promastigotes were maintained in culture at 25°C in 
modified Eagle’s medium (HOMEM) containing 10% (v/v) heat inactivated foetal calf 
serum (ECS). Neomycin (G418, Life technologies) was added at 25 |ig ml * typically, 
and up to 500 pg ml * as required. Cells were inoculated into fresh medium at 
approximately 1 x 10*" cells ml * and were passaged into fresh medium when cultures 
reached late-log or early stationary phase.
Cells were harvested by centrifugation at 2000xg for 5 minutes with 2 subsequent 
washes in PBS each followed by centrifugation as above. Cell pellets were stored at - 
80°C until required.
HOMEM plates were made by a 1:1 dilution of 2X HOMEM with 2% agar containing 
appropriate antibiotics. Plates were allowed to air dry in an airflow hood for 15 minutes 
and were pre-warmed to 25°C for 30 minutes before cells were spread over the solid 
medium. Liquid was allowed to absorb into the plate for 5 minutes before the plates 
were sealed with parafilm and incubated at 25 °C.
2.2.2 Stabilate preparation and long term storage
0.5mls of log phase culture was diluted with an equal volume of fresh medium 
containing 10% DMSO in a Cryotube vial (Nunc). Samples were stored at -70°C 
overnight and transfeiTcd for long term storage under liquid nitrogen.
2.2.3 Transfection of L. mexicana
Transfection of Leishmania was earned out following the methods of Cobum and co­
workers (Cobum et aL, 1991). Leishmania promastigotes were grown to a density of 
0.9-1 X 10^  cells ml'*, harvested and washed twice in electroporation buffer (EPB), 
before resuspension at 1 x 10^  cells ml * in EPB and kept on ice. 4 x 10^  cells (400pl) 
were transferred to a pre-chilled 0.2cm electroporation cuvette (Biorad). 15^g of 
chilled, sterile DNA was added to the cuvettes as appropriate. Cells were electroporated 
using the Genepulser II apparatus with set to 0.45kV (2.25kV/cm), and 500pF 
capacitance, and incubated on ice for up to 10 minutes. Cells were transferred to fresh 
medium and incubated at 25°C ovemight. Cells were plated out onto plates containing
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appropriate antibiotics. Alternatively 1ml of transfected culture was transferred to a 
fresh flask and 9ml of medium containing the appropriate antibiotic added.
2.3 Tissue culture
2.3.1 Hybridoma cells
The Hybridoma cell line expressing the BB2 antibody (Brookman et aL, 1995), was 
grown in Serum Free Protein Free Hybridoma Medium (Sigma). When cells reached a 
density of 10*" cells ml * they were passaged by diluting 1:10 in fresh culture medium. 
Spent medium was recovered for use as antibody in the detection of the TY epitope, by 
removing cells by centrifuging and filtering the medium. Recovered supernatant was 
stored at 4°C with 0.02% NaNg.
2.4 Molecular methods
2.4.1 Plasmid purification
Plasmids were routinely purified from bacterial culture using Qiagen kits, following the 
manufacturers instructions. For small scale purification for use in subcloning or 
restriction digests Qiagen miniprep kits were used, for larger scale purification, such as 
for the transfection of L. mexicana, Qiagen Tip-20 kits were used. Plasmid quality and 
yields were assessed by spectrophotometry. An absorbence reading of 1 at a 
wavelength of 260nm is equivalent to 50|U,g ml"* double stranded DNA.
2.4.2 Ethanol precipitation
Where required DNA was purified or concentrated by ethanol precipitation in 2.5 
volumes 100% ethanol, 300mM NaAcetate (pH 5.2), on ice for 1 hour, and 
centrifugation at 15,000 rpm for 15 minutes. The supernatant was removed and the 
pellet washed twice in 70% ethanol, and then air dried for 15 minutes. DNA was re­
suspended in an appropriate volume of H2O.
2.4.3 Polymerase Chain Reaction (PCR)
PGR was used for the amplification of specific DNA fragments either for subsequent 
cloning or analysis, and the identification of positive transformants by whole-cell PCR. 
A 20pl reaction contained 2pl of lOx PCR buffer, 50ng of DNA template, 20pM of 
each primer, and 2U of Taq polymerase. Taq polymerase lacks proof reading ability
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therefore Pfu polymerase was used where high fidelity PCR was required. Reaction 
conditions varied and are described where appropriate.
Taq amplified PCR products were ligated directly into the pGEM-T vector (Promega). 
Pfu generated fragments were cloned into PCR-script (Stratagene). Alternatively to 
clone Pfu generated products into pGEM-T, completed PCR reactions were heated to 
96°C for 30 minutes, and then incubated at 72°C with lU  Taq polymerase, 200pM 
dATP for 2 minutes. This incoiporated an additional adenosine overhang to the PCR 
products.
Colony PCR was used to screen for bacterial colonies containing conectly orientated 
inserts. A toothpick was touched to a specific colony, and then used to transfer cells 
directly to a 20pl PCR reaction lacking template DNA.
2.4.4 Restriction digests
Restriction enzymes were from New England Biolabs (NEB), and digests were set up 
following the manufacturers recommendations, and using the specific buffer supplied 
with each enzyme. Generally reactions were carried out for 1 hour at 37°C.
2.4.5 DNA gel electrophoresis
DNA was run out on gels containing 0.7- 1.2% agarose in TAE buffer. Samples were 
mixed with 5 x DNA gel loading buffer to give a final concentration of Ix loading 
buffer and electrophoresed at 50- 1 lOV, until the dye in the loading buffer had migrated 
two thirds of the length of the gel. Ikb ladder (Gibco) was used as a marker and 
generally 0.5pg was loaded per lane. Ethidium bromide was added to molten gel at a 
final concentration of 0.3|Lig ml *, unless uniform staining was required in which case 
after electrophoresis the gel was soaked in TAE buffer containing 0.3pg ml * ethidium 
bromide for 30 minutes, and washed in TAE buffer. Gels were visualised with an UV 
light using the Gel Doc 2000 imaging system (BioRad), and analysed using Quantity 
One (Biorad).
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2.4.6 Purification of DNA from agarose gels
DNA fragments were purified from TAE agarose gels, using a sephaglass gel 
purification kit (Amersham) following the manufacturers instructions. DNA was finally 
eluted from the sephaglass in lOpl of sterile water.
2.4.7 DNA ligation
Ligation of PCR fragments into commercially available vectors such as pGEM-T or 
PCR-Script was earned out following the manufacturers instructions. For ligation of 
DNA fragments into other vectors, the plasmid and insert were mixed at a ratio of 
approximately 1:3 in a lOpl reaction containing Ix T4 DNA ligase buffer, and 200U of 
T4 DNA Ligase (NEB). Reactions were incubated at 16°C ovemight.
2.4.8 Transformation of competent bacteria
Competent cells were heat shocked as follows: An aliquot of competent cells was 
thawed on ice, and 40|l i 1 of cells was aliquoted into fresh tubes for each transfoimation. 
ijLil of ligation mix was added to the cells and incubated on ice for 1 hour. Cells were 
heated to 42°C for 45 seconds and returned to ice for a further 2 minutes, and then 
transferred to a tube containing 1ml of pre-warmed SOC medium and allowed to 
recover for 1 hour at 37°C in a rotary incubator. 50-200pl of transformed cells were 
plated out onto LB-agar plates containing appropriate antibiotics, and incubated at 
37°C ovemight.
2.4.9 DNA sequencing
DNA sequencing was carried out by the University of Glasgow Molecular Biology 
Support Unit (MBSU). 500ng of DNA template, and 3.2pM of the appropriate primer 
were supplied.
2.5 Biochemical methods
2.5.1 SDS-PAGE
Whole cell lysates of promastigotes were prepared by the harvesting of 10^  cells. The 
cell pellet was lysed in 75|l i 1 of 0.25% Triton X-100 on ice, and 25pl of 4X SDS-PAGE 
loading buffer was added and the samples boiled for 5 minutes.
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Proteins were separated by SDS-PAGE, typically on 12% acrylamide gels, in Tris- 
Glycine buffer. Pre-stained molecular weight protein standards were used as size 
markers, either MultiMark (Novex), or SEE-blue markers (Invitrogen). Mini gels of 
0.75mm thickness were electrophoresed using the Mini-Protean system (BioRad), and 
larger gels of 0.8mm thickness were run using Gibco vertical gel apparatus. To 
visualise total protein gels were stained with Coomassie blue, and washed with destain, 
alternatively gels could be electroblotted. Gels containing radioactive samples were 
Coomassie stained, and then fixed in destain for 30 mins before drying on a vacuum 
dryer (BioRad) 80°C for 2 hours.
2.5.2 Western blotting
Following SDS-PAGE proteins were transfened to PVDF membrane by electroblotting 
using a BioRad semi dry blotter following the manufacturers instructions. The PVDF 
membrane was pre-soaked for 5 minutes in methanol, and the gel rinsed briefly in 
Western Blot Transfer Buffer prior to transfer. Typically for a single Mini-Gel, transfer 
conditions were 0.1 amps for 30 minutes. After transfer the membrane was transfened 
to Blocking solution and incubated either at 4°C ovemight, or at room temperature for 
1 hour both on a rolling platform. In some cases membranes were rinsed in Ponceau S 
(Sigma) to visualise protein transfer. Membranes were washed for 20 minutes in PBS- 
Tween prior to antibody detection.
2.5.3 Gelatin activity gels
Gelatin gels were prepaied as for noiTnal 10% SDS-PAGE with the addition of 0.1% 
gelatin (v/v) to the resolving gel, added from a 2% gelatin stock preheated prior to gel 
preparation. Protein samples were prepared for loading on gelatin gels by addition of 4x 
SDS-PAGE loading buffer to a final concentration of Ix. Samples were not boiled prior 
to loading on the gel. Gelatin gels were electrophoresed using the buffer and conditions 
described for SDS-PAGE. Gels were subsequently treated by soaking in 2.5% TX-lOO 
for 30 minutes to remove excess SDS, and rinsed in MilliQ water. Activity was 
assessed by incubation at 37°C overnight in an appropriate buffer, as described in the 
text. Activity was visualised by staining with Coomassie and destaining.
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2.5.4 Antibody detection of proteins
Primary antibodies were incubated with the membranes in appropriate blocking 
solution for 1 hour at room temperature. The membrane was washed 3x 10 minutes in 
PBS-Tween, and incubated with secondary antibody in Blocking solution for 30 
minutes at room temperature. Blots were washed 3 x 10 minutes in PBS-Tween. The 
dilution of the primai’y antibody was as appropriate to the specific antibody used. The 
secondary antibody was either anti-mouse IgG or anti-rabbit IgG both conjugated to 
horseradish peroxidase (HRP) (Promega), and was typically used at a dilution of 1 in 
5000. Antibody binding was detected by Supersignal Enhanced Chemiluminescence 
(ECL) detection kit (Pierce) following the manufacturers instructions. The signal was 
detected using autoradiography film (NEN), and the film developed by Kodak X-omat 
automated developer.
2.5.5 Immunofluorescence microscopy
30pl of late log L. mexicana promastigote cell culture were taken and diluted to 100p,l 
in PBS. 20|l i 1 were dropped on to slides, smeared over and allowed to air dry. The cells 
were fixed with in 2.5% paraformaldehyde, PBS for 15 minutes, and washed in PBS 
before the addition of primary antibody diluted as appropriate in PBS. The slides were 
incubated in a humidifying chamber for 30 minutes, washed in several changes of PBS, 
blocked in 10% ECS/ PBS for 30 minutes, then washed as before in PBS. A mixture of 
secondary antibody diluted as appropriate with PBS, and DAPI (4,6-diamidino-2- 
phenylindole) 20pg ml'*, was applied, and the slides incubated in a humidifying 
chamber in the dark for 30 minutes. Slides were washed in PBS, and 25pi of anti- 
quenching agent MOWIOL-DABCO was added underneath a glass cover slip. Cells 
were viewed by UV fluorescence microscopy on a Zeiss Axioplan fluorescence 
microscope. Images were captured using a Hamamatsu digital camera, and OpenLab 
software (Improvision, University of Warwick).
2.5.6 Fluorescence microscopy of live cells
L. mexicana promastigotes expressing GFP were grown to mid log phase, and 1 ml of 
culture taken and the cells washed twice in PBS. The cell pellets were resuspended in 
0.5 ml PBS and NaNs added to a final concentration of 0.005mM. Cells were
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transfeiTed onto a slide and analysed for GFP expression by UV fluorescence 
microscopy using a Zeiss microscope as previously described.
2.5.7 Metabolic labelling
L. mexicana promastigotes were grown to mid log phase, washed twice in PBS and 6 x 
10  ^ cells resuspended in 1ml of labelling medium (Ix Minimum Essential Medium 
(ICN), 2mM L-glutamine, 10% (v/v) dialysed PCS), and lOO^Ci of ’^S-ExpreSS ([“ S] 
Methionine/ cysteine Protein Labelling Mix (NEN)). Cells were grown at 25°C for 6 
hours, washed 3 times in ice cold PBS and the cell pellets and medium fractions were 
stored at -80 °C prior to analysis. For pulse chase labelling experiments, 3.6 x 10^  cells 
were resuspended in lOOpl labelling medium containing lOOpCi of ^^S-ExpreSS per 
time point. Cells were labelled for 12 minutes at 25°C, washed 3 times in ice cold PBS 
and resuspended in an equivalent volume of HOMEM containing 10% (v/v) FCS at 
25°C. lOOpl aliquots of cells were removed at appropriate time points, and the cells and 
medium stored separately at -80 °C in the presence of protease inhibitors (ImM EDTA, 
200pg ml'*, Pefabloc SC, 5 pg ml * pepstatin A, 40 pg ml * leupeptin, 200pM PMSF, 
ImM phenanthroline)
2.5.8 TX-114 fractionation
This was earned out following the method of Bordier (Bordier, 1981). Briefly cells 
were lysed in 200pl TX-114 buffer on ice for 15 minutes, precleared to remove cellular 
debris by centrifugation at 10,000g for 10 mins at 4 °C, and the supernatant overlaid 
onto a sucrose cushion (lOmM Tris-HCl pH7.4, 150mM NaCl, 6% w/v sucrose, 0.06% 
pre-condensed TX-114) in a fresh eppendoif tube. Samples were incubated at 30°C for 
3 minutes, centrifuged at 300g for 3 mins at RT, and the upper aqueous layer removed 
to a fresh tube. 0.5% pre-condensed TX-114 was added to this sample, incubated at 4°C 
for 10 minutes, and then this upper layer was overlayed back on the original sucrose 
cushion. The sample was incubated at 30°C for 3 min, centrifuged for 3 minutes at 
300g at room temperature. The whole aqueous phase was removed to a fresh tube, 
leaving a small TX-114 pellet containing the membrane fraction. The aqueous phase 
was treated with 2% pre-condensed TX-114, incubated at 4°C for 10 minutes, 
transferred to 30°C for three minutes and centrifuged at 300g at RT for 3 minutes. The
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aqueous phase containing the soluble cell fraction was then transferred to a fresh tube, 
and the soluble and membrane fractions subjected to further analysis.
2.5.9 NaCOa Extraction
Pellets containing 3 x 10^  L. mexicana promastigotes were resuspended in 50pl Lysis 
Buffer 1 (H2O containing protease inhibitors), 50pl of Lysis Buffer 2 (lOOmM HEPES, 
50mM KCl, lOmM MgCL, 20% (v/v) glycerol and protease inhibitors) snap frozen, 
thawed and vortexed to lyse the cells. Cells were centrifuged at 15,000 ipm for 15 
minutes to remove cell debris, the supernatant transferred to a fresh tube, 450pl of 
lOOmM NaCOs (pH 11), and protease inhibitors added, vortexed and incubated on ice 
for 30 minutes. The 500pl samples were transfened to ultracentrifuge tubes, and lOOpl 
of sucrose cushion (0.5M sucrose, lOOmM NaCOa (pH 11), and protease inhibitors) 
was pipetted carefully to the bottom of the tube. Samples were centrifuged at 83,OOOg 
for 30 minutes. The upper layer was removed as the aqueous fraction, while the pellet 
was removed as the membrane fraction, and treated by immune-precipitation.
2.5.10 Immune-precipitation
This was earned out with GPI8 antibody R492 (Hilley, 1999) following the method of 
ShaiTua and co-workers (Sharma et aL, 2000). Briefly, cell pellets were resuspended in 
1 X GPI8 solubilization buffer and protease inhibitors, to 1 ml, and centrifuged at 
14,000 rpm for 15 minutes to pre-dear, 50 pi of protein A/G sepharose (resuspended to 
a concentration of 0.5mg ml * in solubilization buffer) with 6pl aGPI8, were added to 
the supernatant and the samples mixed at 4°C for 12 hours. In some cases aGPI8 was 
replaced with 6pi of GPI8 pre-immune serum. Samples were then washed 3 times in 
TEN D and once in TEN buffer (TEN-D buffer in the absence of detergent). 25pi of 2 
X SDS loading buffer was added, the samples boiled prior to analysis by SDS-PAGE. 
For immune-precipitation of Green fluorescent protein (GFP) chimeras, the same 
method was used, but 4pl of Living Colors GFP monoclonal antibody, JL-8, 
(Clontech), was used in place of the GPI8 antibody.
For immune-precipitation of GP63 antibody L3.8 was used (Medina-Acosta et aL, 
1989) Cells were lysed in 1ml IDB and protease inhibitors, and precleared. Medium 
samples had an equivalent volume of 2 x IDB buffer added, and were then made up to
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1ml with 1 X IDB buffer. lOOpl of Protein G Sepharose (resuspended to 0.5 mg ml'  ^ in 
IDB buffer) and lOpl L3.8 antibody were added to the samples, incubated for 12 hours 
at 4°C, and the beads subsequently washed three times in GP63 wash buffer, and once 
in TEN. 40^1 of 2x SDS-Page loading buffer was added to the samples prior to further 
analysis.
2.5.11 PI-PLC digestion
Cells were pulse chase labelled, and 2 samples collected for each time point, washed 3 
times in ice cold PBS and snap frozen. These samples were lysed in 200pl TX-114 
buffer but with the absence of TX-114 and the addition of 0.05% TX-lOO, incubated at 
room temperature for 10 minutes, and centrifuged to pre-dear. Samples were 
transferred to a fresh tube, and 4pl of PI-PLC (Sigma) added to one sample from each 
time point. All samples were incubated at 37°C for 1 h. 0.5% pre-condensed TX-114 
was added to each sample, and the samples incubated at 4°C subsequent to TX-114 
fractionation as previously described.
2.5.12 PNGaseF digestion
Samples to be PNGaseF treated were TX-114 fractionated, and GP63 immune- 
precipitated as previously described. GP63 samples associated with protein G beads 
were spilt into 2 and one half treated with 2 pi PNGaseF (NEB), and the other mock 
treated following the manufacturers instructions.
2.5.13 Purification of GP63 on Concanavlin-A
Cells were grown to stationary phase, the cells harvested, and the medium filtered and 
retained. Cells were lysed in 1 x Con-A binding buffer for 30 mins, centrifuged to 
preclear, and 500pl of ConA sepharose (resuspended to 4 mg ml'* in Con A binding 
buffer), and protease inhibitors (200 pg ml"' Pefabloc SC, 5 pg ml"' pepstatin A, 40 pg 
ml"' leupeptin) added. To the medium 1 vol of 2 x ConA binding buffer, 500pl of 
ConA sepharose and protease inhibitors were added. Samples were mixed for 12 h at 
4°C, washed 4 times in ConA binding buffer, and glycosylated proteins eluted with an 
appropriate volume of elution buffer (IM methyl a-D-mannopyranoside in ConA 
binding buffer).
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2.5.14 Protein G purification of antibody
1.5 mis of packed Protein G beads (Sigma) were washed 2x in binding buffer (20mM 
sodium phosphate , 150mM NaCl (pH 7.4)) and resuspended to a final volume of 10 
mis in binding buffer and packed onto a 10ml column (Pierce). The column was 
washed with 10 column volumes (cv) of binding buffer. 50 mis of BB2 hybridoma cell 
supernatant was allowed to drip slowly through the column, and washed with 10 cv of 
binding buffer. Antibody was eluted with 6 mis of elution buffer (100mm Glycine-HCl 
pH3.0), in 500pl fractions and each fraction neutralised with 50pl IM Tris-HCl pH 9.0. 
Fractions were assessed by spectrophotometry for protein content. An absorbance 
reading of 1 at a wavelength of 280nm is equivalent to 800pg ml ' of protein.
2.6 Buffers and reagents
Antibiotics: Ampicillin- Stock: lOOmg ml"' in distilled water, used at lOOpg ml '.
Kanamycin- Stock: 25mg ml ' in distilled water, used at 25pg ml '. 
Acrylamide gel:
Acrylamide gel Gelatin
12% 10% 10% acrylamide/ 
0.1% gelatin.
dHzO 3.35 ml 4.00 ml 3.5 ml
1.5 M Tris-HCl, pH8.8 2.5 ml 2.5 ml 2.5 ml
10% (w/v) SDS 100 pi 100 pi 100 pi
Acrylamide/ Bis (30%) 4.0 ml 3.3 ml 3.3 ml
2% (w/v) gelatin - - 0.5 ml
10 % ammonium persulfate 50 pi 50 pi 50 pi
TEMED 10 pi 10 pi 10 pi
Stacking gel
dHzO 6.1 ml
0.5M Tris-HCl, pH6.8 2.5 ml
10% (w/v) SDS 100 pi
Acrylamide/ Bis (30%) 1.3 ml
10% ammonium persulfate 75 pi
TEMED 10 pi
Blocking solution: 5% w/v Marvel, 0.01% v/v Tween, in PBS. 
Brefeldin A: Stock is lOmg ml"' in methanol.
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Con-A binding buffer: lOmM Tris-HCl pH 7.4, 0.5M NaCl, 0.5% TX-lOO, ImM 
CaClz, ImM MnCL.
Coomassie: 2.5g Coomassie Brilliant Blue R-250 dissolved in 400ml methanol, 500ml 
H2O, 100ml acetic acid.
DNA gel loading buffer: 0.25% (w/v) bromophenol blue, 30% v/v glycerol in H2O. 
Destain: 40% methanol, 10% acetic acid.
Electroporation Buffer (EPB): 21mM HEPES pH7.5, 137mM NaCl, 5mM KCl, 
0.7mM phosphate buffer, 5mM glucose. Store at 4°C.
GPI8 Solubilization Buffer: 50mM Tris-HCl, pH7.5,150mM NaCl, 5mM EDTA, 
1%NP40, and protease inhibitors.
GP63 wash buffer: 0.1% TX-lOO, 0.02% SDS, 150mM Tris HCl pH 7.5.
IDB buffer: 1.25% TX-lOO, 190mM NaCl, 60mM Tris HCL pH7.5, 6mM EDTA and 
protease inhibitors.
Luria-Bertani (LB) agar: LB broth plus 0.8% (w/v) agar.
LB-broth: 1% bactotryptone (Difco), 0.5% (w/v) yeast extract, 0.5% (w/v) NaCl. 
Made up in distilled water and autoclaved for sterilisation.
MOWIOL-DABCO: 6g glycerol, 2.4g MOWIOL 4-88 (Calbiochem) in 6ml distilled 
water. 12ml 0.2M Tris-HCl, pH8.5 was added and incubated with agitation for several 
hours, incubated at 50°C for 10 minutes, then centrifuged (5000 g, 15 minutes). 1,4- 
diazobicyclo[2.2.2.]octate (DABCO) (Sigma), was added to 0.1% (w/v) final 
concentration and divided into 1ml aliquots, and stored at -20°C.
PBS: lOmM phosphate buffer, 2.7mM KCl, 137mM NaCl, pH 7.4.
PBS-Tween: 0.01% Tween v/v, PBS.
PCR-Mix (lOx): 450mM Tris-HCl pH 8.8, llOmM (NH4)2S0 4 , 45mM MgCL, 67mM 
P-mercaptoethanoI, 44mM EDTA (pH 8.0), lOmMdCTP, lOmM dATP, lOmM dOTP 
lOmM dTTP, 113pg ml ' BSA. Stored at -20°C.
Pro tease inhibitors: Generally ImM EDTA, 200pg m l' Pefabloc SC, 5 pg m l' 
Pepstatin A, 40 pg ml ' leupeptin, 200pM PMSF, ImM phenanthroline unless 
otherwise indicated.
RFl: lOOmM RbCl, 50mM MnCl2.4H20, 30mM K Acetate, 10 mM CaCL, 15% 
glycerol, pH 5.8.
RF2: 10 mM MOPS, lOmM RbCl, 75mM CaCl2.4H20, 15% glycerol, pH6.8.
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SDS-PAGE loading buffer (4x): 200mM Tris-HCl pH6.8, 400mM g-
mercaptoethanol, 8% SDS, 40% glycerol, 0.2% (w/v) bromophenol blue.
TAE (1 x): 40mM Tris acetate, ImM EDTA.
TBS; 20mM Tris, 137 mM NaCl pH7.6.
TEN D: 50mM Tris-HCl pH 7.5, 150mM NaCl, 5mM EDTA, 1% NP40, 0.1% SDS, 
0.5% deoxycholate.
Tris Glycine buffer (Ix): 25mM Tris, 250mM glycine (pH 8.3), 0.1% SDS. 
Tunicamycin: Stock is 2mg ml ' in 25mM NaOH.
TX-114: TX-114 was prepared by pre-condensation after the method of Bordier 
(Bordier et al., 1981). 1ml of TX-114 (Sigma) was made up to 50mls in lOmM Tris- 
HCl pH 7,4, 150mM NaCl, incubated at 0°C for 12 hours, and transfened to 30°C for 
12 hours. The upper aqueous phase was removed and replaced with the same volume of 
lOmM Tris-HCl pH 7.4, 150mM NaCl, and the process repeated x 2. The final lower 
phase was stored at 4°C as the TX-114 stock solution, and was at a concentration of
11.4% (w/v).
TX-114 buffer: lOmM Tris-HCl pH 7.4, 150mM NaCl, 0.5% pre-condensed TX-114. 
Western blotting transfer buffer: 5mM Tris, 2mM glycine, 20% methanol.
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Chapter 3 
Characterisation of Leishmania mexicana GPI8
3.1 Introduction
The addition of a complete GPI anchor close to the C terminal end of a GPI-anchored 
protein occurs in the ER lumen by the simultaneous cleavage of the protein at the GPI 
anchor attachment site and addition of the pre-formed GPI anchor. The GPI anchor is 
attached to the protein by amide linkage between the anchors terminal EtN-P group, 
and the C-terminal carboxyl group of the protein (Ferguson et ah, 1988). This reaction 
is catalysed by an enzyme with transamidase activity.
The GPI: Protein transamidase (GPIT) is a complex which has been well characterised 
in yeast and human cells, and contains at least 4 components. In yeast these complex 
members comprise GAAl (Hamburger et a l, 1995), GPI16, (Fraering et al., 2001) 
GPI 17 (Ohishi et a l, 2001), and GPI8, which has a single membrane-spanning domain, 
and is located within the lumen of the ER (Benghezal et al., 1996). GPI8 is considered 
to be the catalytic sub-unit of the GPIT complex, and directly cleaves the GPI 
attachment signal peptide.
The GPIT complex of trypanasomatids has been less well characterised. The L. 
mexicana GPI8 has been cloned, it has no apparent transmembrane domain, as 
predicted by sequence homology and hydrophobicity, and is considered a soluble 
homologue of yeast and mammalian GPI8 (Hilley et al., 2000). An alternative 
inteipretation of the protein sequence is provided by use of the TOPPRED2 programme 
(Eisenhaber et al., 2001). This predicts that a C-terminal transmembrane domain exists 
between residues 251 and 271 of L. mexicana GPI8. The authors propose that the strict 
structural conservation found amongst the GPIS’s from yeast and humans is unlikely to 
be deviated from in the case of L. mexicana, and the apparent absence of a 
transmembrane domain requires further investiagation (Eisenhaber et al., 2001). The T. 
brucei GPI8 has also recently been cloned (Kang et al., 2002; Lillico et al., 2003). No 
transmembrane domain is predicted at the C-terminus of this protein (Kang et al., 
2002). T. brucei GPI8 has been demonstrated to be soluble as it can be removed from
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trypanosome membranes by a high pH wash (Sharma et a l, 2000). No homologue of 
other transamidase complex members has yet been cloned from trypanasomatids, 
though analysis of sequence data has identified a possible GAAl homologue in L. 
major (Eisenhaber et al., 2001).
3.1.1 Previous work on L. mexicana GPI8
The work in this thesis continues directly on from a previous study (Hilley, 1999), and 
the results from this work are briefly summarised. The catalytic subunit of the GPIT of 
Leishmania mexicana, GPI8, was cloned and partially characterised (Hilley, 1999; 
Hilley et al., 2000). The predicted protein was shown to share 31% homology with 
yeast and human homologues (Hilley et a l, 2000), and also shares significant 
homology with T. brucei GPI8 (Kang et a l, 2002; Lillico et a l, 2003). GPI8 was 
demonstrated to be a single copy gene in L. mexicana, and a GP18 null mutant (Agpi8) 
was produced by targeted gene replacement. The Agpi8 cell line was viable in culture, 
and was demonstrated by immunofluorescence analysis to lack GP63 from the cell 
surface. Introduction of an episomal copy of GPI8 (pGL269) into the Agpi8 cells 
(generating the cell line Agpi8{pXGP18]) restored GP63 to the cell surface. GPI anchor 
precursors accumulated in the mutant cells (Hilley et a l, 2000). In vitro studies 
demonstrated that Agpi8 were able to infect, and replicate within, macrophages at a 
level similar to wild type cells. In vivo studies demonstrated that the mutants were also 
able to infect mice and cause lesions. It was concluded that GPI-anchored proteins of L. 
mexicana promastigotes were not essential for growth in culture, the invasion of 
macrophage, or the infection of mice. Nor were the GPI-anchored proteins required for 
the differentiation of promastigotes to amastigotes in macrophage or mice, and the 
subsequent survival of the amastigotes.
Polyclonal antibodies (R491/ R492) were raised against a recombinant GPI8 (A His- 
tagged form expressed in E. coli), and a second set of antibodies was raised against a 
GPI8 peptide (R77I/ R455). Whilst both sets of antibodies were able to detect 
recombinant GPI8 in E. coli cell lysates, neither pair was able to detect GPI8 in lysates 
from L. mexicana cells, probably due to the low abundance of GPI8 in these cells. 
However, the GPI8His antibodies were able to detect a protein of the expected size in 
T. brucei cell lysates. Immunofluorescence analysis with the R491 GPISHis antibody
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on T. brucei cells identified a protein which co-localised with the ER protein BiP, 
(Hilley, 1999), and the ribosomal protein QM (Lillico et al., 2002).
An episome expressing a GPI8-GFP fusion protein was also produced (pGL190). The 
construct was engineered such that GPP replaces the stop codon at the 3 ’ end of GPI8, 
and therefore is located at the C-terminus of GPI8. Western blot analysis suggested that 
the GPI8-GFP fusion protein was able to partially rescue the Agpi8 mutant cell line 
(Hilley, 1999).
The work described in this thesis continued the characterisation of L. mexicana GPI8, 
and utilised the tools produced by the previous study. The aim of this section of work 
was to identify the GPI8 active site residues, and analyse the mutants produced, in 
order to further characterise L. mexicana GPIT.
3.2 Identification and analysis of L. mexicana GPI8 active sites
Previous studies provided some indication of the possible candidate residues which 
may act as the active site of L. mexicana GPI8. A cell-free assay for GPI anchoring in 
trypanosomes has been used to establish a reaction mechanism for GPI anchor addition 
(Sharma et al., 1999b) described in section 1.4.8. The small nucleophile hydrazine can 
substitute for the GPI moiety within the transamidase reaction, and cause the release of 
VSG into the medium. Sulfhydryl alkylating reagents inhibit this reaction. 
Transamidase activity can be reconstituted in T. brucei membranes depleted of 
transamidase activity by addition of recombinant L. mexicana GPI8. This activity is 
inhibited when L. mexicana GPI8 is first incubated with sulfhydryl alkylating agents 
(Sharma et a l, 2000). Together, these data indicate that GPI8 contains a catalytically 
important cysteine residue.
Sequence analysis of yeast, human and Leishmania GPI8 showed that the proteins 
share significant homology to a unique family (C l3) of cysteine proteases known as 
legumains (Benghezal et a l, 1996; Hilley et al., 2000; Ohishi et a l, 2000). These 
proteases are chai'acterised by a catalytic dyad comprising a histidine and a cysteine 
residue (Banett and Rawlings, 1996). The €13 and GPI8 families now exist as two 
subfamilies (Meyer et a l, 2000).
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This evidence suggests that a sulfhydryl group acts as the active site nucleophile for 
GPIT, and the active site of L. mexicana GPI8 is a cysteine residue. It also seems likely 
that the cysteine acts as a catalytic dyad in conjunction with a histidine, similar to other 
members of the 013/ GPI8 sub-families. Sequence homology has identified conserved 
cysteine and histidine residues in the GPI8 family (Hilley et a l, 2000).
3,2.1 Site specific mutagenesis of potential active site residues
Sequence alignment of L. mexicana GPI8 with other members of the GPI8 subfamily. 
Human, yeast and T. brucei, identified 4 conserved amino acids H63, 094, H I74 and 
0216, which were potential active site residues (Figure 3.1). Each of these residues was 
individually mutated by site directed mutagenesis of the episomal copy of L. mexicana 
GPI8, pXGPI8 (pGL269), using the QuikOhange Site Directed Mutagenesis Kit 
(Stratagene). pGL269 was previously prepared by cloning GPI8 and its 5’ and 3’ 
flanking regions into the pXG episomal expression vector (Ha et a l, 1996), and is 
9.96kb in size (Hilley et a l, 2000).
The QuikOhange Site Directed Mutagenesis Kit is a POR based method that was used 
following the manufacturer’s directions. The primer pairs for site directed mutagenesis 
(Table 3.1) were designed to mutate GPI8 at specific amino acids, with cysteine 
residues mutated to glycine, and the histidine residues converted to alanine (Hilley,
1999). Briefly, a 50pl POR reaction was set up containing lOng of plasmid DNA, 
I25ng of each of the appropriate primers, dNTPs, I x buffer and 2.5U Pfu Turbo, a 
DNA polymerase with proof reading capabilities. The elongation time for the POR 
reaction was set at 20 minutes (2 minutes/ Ikb of plasmid template). Subsequent to the 
POR, the products were treated with lOu of Dpnl, at 37°0 for 1 hour. This was to 
remove parental plasmid DNA. Ipl of each POR reaction was then transformed into 
40pl of XL-1 blue competent cells, and plated out onto LB plates containing ampicillin. 
After overnight incubation at 37°0, approximately 250 colonies were present for each 
POR reaction. Subsequent to plasmid purification, sequencing was used to confirm that 
the plasmids contained the correct mutations, and the plasmids were named pGL449 
(H63A), pGL450 (094G), and pGL451 (H174A). To confirm that only the intended 
mutation had been introduced by the POR method into each plasmid, the entire GP18 
ORF was checked by sequencing. Plasmid DNA was purified using a Qiagen Tip 100,
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and 15|ag of DNA was used to transfect the L. mexicana AgpiS cell line. The resulting 
cell lines were termed AgpiSlpXgpiS^"^"^^] and AgpiSipXgpiS^^^"^^].
The cell line Agpi8[pXgpiSF^^^^] was generated in a previous study (Hilley, 1999).
Primer Mutation Sequence (5’~>3’) Plasmid
OL330 CTCTTCAACTACCGclSCjcACCGCCAATGCGC pGL449
OL332 Cys*‘'-.G ly*' g a c a g c t t c g c c g g c g a c c c g c g a a a t g pGL450
OL334 H is"^-.A la" ' c t a c g t c g c g g g g GCc g g c g c c a a g t c pGL451
OL336 Cys^"-*Gly^"' CCTGGCAGATACAGGCCATGCGATTGCG pGL403
Table 3.1: Primers used to mutate potential active site residues of GP18
Mutated nucleotides are shown in bold and shaded grey. For each mutation a second 
complementary primary was also used. The plasmid pGL403 was produced by Hilley, 
(1999).
3.2.2 Episomal expression in L, mexicana AgpiS cell lines
To confirm that GPI8 was expressed from the episomes transfected into the L. 
mexicana cell lines, a GPI8 antibody (R492) was used. This antibody was demonstrated 
in a previous study to be unable to detect L. mexicana GPI8 by western blotting of WT, 
Agpi8, and Agpi8[pXGPI8] (Hilley, 1999). The antibody was therefore used to 
immune-precipitate proteins from metabolically labelled cells, as this was regarded as a 
more sensitive approach.
To confirm the R492 antibody was suitable for immune-precipitation of GPI8, the cell 
lines WT, AgpiSlpXGPIS], Agpi8[pXgpi^^'^l and AgpiS[pXGP/S-GFP] were 
metabolically labelled with [^^S]ExpreSS protein labelling mix (MEN), for 6 hours in 
labelling medium prior to immune-precipitation. The cell lysates were immune- 
precipitated with either 6pl of pre-immune serum as a negative control, 6pl of aGPI8
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or 5pi of aGFP (Clonetech), and protein A/G sepharose beads following the method of 
Sharma et ah, (2000) as described fully in Chapter 2. Samples were electrophoresed on 
a 12% SDS-PAGE gel, and the gel dried down and exposed to film, or visualised on a 
Typhoon phosphor imager.
Immune-precipitation of WT cells with a GPI8 antibody detected a protein of size 
42kDa with both the pre-immune and immune serum (Figure 3.2 A, Lanes 1 and 2). 
Immune-precipitation from the cell line expressing GPIS'^^'^^ from an episome (Lanes 
5 and 6) also detected a 42kDa protein using both pre-immune, and immune serum. 
However, the protein precipitated with the immune serum was greatly enriched when 
compaied to the pre-immune immune-precipitation. This suggested the pre-immune 
serum detected a small amount of an unspecified 42kDa protein, whilst the immune 
serum detected a specific 42kDa protein. There was no enrichment of the 42kDa 
protein in WT cells when pre-immune and immune serum were compared, this 
suggested that a specific protein could not be detected in these cells.
A specific protein of size 42kDa was immune-precipitated from the GPI8 and 
Gpi8 ^216g ej^ p^i-essing cells (Lanes 6 and 8), whilst from the cell line expressing the 
GPI8-GFP fusion protein, a protein of size 72kDa was immune-precipitated with both 
the aGPI8 polyclonal antibody and the commercially available aGFP antibody (Lanes 
4 and 10). Precipitation with the pre-immune serum produced no proteins of 
comparable intensity (Lanes 3, 5, 7 and 9) suggesting that immune-precipitation with 
the antibody was protein specific.
The predicted size of GPI8 is 42kDa, and the predicted size of the GPI8-GFP fusion 
protein is 75kDa. The R492 polyclonal GPI8 antibody, therefore, is able to specifically 
immune precipitate a protein of the predicted size of GPI8 or GPI8-GFP from cell lines 
expressing episomal copies of these proteins. The use of the GFP antibody 
demonstrates that a protein of the expected size (72kDa) was immune-precipitated from 
the GPI8-GFP expressing cell line, comparable in size to that precipitated using the 
GPI8 antibody. This further demonstrates that the protein that the R492 antibody is 
detecting is GPI8. This experiment confirmed the validity of using immune- 
precipitation with the R492 antibody, as a method for detecting GPI8.
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The R492 polyclonal GPI8 antibody was then used to confirm GPI8 expression in all 
cell lines expressing different mutant forms of GPI8 from an episome (Figure 3.2 B). 
As expected, no GPI8 protein was detected in the AgpiS cell line (Lane 2). However, as 
in the previous experiment, no GPI8 was detected in WT cells (Figure 3.2 A, lane 2 and 
Figure 3.2 B lane 1). This is an indication of the low level of expression of GPI8 in 
wild type cells, and suggests that re-expression from an episome vastly over-expresses 
GPI8 compared to normal levels. A protein of size 42kDa, the predicted size of GPI8, 
was detected in all cell lines re-expressing the different foiTns of GPI8 (Figure 3.2 B, 
lanes 3-7).
3.2.3 GPI8 activity in active site mutants
The effect of the 4 mutations on L. mexicana GPI8 activity were assessed by examining 
the effect on GP63, the major GPI-anchored protein of Leishmania promastigotes. The 
AgpiS line itself has been shown to be deficient in the major GPI-anchored surface 
protein of L. mexicana, GP63 (Hilley et al., 2000). Re-expression of GP18 in AgpiS 
(the Agpi8[pXGPI8'\ line) restored GPI-anchored GP63 to the cell surface. Western blot 
and immunofluorescence analysis with antibodies specific to GP63, were used to assess 
the effect of the GPI8 mutations on the ability of the GPIT complex to add GPI-anchors 
onto GP63. GP63 could not be detected in cell lystates prepared from the GPIS'^ '^ '^  ^
expressing cell line, though expression of GPI8 in this cell line had not previously been 
confirmed (Hilley, 1999).
3.2.3.1 Western blot analysis of GP63 expression
Western blot analysis was used to study the effect of the GPI8 mutations on GP63 in 
total cell lysates (Figure 3.3). Cell lysates containing 10^  cells grown to mid to late log 
stage, were prepared, and 10^  cell equivalents were electrophoresed by 12% SDS 
PAGE. The gel was electroblotted prior to antibody detection of GP63. The primary 
antibody used was a mouse monoclonal, raised against L. major GP63, a gift from Dr. 
Robert McMaster, University of British Columbia, Vancouver, Canada (Button et al., 
1991). The antibody has been demonstrated to cross react with L. mexicana GP63 in 
western blotting, but is unable to detect GP63 in its native form in immunofluorescence 
experiments. The primary antibody was used at a dilution of 1:50; the secondary 
antibody, an anti-mouse IgG-horseradish-peroxidase conjugate (Promega), was used at
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a dilution of 1:5000. Antibody detection was by ECL (Pierce), and the result is shown 
in Figure 3.3. The WT lysate had a band pattern that is characteristic of GP63 detection 
using this primary antibody (Lane 1). A protein of size 63kDa (GP63) was present; a 
second protein of 50kDa was also present at a lower abundance. Whether this smaller 
protein is an isofomi, or degradation product of GP63, or whether it is an unrelated 
cross-reacting protein is unclear. The GPI8 null-mutant lacked GP63 in its cell lysate, 
though the protein was not completely absent as a trace of protein of size 63kDa could 
be detected (Lane 2). Re-expression of the native gene restored GP63 (Lane 3). In 
AgpiS expressing GPIS' '^ '^ '^  ^ or GPI8'^^""' ,^ GP63 was not detected (lanes 6 and 7 
respectively), whereas GP63 was present in cell lines expressing GPIS^'’^  ^or GPIS'^ '^^ '^  
(Lanes 4 and 5). This suggests the mutant forms of GPI8 expressed in the 
AgpiSipXgpiS^^^"^^] and Agpi8[pXgpi8^^^^^] cell lines are not active.
3.2.3.2 Immunofluorescence of surface bound GP63
Surface expression of GP63 was examined by immunofluorescence microscopy. The 
cells were prepared as described in Chapter 2, Cells were washed in PBS, air dried onto 
slides, fixed with 2.5% paraformaldehyde/ PBS for 15 minutes, and washed in PBS 
before the addition of primary antibody diluted as appropriate in PBS. Cells were not 
treated with methanol/ acetone during the fixation step, therefore cell membranes were 
not permeabilised. This fixation method detected protein expression on the cell surface. 
The primary antibody (L3.8) was a mouse monoclonal antibody raised against L. 
mexicana GP63, and was a gift from Dr. David Russell, Washington University, St 
Louis, USA (Medina-Acosta et al., 1989). L3.8 was used at a dilution of 1:100. The 
secondary antibody was an anti-mouse FITC conjugate (Sigma), used at a dilution of 
1:500. Cells were visualised by fluorescence microscopy and the images are shown in 
Figure 3.4. WT cells exhibited strong cell surface fluorescence. The secondary antibody 
only control confirmed that this fluorescence was due to the protein detected by the 
primary aGP63 antibody, and was surface-bound GP63. Surface bound GP63 was 
absent from the AgpiS cell line, but was restored in the Agpi8[pXGPI8] cells. GP63 was 
also restored to the surface of AgpiS cells re-expressing the GPI8 mutants GPIS'^^^  ^and 
GPIS'^ '^^ ,^ but was absent from the surface of AgpiS cells re-expressing the GPI8 
mutants GPI8'^'^''^ and GPIS'^ '^^^. These results confiim the data from the western 
blotting experiments; the GPI8 proteins expressed from the AgpiSipXgpiS^^^"^^] and
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Agpi8[pXgpi8^^^^^] cell lines are unable to restore GP63 to the cell surface, 
demonstrating that GPIS""'** and GPI8“ ‘“  lack GPIT activity.
3.3 Evidence that GPI8 is a component of a larger complex
In yeast and mammalian cells GPI8 has been shown to form a complex with other 
proteins to form an active GPIT (Meyer et ah, 2000; Vidugiriene et al., 2001), In an 
attempt to define the role of GPI8 as part of a complex in L. mexicana, the gene 
encoding non-functional GPI8^^"^^ was expressed from an episome in wild type cells 
(to give cell line WT[pXgpi8^^^^^]). This cell line was compared with wild type 
promastigotes expressing episomal GPI8 (cell line WT[pXGP/S]).
The plasmids pGL269, and pGL403 were transfected into WT cells. The cell lines were 
grown initially in medium containing 25pg ml ' of the antibiotic G418, to select for the 
episome. However, to increase the level of GPI8 expression within these cell lines, the 
concentration of G4I8 in the culture medium was increased, thereby increasing the 
copy number of the episome and hence protein expression. Cultures were grown in 
medium containing 125pg ml"' of G418. Cells from these cultures were added to 
medium containing 500pg ml"' G418. For each of the two cell lines, cultures were 
maintained in medium containing the 3 different concentrations of G418.
Expression of GPI8 was verified in the two cell lines WTCpXgp/S^ '^^* ]^ and 
WT[pXGP/S], by metabolic labelling of cells grown in 125pg ml"' G418. Cells were 
grown to mid to late log stage and labelled with ^^S-ExpreSS for 6 hours prior to 
immune-precipitation with an a-GPI8 antibody. Protein samples were electrophoresed 
by 12% SDS-PAGE, the gel dried and visualised with a Typhoon Phophor Imager 
(Figure 3.5). A protein of size 42kDa was present in both the WTCpXgpiS^^"^* ]^ and 
WT[pXGPI8] cell lines. This confirms GPI8 episomal expression in these cell lines.
The expression of GPI-anchored GP63 in the two cell lines was examined by western 
blot analysis (Figure 3.6). WT cells expressing the functional episomal copy of GPI8 
(Lanes 3-5) were found to express GP63 at levels similar to the wild-type parasites 
(Lane 1). An increase in the concentration of G418, and hence GPI8 levels, did not alter 
the levels of GP63 (Compare lanes 3, 4 and 5). However, cells expressing the mutated
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form of GPI8 showed decreased levels of GP63 in the cells compared to WT cells 
(Compare lane 1 with lane 6), and the amount of GP63 decreased as GPI8^^'^^ 
expression increased (Compare lanes 6, 7 and 8). Expression of an inactive GPI8 in WT 
cells therefore affects GP63 processing.
The effect on GP63 cell surface expression was then examined by immunofluorescence 
microscopy (Figure 3.7). Over-expression of GPI8 did not effect GP63 surface 
expression, whilst expression of GPI8‘^ "^’^  in wild-type cells drastically reduced the 
amount of GP63 on the cell surface (see cells grown in 25pg ml"' G418). At the highest 
concentration of antibiotic (500 pg ml"'), surface expression of GP63 was almost 
undetectable. This demonstrates that expression of GPIS'^^"’'^  in WT cells inhibits cell- 
surface anchoring of GP63.
Thus, expression of inactive GPI8 in wild type promastigotes produced a pronounced 
dominant-negative effect, which provides compelling evidence that GPI8 is required 
for transamidation activity and is likely to be part of a GPIT complex in L. mexicana.
3.4 The fate of GP63 in GPI8 mutant cell lines
It has been established that the mutant fonns of GPI8 affect GP63 processing, in that 
GP63 is lost from the cell lysate and cell surface of those cells which do not have an 
active GPIT. Studies in T. brucei suggest that cells which have a mutation at the GPI 
anchor addition site show a build-up of proteins destined to be GPI-anchored, within 
the Golgi (Bangs et al., 1997). Here they are thought to be rapidly degraded, suggesting 
that GPI anchors may have some involvement in the forward trafficking of some GPI- 
anchored proteins (McDowell et al., 1998). In Leishmania, GP63 mutated at the GPI- 
anchor addition site and expressed in a GP63 deficient cell line, was demonstrated to be 
secreted from the cell (McGwire and Chang, 1996). Both of these studies in 
trypanosomatids used artificial reporter systems with a defect at the site of GPI anchor 
addition. I therefore examined the processing of a GPI-anchored protein in a cell line 
with a defect in the GPI-anchoring pathway. The processing of GP63 was therefore 
examined in the cell lines expressing the different mutants of GPI8.
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3.4.1 Metabolic labelling of GP63 in different GPI8 mutant cell lines
The fate of GP63 within these cell lines was examined by metabolic labelling. Cells 
were labelled for 6 hours with [^^SjExpreSS, and GP63 immune-precipitated with the 
L3.8 antibody from either cell lysate, or the culture supernatants, as described in detail 
in section 2.5.10. Protein samples were electrophoresed on 12% agarose gels, which 
were dried down and then exposed to X-Ray film, or the Typhoon Phosphor imager.
Secretion of GP63 was first examined (Figure 3.8, panel A). From WT parasites (Lane 
1), a small amount of 3 isofoiTns of GP63 were detected (63, 64, 65 kDa - designated 
63s, 64s and 65s for secreted), with the 63s isoform being the most abundant. In 
contrast, a large amount of the 65s isofomi was detected in the medium in which AgpiS 
cells had been grown (Lane 2). Re-expression of GPI8 in the AgpiS null mutant 
resulted in only small amounts of GP63 being secreted, with isoform sizes comparable 
with those secreted from WT cells (Lane 3). Large quantities of the 65s isoform were 
detected also in the AgpiS cell lines expressing GPI8'^ "^ '^^  (Lane 7) and GPI8^'^''^ 
(Lane 6), as well as GPIS^^''^ (Lane 5). However, the AgpiS cell line expressing 
GPI8H63A j^jniicked the situation in wild type cells with little GP63 secreted. Thus a 
high level of secretion was associated with cells having a non-functional GPIT. WT 
cells re-expressing GPI8 or the inactive GPI8'^^"’° from an episome were also 
examined (Lanes 8 and 9). The cells were grown in 125pg ml ' G418 in order to 
increase the level of expression from the episome. WT cells over-expressing the 
functional copy of GPI8, processed GP63 as found in WT cells. A small amount of the 
65s, 64s and 63s forms were secreted into the medium, with the 63s being the most 
abundant. In contrast WT cells over-expressing GPI8^ '^^^  ^process GP63 as found in the 
AgpiS cells. A large amount of the 65s isoform of GP63 was secreted into the medium.
The presence of GP63 was also analysed in the cell lysates (Figure 3.5, panel B) by 
immune-precipitation with the same a-GP63 antibody. Three isoforms of GP63 were 
detected in WT cells (63, 64, 65 kDa - designated 63c, 64c and 65c for cell-associated), 
with the 63c isoform being most abundant. In the AgpiS cell line, only the 65c isofoi*m 
was detected (Lane 2). The two smaller isoforms of GP63 (63c and 64c) were present 
in Agpi8[pXGP18'\ lysates (Lane 3), at approximately equal levels. AgpiS cell lines 
expressing GPI8^'^"'^ (Lane 6) or GPIS*^ '^^ *^  (Lane 7) were similar in cell-associated
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profiles to AgpiS with the 65c isoform predominating, whereas the AgpiS cell line 
expressing GPI8™^^ (Lane 4) was the same as wild type with abundant 63c isoform. 
The AgpiS cell line expressing GPIS^^''^ (Lane 5) gave an intermediate pattern, with all 
three isoforms of GP63 present, however the 65c form was the most prevalent. The 
pattern in WT cell-1 ysates over-expressing the functional form of GPI8 was as that 
found in WT cells only. The pattern in WT cells over-expressing GPI8^ '^ '^^ 
corresponded to that found in the AgpiS cell line.
These results confirm that GPIS '^^"''  ^ and GPI8^^" '^  ^ are inactive forms of GPI8, the 
phenotype of these cell lines mimics that of the AgpiS cell line. GP63 is secreted into 
the medium in the cell lines without an active form of GPI8, and is not degraded 
intracellularly as previously suggested (Hilley et a l, 2000).
3.5 Discussion
Re-expression of episomal GPI8 in the AgpiS cell line provides an excellent model for 
assessing GPI8 activity. Whilst the activity of the GPIT enzyme cannot be measured 
directly, GP63 provides a convenient marker for the study of GPI8 activity. The use of 
the AgpiS cell line in previous work demonstrated that loss of GPI8 resulted in the loss 
of GP63 from the cell surface, whilst the episome pXGPIS was able to rescue this 
phenotype (Hilley et a l, 2000). [^H]ethanolamine labelling confirmed that the AgpiS 
cell line was deficient in GPI-anchored GP63, and showed an accumulation of putative 
protein anchor precursors (Hilley et a l, 2000). The episome therefore provides an ideal 
system for studying the mutation of GPI8.
Precipitation of GPI8 from all cell lines with an episomal copy of GPI8, confirmed that 
the protein was expressed, and demonstrated that lack of GPI8 activity was not due 
simply to lack of GPI8 expression. Use of the GPI8-GFP construct provides an 
important tool in the validation of the R492 GPI8 antibody, as recognition of the 
predicted 75kDa protein by both aGFP and aGPI8 confirmed that the GPI8 antibody 
does indeed recognise GPI8. This is an important result, because in previous studies the 
antibody was unable to recognise L. mexicana GPI8 by western blotting, and therefore 
evidence for the episomal expression of GPI8 was not provided (Hilley, 1999). GPI8
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was detected in all cell lines expressing an episomal copy of GPI8 including the 
Agpi8[pXgpi8^^^^^] cell line produced in a previous study.
In WT cells GPI8 was not detected (Figure 3.2). This may be due to the natural low 
level of expression of GPI8 in the WT cells and suggests that all components of GPIT 
may be expressed at a similarly low level. Use of the episome pXGPIS caused vast over 
expression of GPI8 and related mutants. However, this over expression did not appear 
to effect GPIT activity as substantiated by the use of both the Agpi8{pXGP18] and 
WT[pXGP/<S] cell lines. In these cell lines GP63 was still processed as found in WT 
cells.
The GPI8 mutations GPIB^^ '^  ^ and GPI8'^ '^'‘^  restored GPIT activity, as assessed by 
western blotting and immunofluorescence microscopy of GP63. However, the 
mutations GPIS' '^^"'  ^ and GPI8*^ "^’'^  were not able to restore GP63 to the cell surface, 
indicating that these two mutant fonns of GPI8 are inactive and unable to transfer a 
GPI anchor to the C-terminus of GP63. This provides evidence that the residues H174 
and C216 of GPI8 are essential for GPI anchoring, and indicates that these are the 
active site residues of L. mexicana GPI8.
It is possible that the mutations GPI8' '^^"^  ^ and GPIS'^^"’'^  each cause conformational 
changes in the GPI8 protein, which inactivates the protein. This is a possibility as the 
structure of the protein is at present not known. The importance of a single residue in 
the maintenance of tertiary structure is feasible in the case of cysteine, as it is possible 
that the sulphydryl group interacts with a second cysteine to form a disulfide bridge. It 
is possible that the residue C216 interacts with one of the other 8 cysteine residues 
present in L. mexicana GPI8. However cysteine residues involved in disulfide bridge 
formation would be expected to be conserved amongst the GPI8 subfamily. Mutation of 
the only other conserved residue, C94, does not abolish GPIT activity. Expression of 
GPI8 C216G cells also suggests that loss of activity is due to the loss of the
catalytic site rather than a conformational change. It seems unlikely that a protein 
inactivated due to conformational changes would be able to interact with other complex 
members, and therefore could not out compete the resident WT protein, producing a 
dominant negative effect. Comparison of this work with other studies provides further
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evidence that H174 and C216 are not responsible for maintenance of protein structure, 
but are the catalytic dyad for GPI8.
The identification of C216 as a catalytically important residue complements results 
which demonstrate that a cysteine group acts as the active site residue for the T. brucei 
GPIT (Sharma et al., 1999b), and L. mexicana GPI8 (Sharma et ah, 2000). A cell-free 
system was established to examine the mechanism of GPI anchor addition and utilised 
trypanosome membranes with endogenous GPIT activity and detectable amounts of the 
GPI-anchored protein VSG. The small nucleophile hydrazine was used as a nucleophile 
substitute for the ethanol amine residue of the GPI anchor. Addition of sulfhydryl 
alkylating agents into the assay resulted in the inhibition of hydrazine-induced release 
of VSG, and this was concluded to be due to the inactivation of an active site cysteine 
(Shaima et a l, 1999b). In a similar experiment using a mammalian system, the 
sulfhydryl alkylating agents did not reduce the amount of preprominiPLAP converted 
to GPI-anchored miniPLAP (Shaima et a l, 1999b). However, this was thought to be 
due to a limitation of the assay, rather than to a difference in activity between 
trypanosome and mammalian GPIT. The mammalian system used an in vitro translated 
reporter protein, which was added to membranes. Sulfhydryl alkylating agents were not 
added at the outset of the assay as they inhibit translocation, and it was thought GPI 
anchor addition had occurred during this delay (Sharma et aL, 1999b). Washed 
trypanosome membranes lacked GPIT activity, and this deficiency was reversed by the 
addition of recombinant L. mexicana GPI8 to the assay (Sharma et a l, 2000), whilst 
recombinant GPI8 incubated first with sulfhydryl alkylating agents could not 
reconstitute activity. These data provide evidence that the active site residue of T. 
brucei and L. mexicana GPI8 is a cysteine.
Sequence analysis has demonstrated that GPI8 has identity to the Clan CD, CI3 family 
of cysteine proteases (Benghezal et a l, 1996; Hilley et a l, 2000). Legumain from the 
plant legume, the jack bean, Canavalia ensiformis, was the first protein in this C13 
family to be identified. It showed specificity for the cleavage of asparaginyl bonds, and 
was inhibited by sulfhydryl alkylating agents (Abe et a l, 1993; Barrett and Rawlings, 
1996). Legumain-like proteins have since been identified and characterised in 
mammals including mouse (Chen et a l, 1997) and pig (Chen et a l, 1998). Families of
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cysteine peptidases are characterised by highly conserved regions which form the 
catalytic site (Banett and Rawlings, 1996), Within the C13 family this consists of a 
catalytic dyad; a histidine residue is thought to deprotonate the active site cysteine 
(Barrett and Rawlings, 1996; Meyer et aL, 2000). The GPI8 homologues appear to 
form a subfamily of the original C13 family (Meyer et a l, 2000). The asparaginyl 
endopeptidase subfamily shows significant sequence similaiity around the active site 
histidine/ cysteine, whilst the transamidase subfamily shows little homology around the 
active site histidine/ cysteine (Sajid and McKenow, 2002).
The active site residues of yeast GPI8 (Meyer et a l, 2000), and mammalian GPI8 
(Ohishi et a l, 2000) have recently been identified. Sequence alignment of the C13 and 
GPI8 families identified in yeast Cys85 as conserved amongst the GPI8 family, whilst 
C199 was conserved amongst the entire C13/ GPI8 families with the exception of 
Schistosoma mansoni hemoglobinase B (Meyer et a l, 2000). His94 was conserved in 
18 of the 19 identified C13/ GPI8 family members, whilst H157 was conserved in all 
19. Deletion of GPI8 from yeast cells is lethal, therefore the four conserved sites were 
mutated and used in complementation experiments in a yeast GPI8/ AgpiS mutant and 
WT cells. The Cysl99 and Hisl57 mutations were unable to rescue AgpiS spores in 
tetrad analysis, whilst expression in WT cells led to growth anest, and the build up of 
GPI anchor precursors. Thus, CI99 and H I57 were identified as the active site residues 
of yeast GPI 8 (Meyer et a l, 2000). A similar approach identified Cys206 and His 164 
as the active site residues in human GPI8 (Ohishi et a l, 2000). C206A and H164A 
expressing vectors were unable to complement K-cells, a mammalian cell line which 
lack GPIT activity. The addition of C206A and H i64A GPI8 to K-cell membranes 
failed to produce the hydrazide form of miniPLAP in a cell free assay, demonstrating 
the absence of GPIT activity (Ohishi et a l, 2000). The residues H174 and C216 of L. 
mexicana GPI8 are homologous to those identified as the active site histidine and 
cysteine residues in yeast and human GPI8s (Figure 3.1). The data presented provides 
convincing evidence that H I74 and C216 are the L. mexicana GPI8 catalytic dyad.
Metabolic labelling of cells and immune-precipitation of GP63 reveals that while the 
mutant GPI8'^ '^''  ^ does not abolish GPIT activity, it does, however, show an abeiTant 
phenotype when compared with WT cells. Similar to WT, GP63 is trafficked to the ceil
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surface, as demonstrated by immuno-fluorescence microscopy, and processed to a 63 
kDa form as demonstrated by metabolic labelling and immune-precipitation with 
aGP63. However, unlike WT cells, the AgpiSipXgpiS^^"^^] cell line secretes a large 
amount of a 65kDA form of GP63 into the medium. The 65s form of GP63 is 
abundantly secreted from AgpiS cells and the cell lines expressing the active site 
mutants GPIS"'^''^ and indicating this phenotype is associated with an
inactive GPIT and is the result of the failure to add a GPI anchor to the GP63 protein. 
GPIS*^ '^'*^  is therefore a dysfunctional enzyme, with reduced GPIT activity (Figure 3.9). 
Mutation of His54 in yeast GPI8 and Cys92 in human GPI8 also led to a partial loss in 
function (Meyer et aL, 2000; Ohishi et aL, 2000). It is not clear if this partial loss in 
function is due to improper folding of the proteins, possibly preventing efficient 
integration into a GPIT complex. The residues may have some catalytic importance, or 
play a role such as the recruitment of GP63 into the GPIT complex. Alternatively, the 
residue may be implicated in linking GPI8 to other complex members. As C94 is 
conserved amongst all the GPI8 family, but not the CI3 subfamily (See Figure 3.1), it 
is possible that this residue forms an intercomplex disulfide bridge with another 
member of the putative GPIT complex. This is possible particularly as the homologous 
mutation in human GPI8 (C92A) causes a similar decrease in activity (Ohishi et aL,
2000). The coiTesponding mutant in yeast (C85A), was only assessed for its ability to 
complement the GPI8 deletion, and the level of GPI8 activity in this mutant was not 
addressed (Meyer et aL, 2000).
Expression of the active site mutant GPIS'^ '^*’*^ in WT cells leads to a pronounced 
dominant negative effect. GP63 was not processed to the cell surface, and was secreted 
from the cells in the 65s form, similar to the phenotype seen in AgpiS cells. This was 
not an artefact caused by the over-expression of GPI8 from an episome, as 
demonstrated by the finding that expression of wild type GPI8 from an episome did not 
effect GP63 processing. This provides evidence that GPI8 is a component of a larger 
GPIT complex. GPI8 was undetectable in WT cells by immune-precipitation, so is 
likely to be expressed in the cell at a low level. Other complex members would be 
expected to be expressed at comparable levels, competition between functional and 
non-functional GPI8 to form this GPIT complex would be limiting. It could be argued 
that the vast over-expression of GPI8‘^ '^*^  ^ results in the mutant forai of GPI8 out-
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competing the WT form only with regard to the proteins binding to GP63. However, 
competition to bind to GP63 is unlikely to be limiting as GP63 is an abundant protein 
in the cell, making up approximately 1% of the total protein in promastigotes (Bouvier 
et aL, 1995).
The dynamics of this dominant negative effect could not be examined by the method 
used. Expression of GPI8 from the pXG episome could not be switched on or off, nor 
the level of GPI8 expression be tightly controlled, therefore the rapidity with which the 
GPIT reaction was inhibited could not be assessed. Use of an inducible expression 
system would allow a closer examination of the kinetics of GPIT complex formation, 
both with respect to timing, and the level of expression of GPIS*^ '^^ *^  required to 
produce a dominant negative effect.
Evidence from other systems also demonstrates that GPI8 is the catalytic sub-unit 
within a larger GPIT complex. Removal of T. brucei GPIT activity from trypanosome 
membranes by a high pH wash, and reconstitution of that activity with LmGPI8-his, 
suggested that in protozoa the GPIT is part of a complex, and this complex may be 
dynamic (Shamia et aL, 2000). L. mexicana and T. brucei GPI8 lack a transmembrane 
domain, and it is conceived that at least one other component with a transmembrane 
domain is present in the complex to link GPI8 to the ER membrane. Binding of pro­
protein to the GPIT has been shown by the cell-free assay system to be reversible 
(Sharma et aL, 1999b).
In higher eukaryotes GPI8 has been demonstrated to form part of a complex with at
least three other components (GAAl, GPI 16/ PIG-S, and GPI17/ PIG-T), which
associate stably (Ohishi et aL, 2000; Fraering et aL, 2001; Ohishi et aL, 2001). In yeast
cells, GAAl and GPI8 were first cloned from a temperature-sensitive GPI deficient cell
line (Hamburger et aL, 1995; Benghezal et aL, 1996). Immune-precipitation
experiments demonstrated that GAAl and GPI8 associate as a complex, with a third
protein GPI16 (Fraering et aL, 2001). Yeast GPI 17 was identified through homology
with the mammalian protein PIG-T (Ohishi et aL, 2001). In mammalian cells
homologues of yeast GPI8 and GAAl were identified, (Yu et aL, 1997; Hiroi et aL,
1998), and demonstrated to act as components of a GPIT complex (Ohishi et aL, 2000).
PIG-S and PIG-T were isolated as GPIT complex members by co-precipitation with
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GPI8. The 4 known members of the GPIT complex were each shown to be essential for 
GPI anchor attachment (Ohishi et aL, 2000; Fraering et aL, 2001).
Studies using photo-crosslinking methods were able to co-precipitate GPI8, GAAl and 
2 additional proteins of sizes 60 and 120 kDa from mammalian cells (Vidugiriene et aL,
2001). The 120kDa protein does not match the size of any components of the GPIT 
complex so far identified. The GPI complex was also shown to sediment at a size 
corresponding to 460kDa, and not in the range for 240kDa, which is the size, predicted 
from the 4 known components (Vainauskas et aL, 2002). This suggests other members 
of the GPIT complex may exist.
GPI8 can be cross-linked directly to the pro-protein, demonstrating a direct association 
occurs between GPI8 and the protein to be anchored (Spurway et aL, 2001; Vidugiriene 
et aL, 2001). This provides further evidence that GPI8 is the catalytic sub-unit of the 
GPIT complex, and directly cleaves the GPI attachment signal peptide. The role of the 
other complex members is unclear. GAAl has 6 transmembrane domains and is 
thought to anchor the catalytic subunit to the ER membrane. It is anticipated that some 
GPI-attachment signal-peptide recognition mechanism exists to prevent cleavage of 
unrelated proteins, and it is speculated that other sub-units of the complex may regulate 
this (Meyer et aL, 2000). A 70 kDa protein, possibly GAAl, could be cross-linked to 
the pro-protein, but only in conditions whereby the protein was unable to be GPI- 
anchored. This suggests that GAAl may directly associate with the pro-protein and 
have a functional role within the GPIT complex (Vidugiriene et aL, 2001). However, 
use of the cysteine-specific cross-linking reagent BMH detected pro-protein, with a 
mutation at the co site, linked to GPI8, but not GAAl. It was speculated that this may be 
due to lack of interaction between GAAl and the pro-protein, or that the method used 
was not sensitive enough to detect the interaction (Spurway et al., 2001). Loss of PIG-T 
prevents the complex formation of the other three members, suggesting a critical role 
for PIG-T in the maintenance of the complex (Ohishi et aL, 2001).
It is unclear if the GPIT complex formed in higher eukaryotes is stable or dynamic. The
dynamics of the dominant negative effect produced by expression of a GPI8 active site
mutant in yeast cells suggested rapid incorporation of the mutated protein into existing
complexes. This implies that the GPIT complex is dynamic in nature (Meyer et aL,
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2000). However, it is clear that the complex is relatively stable as the sub-units do not 
dissociate during extraction and purification, even in the absence of pro-protein and 
GPI anchor precursors (Ohishi et a l, 2001).
The GPI: Protein transamidase has been demonstrated in higher eukaryotes to be a 
large complex containing at least 4 members. While no other members of the GPIT 
complex have yet been cloned from protozoa, sequence analysis has identified a 
putative GAAl homologue in L. major (Eisenhaber et a l, 2001). The data presented 
strongly indicates L. mexicana GPI8 is the catalytic sub-unit of a larger GPIT complex, 
reminiscent of the situation found in higher eukaryotes. Identification of other complex 
members, and the effects of the loss of GPI anchoring on the onward processing and 
trafficking of GPI-anchored proteins, represent areas for further study.
The fate of GP63 was examined in the cell lines with an active, inactive and 
dysfunctional GPI8. GP63 was secreted at high levels into the medium in the absence 
of GPI8 activity, as demonstrated by metabolic labelling and immune-precipitation 
analysis (Figure 3.8). This is in contrast with previously reported findings, where GP63 
was not detectable in the culture medium by western blotting, and was thought to be 
degraded intracellularly (Hilley, 1999; Hilley et aL, 2000). This is an indicator of the 
greater sensitivity of the use of immune-precipitation and metabolic labelling. The 
results demonstrate that GP63 is processed and trafficked differently in cells that lack a 
functional GPIT (AgpiS, Agp»[pXgpiS“ "^°], AgpiS[pXgpi^'^^*\ WT[pXg/?;S“ '“ ]). 
Failure to add a GPI anchor to the protein results in secretion of GP63 from the cell 
instead of surface anchoring, and this secreted isoform is of size 65kDa. Proteins with a 
functional GPIT produce GPI-anchored GP63, which is trafficked to the cell surface, 
and has isoforms of 3 different sizes (63kDa, 64Da and 65kDa). These isofonus may 
represent GP63 at different stages of processing. The presence of different subsets of 
GP63 isoforms within the 2 sets of cell lines may be due to differences in processing, 
such as the failure to remove the C-terminal signal sequence in cell lines lacking GPIT 
activity. The processing of GP63 will be addressed in the next chapter.
GPI8 activity can be defined with respect to the fate of GP63. These results are
summarised in Figure 3.9. Cells with an active GPI8 traffic GP63 to the cell surface,
with a small amount secreted. Cells with an inactive GPI8 do not traffic GP63 to the
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cell surface, and secrete an abundant amount of GP63 into the medium. GPI8^ '^*^° and 
GPIS '^^"''^ are non-functional enzymes, whereas GPI8™^^ is fully functional. The cell 
line expressing dysfunctional GPIS'^ "^''^  has an intermediate phenotype, with GP63 
trafficked to the cell surface, but also a large quantity of GP63 secreted from the cell.
Figure 3.1: Amino acid sequence alignment of Leishmania mexicana GPI8 
with homologues from other species, and Legumain a C13 cysteine protease.
L. mexicana (Lm) GPÏ8 (Ace No:AJ242865/ Protein ID:CAB55340) alignment 
with GP18 from T. brucei (Tb (AJ439686/ CAD291141)), Plasmodium falciparum 
(Pf (AJ401202/ CAD96076)), Saccharomyces cerevisiae (Sc (AQ450372/ 
P49018)) and Homo sapiens (Hs (AF022913/ AAB81597)), and Canavalia 
ensiformis Legumain (Lg (D31787/ BAA06599.1)) a member of the C13 cysteine 
protease sub-family. The alignment was performed using Align X (InforMax. Inc). 
Identical residues are shaded pink, conserved and similar residues are shaded grey. 
Weakly similar residues are shown in blue. Conserved cysteine and histidine 
residues which are potential active site residues are indicated (*^ ), and numbered 
according to their position within the L. mexicana GPI8 sequence.
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Figure 3.2: Analysis of GPI8 expression in cell lines containing an episome.
Cell lines were metabolically labelled with S^^ExpreSS for 6 hours hours prior to 
immune-precipitation from the cell lysate. Equivalent samples were 
electrophoresed by 12% SDS PAGE, the gels dried down and visualised with a 
Typhoon Phosphor imager.
Panel A) Samples were immune-precipitated with the R492 GPI8 antibody (Lanes 
2, 6, 8 and 10), or a GFP antibody (Lane 4). Alternatively samples were immune- 
precipitated with R492 pre-immune serum (Lanesl, 3, 5, 7 and 9), to demonstrate 
antibody specificity. The 42kDa protein GPI8, and the 72kDa protein GPI8-GFP 
are indicated
Panel B) Samples were immune-precipitated with the R492 GPI8 antibody, to 
confirm GPI8 expression in the àgpiS cell lines re-expressing different forms of 
GPI8 from an episome.
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Figure 3.3: Analysis of GP63 expression in cell lines expressing modified GPI8.
Cell lysates were prepared from the cell lines WT, AgpiS, Agpi8[pXGPI8], 
Agpi8[pXgpi8^^^% Agpi8[pXgpi8^^*% Agpi8\pXgpi8^^'^'^^] and 
Agpi8[pXgpi8^^^^^]. These were subjected to SDS-PAGE and electrophoresed at 
1x10  ^cell equivalents per lane, and electroblotted. The blot was exposed to a L. 
major GP63 monoclonal antibody at a dilution of 1:50. The 63kDa GP63 protein is 
indicated.
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Figure 3.4; Immunofluorescence detection of surface bound GP63.
L. mexicana promastigotes were fixed in 2.5% paraformaldehyde and cells were 
incubated with a GP63 primary antibody (L3.8) at a dilution of 1:100, and a FITC 
conjugated anti-mouse secondary antibody (Sigma) at a dilution of 1:500.
Cells were examined with a Zeiss microscope and images were visualised using a 
Hamamatsu digital camera and analysed in OpenLab.
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Figure 3.5: Expression of GPI8 in WT promastigotes expressing episomal 
copies of GPI8,
Cell lines were grown in 125 pg ml ' G418, and metabolically labelled with 
S^^ExpreSS for 6 hours hours prior to immune-precipitation from the cell lysates 
with the R492 a-GPI8 polyclonal antibody. Equivalent samples were 
electrophoresed by 12% SDS PAGE, the gel dried down and visualised with a 
Typhoon Phosphor imager. The 42kDa GPI8 protein is indicated.
WT AgpiS WT\pXGPI8] WT[pXgpf8C2i6G] 
kDa 1 2 3 4 5 6 7 8
GP63
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Figure 3.6: Analysis of GP63 expression in WT promastigotes expressing GPI8 
and GPI8^ '^^  ^from episomes.
Western blot analysis of GP63 expression in L. mexicana lysates. Cell-lines 
WT[pXGP/<5] (lanes 3-5) and WT[pXgp/<5^ '^^°] (Lanes 6-8) were grown in 
increasing concentrations of G418 to select for increased plasmid copy number and 
a higher level of expression of GPI8 or GPI8^ '^^®. Lysates were prepared from 10* 
cells, and 10  ^cell equivalents per sample were electrophoresed by 12% SDS- 
PAGE, and electroblotted. Western blot analysis was performed with an a-GP63 
monoclonal antibody used at a dilution of 1:50. GP63 is indicated.
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Figure 3.7: Immunofluorescence detection of surface bound GP63 in wild type 
cells expressing either a functional or non functional form of GPI8 from an 
episome.
Cells expressing episomal copies of GPI8 were grown in increasing concentrations 
of G418 to increase episomal copy number, and hence GPI8 expression. L. 
mexicana promastigotes were fixed in 2.5% paraformaldehyde. Fixed cells were 
incubated with a GP63 primary antibody (L3.8) at a dilution of 1:100, and a FITC 
conjugated anti-mouse secondary antibody (Sigma) at a dilution of 1:500, to allow 
detection of surface bound GP63.
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Figure 3.8: Secretion of GP63 from AgpiS. Leishmania promastigotes were 
cultured with ^^S-ExpreSS for 6 h. Samples from the medium {Panel A) or cell 
lysates {Panel E) were collected, immune-precipitated with a-GP63 antibody and 
electrophoresed on a 12% PAGE gel. Gels were scanned with a phosphor imager. 
Secreted GP63 (65s, 64s, 63s in kDa) and cellular GP63 (65c, 64c, 63c in kDa) are 
indicated.
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Figure 3.9: Summary of the activity of GPI8 based on the ultimate fate of 
GP63.
Cells with a fully functional GPI8 traffic GP63 to the cell surface, whilst cell lines 
without a functional GPI8 secrete large amounts of GP63 from the cell. The 
AgpiSlpXgpiS^^"^^] cell line has a dysfunctional GPI8, and has an intermediate 
phenotype with secretion from the cell and transport to the surface.
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Chapter 4
Characterisation of the trafficking and processing of the GPI- 
anchored protein GP63 in WT and AgpiS cell lines.
4.1 Introduction
GP63 is the major GPI-anchored protein of Leishmania promastigotes as described in 
detail in section 1.3. Previous studies of GP63 have identified funetional domains 
characteristic of a GPI-anchored metalloproteinase by sequencing studies and site 
directed mutagenesis (Button and McMaster, 1988; McMaster et a i, 1994). These 
domains are thought to be processed during the trafficking of the protein to the cell 
surface (Figure 4.1), though the precise intracellular processing of GP63 in WT cells 
has not previously been fully analysed. It has been shown that modification of GP63 for 
secretion, by deletion of the C-tenninal end, results in the release of an inactive protein 
using either a baculovirus expression system, or Cos-7 cells (Button et aL, 1993; 
McMaster et aL, 1994; Macdonald et a l, 1995). Mutation of the anchor addition site of 
L. major GP63, and expression in a L. amazonensis GP63 deficient cell line resulted in 
the secretion of an active protein (McGwire and Chang, 1996). In Chapter 3 it was 
demonstrated that both the processing and trafficking of GP63 is affected by the loss of 
GPI8 activity from the cells. The aim of this section of work was to characterise these 
differences in greater detail.
4.2 Comparison of processing in WT versus AgpiS cells
4.2.1 Sequence analysis of L. mexicana GPl anchored GP63
In order to chai'acterise the processing of GP63 in the L. mexicana WT and AgpiS cell
lines the protein’s functional domains were identified. Previous studies have focused on
L, major and L. amazonensis, and the multiple genes encoding GP63 have been shown
to be highly conserved within and between species (Button and McMaster, 1988). L.
mexicana is atypical, in that amastigotes express a non GPI-anchored form of GP63
tenned Cl in a stage regulated manner (Medina-Acosta et aL, 1993). The Cl GP63 has
been sequenced and shown to vary from L. major GP63 in its C-terminal sequence, and
increased number of N-glycosylation sites (9 potential sites were identified) (Medina-
Acosta et a l, 1993). The characteristic homology of the GPI-anchored promastigote
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form (C2) of L. mexicana GP63 was confirmed by sequencing a copy of C2 GP63. A 
plasmid pSK-4 (a gift from Dr D. Russell, Washington University, renamed pGL454) 
containing GP63 cDNA from L. mexicana cloned into the EcdPl site of pBluescript SK 
(Medina-Acosta et aL, 1993) was sequenced and the predicted protein compared with 
GP63 from L. major and L. amazonensis (Figure 4.2).
The L. mexicana GPI-anchored form of GP63 is predicted to have a precursor protein 
of size 602 amino acids, whilst the mature peptide is predicted to be of size 477 amino 
acids. The functional domains were predicted either by use of the ‘big-PI predictor’ 
(Eisenhaber et aL, 1998), or by homology to domains identified in L. major and L. 
amazonensis GP63. An ER signal sequence is predicted from residues 1-37 (Eisenhaber 
et aL, 1998), homologous to those found in L. major and L. amazonensis (Button and 
McMaster, 1988; Button et aL, 1993). A Pro-region is predicted from residues 38 to 
100 based on similarity to L. major and L. amazonensis (Button and McMaster, 1988; 
Macdonald et aL, 1995). The GPI anchor addition site is predicted to be at residue 577, 
with a hydrophobic region from 586-602 (Eisenhaber et aL, 1998). 3 potential N- 
glycosylation sites are predicted at positions 300, 407 and 534, these sites are 
conserved in both L. major and L. amazonensis. All 3 sites have been shown by site- 
directed mutagenesis in L. major to be N-glycosylated (McGwire and Chang, 1996). 
The zinc-binding domain is also conserved at position 262 to 266 based on homology 
to the L. major and L. amazonensis sequences (McMaster et aL, 1994). The identity 
between L. mexicana, L. major and L. amazonensis GPI-anchored GP63 is 76.9%, and 
the similarity between L  mexicana and L. major 82%, and between L. mexicana and L. 
amazonensis is 90%. This demonstrates that, unlike the amastigote form of GP63, the 
L. mexicana promastigote form of GP63 is highly conserved between species.
4.2.2 Pulse-chase labelling of cells.
Lack of an active GPI8 effects the processing and trafficking of GP63 when compared 
with WT cells. To examine these variations in more detail WT promastigotes, AgpiS 
and AgpiS{pXgpiS^^^^^] cells were analysed by pulse-chase labelling. Cells were 
metabolically labelled with ^^S-ExpreSS for 12 minutes and then chased in cold 
medium for a period up to 300 minutes. GP63 was immune-precipitated from the cells 
or culture medium and analysed by SDS-PAGE. The processing of GP63 within the
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cells was also examined by partitioning the cells into soluble and membrane associated 
fractions by either extraction with TX-114 or NaCOa (Figure 4.3).
The data shown in figure 4.3 is representative of a number of repeated experiments. 
Pulse-chase labelling of cells and extraction with TX-114 (Figure 4.3, A) demonstrated 
that in WT cells GP63 partitioned exclusively into the membrane associated fraction at 
all time points. At time 0 minutes of chase, the major isoform of GP63 was 65c 
(cellular). After 20 minutes, the majority of 65c had been chased into 64c and by 40 
minutes 64c was in the process of being chased into 63c. By 180 minutes all detectable 
label was in the 63c isoform. In contrast to wild type cells, only the 65c isofoim was 
detected in the AgpiS and Agpi5[pXgpi5*^ '^^‘^ ] lines (Figure 4.3, A). Moreover, most of 
this 65c form remained in the soluble phase in AgpiS and AgpiS[pXgpiS^^^^^] cells. 
NaCOs extraction of pulse-chase labelled cells produced similar results (Figure 4.3, B). 
In WT cells GP63 partitioned exclusively into the membrane associated fraction at each 
time point. During the chase period the protein underwent a size change from a 65c 
isoform present at time 0, to reach a 63c isoform at time 180 minutes. In the AgpiS cells 
only the 65c isoform of GP63 was detected throughout the chase period. This 65c 
isoform partitioned into both the soluble and membrane fractions, differing from the 
result seen following TX-114 fractionation.
2 forms of GP63 were secreted from WT cells, a 65s (secreted) and 63s form (Figure 
4.3, C). Only a 65s foim of GP63 was secreted from the AgpiS and Ag/?/S[pXgp/S^^^^^] 
cell lines. A low level of ^^S-labelled GP63 was secreted from wild type parasites, 
while high levels of secreted GP63 could be detected over a ISO minute chase period 
for both AgpiS and AgpiS[pXgpiS^^^^^] (Fig 4.3, C). In order to quantify this difference 
the level of GP63 secretion was measured using a Typhoon Phosphor-imager, and 
quantified using the Image Quant programme (Molecular Dynamics). To allow direct 
comparison between WT and AgpiS cells the results from individual experiments were 
used in which both cell lines were labelled in tandem and all conditions such as cell 
numbers, quantity, activity of and exposure times to the phosphor-imager were 
identical. The results from a 300-minute pulse-chase experiment are shown (Figure 4.4) 
and are representative of a number of individual experiments. After 300 minutes the 
level of GP63 secretion from WT cells was estimated to be only 13% of that secreted
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from AgpiS cells, with the ti/2 for AgpiS GP63 secretion estimated to be 120 minutes 
(Figure 4.4). This clearly demonstrates the higher rate of secretion of newly synthesised 
GP63 in cells with a non-functional GPI8.
Repetition of pulse-chase experiments and Triton X I14 fractionation (Figure 4.3A) 
consistently produced the same results, and suggested that the intracellular distributions 
of GP63 within WT and AgpiS cells differed. A plot of the distribution of GP63 within 
the two cell lines confirmed this (Figure 4.5). The two graphs were calculated from data 
from a single pulse-chase experiment and were therefore directly comparable. The 
graphs show some fluctuations due to experimental error, particularly with regards to 
the WT membrane fractions, however the general trends can be inteipreted and are 
representative of a number of experiments. In the WT cells GP63 remained almost 
exclusively in the membrane fractions, the small quantities of GP63 secreted from the 
cell were comparable to the amount of material found in the soluble cell fraction. In the 
AgpiS cell line intracellular GP63 remained in the soluble fraction, and this amount 
decreased during the chase period as GP63 was secreted from the cell. A small amount 
of GP63 remained in the membrane-associated fraction. The graphs clearly demonstrate 
the difference between the intracellular distribution of GP63 in WT and AgpiS cells.
To investigate the possibility that the expression levels of GP63 differed between the 2 
cell lines the level of total expression was calculated by combining the quantity of 
GP63 present in each cell fraction (Figure 4.6). The pattern of GP63 protein expression 
was similar, though expression from the AgpiS cells was approximately 20% lower than 
in WT cells (approximately 8,000,000 units compared to 10,000,000 at time 300 
minutes). It is possible that this is due to some degradation of the protein intracellularly.
4.3 Processing events within WT and AgpiS cell lines
The results from the pulse-chase labelling experiments clearly demonstrate that GP63 
in AgpiS cells is processed differently than GP63 in WT cells. The 65c fonn was 
speculated to represent a precursor fonn of GP63, which underwent further processing 
in WT cells to reach the mature 63c fonn. In the AgpiS cells it appeared that the 65c 
form was not processed to the fully mature form. Thus lack of GPI-anchor addition to 
the protein appeared to prevent further downstream processing. To investigate this
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hypothesis the processing of GP63 in both WT and the AgpiS cells was examined in 
greater detail. The removal of the C-terminal GPI-signal sequence, addition of the GPI 
anchor, variations in glycosylation, and activation by removal of the pro-region were all 
examined.
4.3.1 Timing of anchor addition
It was speculated that the 65c form of GP63 present in both WT and AgpiS cells 
represented an un anchored form of GP63. The timing of GPI anchor addition during the 
processing of GP63 was examined by determining which forms of GP63 had a GPI 
anchor. Treatment of a GPI-anchored protein with the enzyme phosphatidylinositol 
phospholipase C (PI-PLC), cleaves the GPI-anchor at the PI moiety, and subsequent 
TX-114 fractionation results in the protein partitioning into the soluble, rather than the 
membrane phase. WT promastigotes were labelled with ^^S-ExpreSS for 12 minutes 
and then chased in cold medium for a period up to 180 minutes. Samples were taken at 
time 0 minutes, 40 minutes and 180 minutes and lysates treated with or without PI-PLC 
followed by TX-114 fractionation and GP63 immune-precipitation (Figure 4.7). At 
time 0 minutes of chase only the major 65c protein was present. This isoform 
partitioned into the membrane-associated fraction (lane 2), but after PI-PLC treatment 
was found in the soluble fraction (lane 3) consistent with the GPI anchor having been 
removed. This pattern of results was repeated with samples taken at time 40 minutes, 
and time 180 minutes, all protein isofonns detected were present in the membrane 
fraction, but subsequent to PI-PLC treatment were detected in the soluble fraction. This 
demonstrated that in WT cells all isoforms of GP63 detected by pulse-chase labelling 
were GPI-anchored, and that GPI anchor addition occurred very rapidly after 
translocation into the ER. It should also be noted that a fourth minor isofoim of GP63 
could be detected (lanes 6 and 7). As all the detected isoforms of GP63 were GPI- 
anchored, additional post-translational modifications, such as glycosylation and 
activation must occur to process the 65c isofonn to the 63c isoform.
4.3.2 Glycosylation 
ConA precipitation
Glycosylation of GP63 was examined by testing if the protein bound to the lectin 
Concanavalin A (ConA), which interacts with the tri-mannose core common to all N-
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linked glyeans. Cells were grown to late log phase, the medium collected and proteins 
ConA precipitated using ConA sepharose beads. In a separate experiment 1x10  ^ cells 
were collected and proteins ConA precipitated from the cell lysate. Samples were 
electrophoresed on 12% SDS-PAGE gels, electroblotted and GP63 was detected by 
western blotting with a GP63 antibody (Figure 4.8). A control experiment using 
sepharose 4B beads in place of ConA sepharose beads demonstrated that GP63 did not 
bind to Sepharose beads non-specifically (data not shown). Proteins were detected in 
the ConA precipitated medium and cell samples from both cell lines (Figure 4.8). A 
much higher level of glycosylated GP63 bound to ConA from WT cell lysate material 
(lane 5) than from AgpiS cell lysates (lane 6). In contrast glycosylated GP63 was 
present at a lower level in the medium of WT cells (lane 3) compared with that from 
AgpiS cells (lane 4), and the size of GP63 precipitated was larger in the AgpiS samples. 
This demonstrates that GP63 is N-glycosylated in both WT and AgpiS cells and that N- 
1 inked glycosylation can occur in the absence of GPTT activity.
Tunlcamycin Treatment
To examine the effect that loss of N-glycosylation would have on GP63 processing, the 
two cell lines were grown in medium containing 5 pg mF  ^ tunicamycin to inhibit N- 
linked glycan formation. Pulse-chase labelling was used to examine the processing of 
GP63 under these conditions (Figure 4.9, A and B). GP63 was processed differently in 
WT cells grown in the presence or absence of tunicamycin. A smaller fonn of GP63 
(approximately 63 kDa, designated 63ct - cellular material with tunicamycin) was 
present at time 0, and this was chased into a 60 kDa (60ct) after 180 minutes. Only a 
single minor intermediate form of GP63 was identified in cells grown in the presence of 
tunicamycin, compared to the one major (64c) and one minor protein identified in 
normally grown WT cells. The AgpiS cells grown in the presence of tunicamycin also 
expressed a smaller GP63 (63ct). However, this was not chased to a 60 kDa form. The 
size difference between the proteins isolated at time 0 from cells grown in the presence 
and absence of tunicamycin coirelates with the lack of N-glycosylation. The lower 
number of detectable intennediate fonns present in WT cells grown in the presence of 
tunicamycin, indicates that one of the isoforms detected during GP63 maturation may 
be a result of N-glycan processing. GP63 could not be detected in the medium of wild 
type cells grown in the presence of tunicamycin (Figure 4.9, B). The level of GP63
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detected in the medium of the AgpiS cell line grown in the presence of tunicamycin was 
barely detectable over background levels, contrasting with the high levels of GP63 
secreted by the AgpiS cells grown under normal conditions. This suggests that N-linked 
glycosylation is important for the secretion of GP63, from both WT and AgpiS.
PNGaseF treatment
The timing of glycosylation was further examined by PNGaseF treatment of GP63. 
PNGaseF cleaves N-glycans between the innermost GlcNAc and asparagine residues. 
WT and AgpiS cells were labelled with ^^S-ExpreSS for 12 minutes and then chased in 
cold medium for a period up to 180 minutes. Samples were taken at appropriate time 
points and cell lysates TX-114 fractionated and GP63 immune-precipitated. The 
membrane fraction from the WT cells, and the soluble fraction from the AgpiS cells 
were taken and each sample was divided in two, one half was treated with PNGaseF, 
and the other half mock treated. Samples were then electrophoresed by 12% SDS- 
PAGE, and scanned with the phosphor-imager (Figure 4.10). At each time point in both 
cell lines all GP63 isofonns decreased in size subsequent to PNGaseF treatment. This 
size decrease conelates with the loss of N-glycosylation and confirms the results from 
the tunicamycin experiment that all fonns of GP63 identified by pulse-chase labelling 
are N-glycosylated.
Four isoforms of GP63 were detected in WT cells subsequent to PNGaseF treatment 
(63kDa, 62kDa, 61kDa and 60kDa, designated cp-cellular material with PNGaseF). In 
AgpiS the single 65c form of GP63 present at all time points resolved into 2 smaller 
forms (63cp and 62cp) subsequent to PNGaseF treatment. This was similar to the 
situation in WT cells at time 0 minutes of chase. This suggests that the 65c form of 
GP63 may be composed of 2 different isoforms of GP63. In WT cells these 2 isoforms 
appear to be processed simultaneously, to reach a 63c foim, whilst in AgpiS cells both 
forms remain unprocessed.
4.3.3 Activation of GP63 by removal of the Pro-region.
GP63 is activated as a metalloproteinase by the removal of the pro-region (McMaster et 
aL, 1994; Macdonald et aL, 1995). GP63 is known to be active when it reaches the 
surface of the cell, however the precise mechanism and timing of this activation is not
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known (Macdonald et al., 1995; McGwire and Chang, 1996). In order to establish if the 
secreted form of GP63 from AgpiS cells was active, the activity of GP63 toward gelatin 
was examined by substrate SDS-PAGE. Previous studies have demonstrated that GP63 
activity can be detected in WT cell lysate material by this method (Funk et at., 1994; 
McGwire and Chang, 1996).
In a preliminary experiment cells were grown to late log phase, washed and pelleted. 
The cells were prepared as for nonnal SDS-PAGE, with the exception that the samples 
were not boiled prior to loading. Samples were electrophoresed on a 10% acrylamide, 
0.1% gelatin gel, and subsequently the gel divided in two, and one part electro-blotted 
to allow detection of GP63 by western blotting. The other section of the gel was 
washed in 2.5% TX-100 to remove excess SDS, and incubated overnight in O.IM Na 
Acetate pH 5.5, ImM DTT at 37°C. The gel was stained in Coomassie blue R280 to 
allow visualisation of the gelatinolytic activity (Figure 4.11). Activity was detected in 
both AgpiS (lanes 1 and 2), and WT cell lysates (lanes 3-5). Differing cell equivalents 
(5x10^, 2x10^, or 1x10^) were loaded to determine the sensitivity of the assay, and the 
same banding pattern was present for each (compare lanes 3 ,4  and 5). The western blot 
of the remaining portion of the gelatin gel demonstrated that, while electro-transfer of 
proteins from gelatin gels was possible, the transfer efficiency was greatly reduced 
compared to normal SDS-PAGE gels. Both the incomplete transfer of the pre-stained 
higher molecular weight markers and Ponceau S staining of the blotted membrane, 
indicated that transfer of larger proteins was very inefficient. GP63 was detected in WT 
cells when 5x10^ cell equivalents were loaded (Figure 4.11, lane 6). Stained markers 
run on the gel were not considered an accurate indicator of size as samples were not 
denatured prior to loading, however non-denatured GP63 had a mobility close to that of 
the 64kDa marker. The markers were used to accurately align the activity gel with the 
western blot, allowing the identification of GP63 on the gelatin gel (Indicated in figure 
4.11). Active GP63 is present only in the WT cell lysates. The identity of the lai'ger 
protein with gelatinolytic activity present in both WT and AgpiS cell lysates is not 
known. A search of the MEROPS database (Rawlings et al., 2002) for other 
metalloproteases present in Leishmania suggest that in L. major (the Leishmania 
species undergoing sequencing by the genome project) 3 ORFs have been identified 
which might encode for putative metalloproteinases.
104
Chapter 4
Several experiments were performed to test if secreted GP63 was active. Firstly 
Vivaspin 20ml concentrators (Nalgene) were used to concentrate medium samples. 
However when the concentrated samples were electrophoresed on gelatin gels a high 
level of background protein was present, caused by the concentration of proteins from 
FCS, which was also present in the medium. The level of background proteins masked 
the detection of gelatinolytic activity. Secondly secreted GP63 was purified from the 
medium by immune-precipitation with a GP63 antibody. This method also caused 
masking of activity due to the high level of background proteins visable on the gel. This 
was due to cross-contamination with both the antibody and non-specific proteins from 
the FCS which co-precipitated. This method had the added disadvantage in that the 
presence and level of GP63 in the samples could not be determined by western blotting, 
as both the L3.8 GP63 antibody used for immune-precipitation and the antibody used 
for GP63 detection by western blotting, were mouse monoclonals, and so cross-reacted. 
Thirdly GP63 was purified from the medium by ConA precipitation. This method had 
an advantage in that ConA sepharose was available in sufficient quantities to allow 
purification from a large volume of medium. Secreted GP63 was readily detected in 
both WT and AgpiS samples, by western blotting of medium samples purified by this 
method (Figure 4.12, A). When the same samples were run on a gelatin gel, assessment 
of the gelatinolytic activity of the ConA purified medium samples was not possible 
(Figure 4.12, B). Glycosylated proteins present in the semm had co-affinity purified 
with the secreted GP63, and the high level of background protein prevented the 
detection of gelatinolytic activity.
Two gelatin gels were compared to assess GP63 activity in cell lysates under different 
activation conditions, as a pH of 8.0 was considered closer to the pH optimum at which 
GP63 was active (Ip et aL, 1990). One gel was incubated with O.IM Na Acetate pH 5.5, 
ImM DTT, the other with 50mM Tris-HCl pH 8.0 at 37°C overnight. The banding 
pattern on the gels was similar but a greater level of activity was present on the gel 
incubated at pH 8.0 (Data not shown). This condition was therefore used in all 
subsequent activity experiments to increase the sensitivity of the assay.
To prevent the contamination of medium samples with proteins from FCS, cells were 
grown to mid-log phase in normal conditions, washed in PBS, resuspended in HOMEM
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in the absence of FCS, and allowed to grow for a further 6 hours. Medium samples 
were then collected and analysed. Figure 4.13 shows a representative experiment. In 
this case 1.7x10^ WT and 3.4x10^ Agp/5 cells were grown to mid log phase, washed 
and grown in HOMEM in the absence of FCS for 6 hours. Both cell and medium 
samples were ConA precipitated, examined for activity by electrophoresis on gelatin 
gels, and western blotted to detect GP63. All samples had gelatinolytic activity (Figure
4.13, A). The eharacteristic protein thought to be GP63, as assessed by motility, was 
present in both the WT cell and medium samples (Lanes 1 and 3). No similar sized 
protein was present in either the AgpiS cell or medium samples (Lanes 2 and 4). Some 
activity was detected in the AgpiS medium sample, however this protein had a faster 
electrophoretic mobility than the protein predicted to be active GP63 in WT cells. This 
active protein may be an isofonn of GP63.
Western blotting with an aGP63 antibody detected GP63 in all 4 samples (Figure 4.13, 
B). The GP63 isoform secreted from AgpiS cells had a slower electrophoretic mobility 
than the WT isofoim when electrophoresed by SDS-PAGE (Compare lanes 7 and 8). 
This result was repeated when the samples were not denatured prior to electrophoresis. 
The faster mobility of the gelatinolytically active protein detected in the medium 
sample from the AgpiS cells (Figure 4.13, A, lane 4), and the failure to detect a similar 
sized protein by western blotting suggested that it was not an isofoim of GP63. 
However, a western blot of these samples electrophoresed on a gelatin gel was only 
able to detect GP63 in the WT cell samples due to the inefficiency of transfer. It was 
therefore not possible to establish conclusively the mobility of the GP63 isoform 
secreted from AgpiS cells, when electrophoresed under these conditions.
Western blotting and detection of GP63 demonstrated that GP63 was present at reduced 
levels in the AgpiS cells and medium compared to WT, when grown in medium lacking 
FCS (Figure 4.13, B). The level of GP63 secretion from the AgpiS cell line was higher 
than that from WT cells when grown under noimal conditions (Figure 4.4). It is 
possible that AgpiS cells are unable to grow in conditions lacking FCS. To test this WT 
and AgpiS cells were grown in medium with or without FCS for 6 hours, and the 
number of dead cells counted. There were a higher number of dead cells in the medium 
lacking FCS, and in this medium AgpiS cells showed a greater level of cell death
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compared to the WT cells. A growth curve of cells grown in these conditions would 
provide more accurate evidence for this. Repeated experiments in which the conditions 
of cell growth, such as cell density, FCS concentration, and culture volume, were 
altered each failed to conclusively detect active GP63 secreted from the AgpiS cell line. 
It was not clear if this failure was due to the low levels of GP63 secreted when cells 
were grown in the conditions optimal for the assay method, or if GP63 was secreted in 
an inactive form.
It was possible that the failure to conclusively demonstrate GP63 activity in the 
secreted protein from AgpiS cells was because the protein was inactive. 
Metalloproteinases can be activated by treatment with HgCL, as this compound 
disrupts the cysteine-zinc complex which exists between the pro-region and zinc- 
binding domain (Springman et aL, 1990). This method has previously been used to 
activate GP63 secreted using a baculovirus expression system (McMaster et aL, 1994; 
Macdonald et aL, 1995). Cells were grown to late log phase, washed and incubated in 
5mis of HOMEM lacking FCS for 4 hours and the medium collected and pre-cleared 
prior to ConA precipitation. The eluted samples were treated with or without 2pM 
HgCL at 37°C for 1 hour prior to electrophoresis on a 10% SDS-PAGE with 0.1% 
gelatin, and one gel was treated for gelatinolytic activity (Figure 4.14, A). An active 
enzyme was detected in the AgpiS medium sample subsequent to HgCL treatment. This 
gelatinolytically active protein was the same size as that detected in the WT sample, 
and was barely detectable in the untreated sample (compare lanes 4 and 5). Treatment 
of the WT sample with HgCL appeared to inactivate GP63, however subsequent 
experiments did not support this finding. WT cell lysates were treated with increasing 
concentrations of HgCL but active GP63 was still detected as determined by 
gelatinolytic activity. The apparent loss of activity seen in this experiment was 
therefore concluded to be due to experimental eri’or. A second gelatin gel was western 
blotted using a GP63 antibody, but GP63 was not detected in either the WT or AgpiS 
samples (data not shown). The purified medium from an estimated 1.5 xlO^ cells was 
loaded, and the level of GP63 present was thought to be below detectable levels.
HgCb treatment of the inactive protein prior to electrophoresis would result in the 
activation and the possible removal of the pro-region by proteolysis. The activated
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AgpiS protein would be smaller in size, and therefore be predicted to have a faster 
electrophoretic mobility than the inactive enzyme. However, a second gelatinolytically 
active enzyme was present in the AgpiS untreated sample (Figure 4.14 A, lane 4), with 
increased mobility compared to the activated enzyme (Lane 5). This protein was absent 
following HgCL treatment, and it was possible that this was an isoform of GP63 which 
could be fully activated by HgCL treatment, which caused it to run with decreased 
mobility under denaturing conditions. Activation of AgpiS GP63 subsequent to 
electrophoresis on a gelatin gel would be expected to identify a different sized isofonn 
of GP63 from WT. This would provide further evidence that an inactive protein was 
being activated by pro-region removal.
Cells were grown in the absence of FCS for 4 hours and the medium pre-cleared and 
ConA precipitated. WT cell lysate (5x10*^  cell equivalents) and medium samples from 
an estimated 2x10^ cells were electrophoresed on 10% SDS PAGE gels containing 
0,1% gelatin. The gels were treated as previously, with the exception that one gel was 
also incubated with 20mM of the metalloproteinase inhibitor 1-10 phenanthroline, and 
a second gel incubated with 4pM HgCL during washing and activation steps (Figure
4.14, B). Gelatinolytic activity was present in all samples. Incubation with 1-10 
phenanthroline reduced activity in the medium, and cell lysate samples (Compare lanes 
1 and 4, 2 and 5 and 3 and 6). Incubation with HgCL appeared to increase activity in 
the AgpiS medium sample (Compare lanes 1 and 7). This increase in activity appeared 
to be greatest in a protein that had slower electrophoretic mobility than the protein 
predicted to be GP63 in the WT cells. It was not clear if all the active proteins visible in 
the AgpiS sample were different isoforms or degradation products of GP63. It is 
possible that AgpiS cells secrete a second glycosylated protein with gelatinolytic 
activity.
The results from these experiments, suggested that the secreted foi*m of GP63 from WT 
cells was active whilst the protein secreted from AgpiS cells was inactive. Treatment 
with HgCL appealed to increase activity in the AgpiS samples. However the technical 
difficulties associated with purifying large quantities of secreted protein from medium 
containing FCS, and the poor growth of the AgpiS cells in medium lacking FCS, meant 
that it was not possible to conclusively identify active or inactive GP63 secreted from
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AgpiS on gelatin gels. The results also showed a large degree of variability, this poor 
reproducibility may have been a due to the low levels of GP63 activity being outwith 
the limits of detection for the assay. Previous work has studied the gelatinolytic or 
caseinolytic activity of GP63 in cell lysate material by gel electrophoresis (Funk et aL, 
1994; McGwire and Chang, 1996). Where secreted GP63 was examined GP63 was 
secreted from either Cos7 cells or insect cells in a baculovirus expression system, into 
serum free medium and the protein purified by affinity purification (Button et aL, 1993; 
Macdonald et aL, 1995). The activity of GP63 has also been studied using succinylated 
casein as a substrate, and measuring GP63 activity by absorbance (Macdonald et aL, 
1995; McGwire et aL, 2002). In order to further investigate the presence or absence of 
GP63 activity in secreted forms of GP63, the Quanti Cleave Protease Assay Kit (Pierce) 
was used. Preliminary experiments were unsuccessful, and time constraints prevented 
the production of conclusive data. In theory this method would provide a more sensitive 
method of detecting metalloproteinase activity, and would remove the problem of FCS 
causing excessive background interference.
4.4 Trafficking of GP63 from the cell
The results suggest some differences in the both the processing and trafficking of GP63 
within both the WT and the AgpiS cell lines. Whilst GPI-anchor addition was clearly 
the most obvious difference in the processing of GP63 in the 2 cell lines, an unanchored 
isoform was not one of the processing intennediates detected in WT cells in this study. 
PI-PLC treatment demonstrated that all WT isoforms detected were GPI-anchored, and 
anchor addition occurred very rapidly in WT cells. It appeared that lack of a GPI 
anchor was affecting the downstream processing of GP63. It seems possible that this 
variation in processing is a result of GP63 trafficking through different pathways, or 
different compartments in the same pathway within the two cell lines. It is also possible 
that two different pathways for GP63 trafficking are present within the WT cell line.
The trafficking of GP63 from the cell was further examined, initially by examining the 
secretion of GP63 from WT cells. The results from pulse-chase labelling experiments 
clearly indicated that 2 foims of GP63 were secreted from WT cells (See figure 4.3, C, 
time point 180 minutes). The 65s isoform was visible within 20 minutes in WT, AgpiS 
and AgpiSipXgpiS^^^^^] cells, whilst the 63s protein was detected only after 80
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minutes. This suggests that the kinetics of secretion for the 2 isofonns are different and 
indicate that the two isoforms may be trafficked through 2 different pathways. The 65s 
form of GP63 may be a non-GPI-anchored isoform that was secreted directly from the 
cell. The 63s form may be a mature processed form of GP63, released from the cell 
surface by cleavage of the GPI-anchor.
4.4.1 TX-114 fractionation
In an attempt to examine the presence or absence of a GPI anchor on the secreted forms 
of GP63 from WT cells, medium samples were subjected to TX-114 fractionation and 
PI-PLC treatment. WT and AgpiS cells were grown to mid log phase and Ix 10  ^ cells 
were labelled with ^^S-ExpreSS for 6 hours, the medium collected, and pre-cleared to 
remove cellular debris. Samples were divided into 2 and one half treated with PI-PLC 
prior to TX-114 fraetionation and immune-precipitation with a GP63 antibody (Figure
4.15). The low level of GP63 secretion in WT cells meant that the quantity of protein 
obtained was close to the limits of detection. However it was clear that the 2 isoforms 
of GP63 partitioned into different phases. The 65s isoform was detected in the soluble 
phase (Lane 1), whilst the 63s isoform partitioned into the membrane associated 
fraction (Lane 2). After PI-PLC treatment the 63s form of GP63 was absent from the 
membrane fraction and appeared in the soluble fraction indicative of the presence of a 
GPI anchor. This result suggests that the 65s form is secreted as a soluble form in the 
WT cell line, whilst the 63s foraa is secreted or released into the medium with a GPI 
anchor. This was an unexpected result as it was expected that the 63s form present in 
WT medium was released from the cell surface by cleavage of the GPI anchor, and thus 
would partition into the soluble phase of TX-114. It seems possible that the 63s form of 
GP63 was contamination from cellular material, though medium samples were pre­
cleared prior to immune-precipitation to prevent this. If cellular contamination were 
responsible for the presence of the 63s protein present in the medium, then the relative 
amounts of 63s versus 65s would be expected to be higher to reflect the high levels of 
the 63c isoform of GP63 present within the cell. Cellular contamination would also be 
expected to release other GPI-anchored GP63 intennediates, such as the 64c isofonn, 
into the medium, but this protein was not detected. This suggests that the GPI-anchored 
form of GP63 was not present in the medium due to cellular contamination. In WT cells
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a 65kDa unanchored isoform of GP63 is secreted into the medium within 20 minutes, 
and a 63kDa GPI-anchored isoform is released into the medium within 80 minutes.
4.4.2 Brefeldin A treatment
To examine the intracellular trafficking of GP63 in more detail, cells were grown in 
Brefeldin A (BFA). Brefeldin A inhibits secretion by disruption of the Golgi body 
(Donaldson et al., 1992). It was thought that comparison of the trafficking of GP63 in 
WT and AgpiS cells grown in BFA would allow some elucidation of whether GP63 was 
trafficked through separate pathways, and whether processing events occurred in pre or 
post-Golgi compartments.
Cells were grown with or without lOpg ml"' BFA for 4 hours prior to pulse-chase 
labelling with -Express, and immune-precipitation of GP63 as previously described. 
BFA was also added to the medium during the chase period as appropriate. A 
comparison between treated and untreated cells (Figure 4.16 panel A), shows there is 
no apparent difference in the processing of GP63, as assessed by the number of 
intermediates formed, or the timing of this process. In both treated and untreated WT 
cells the 65c isofoiTn was processed through intermediate stages to reach the 63c 
isoform after 180 minutes of chase as seen previously (see figure 4.3). In both treated 
and untreated AgpiS cells the 65c isoform of GP63 remained through out the chase 
period with no further processing. The secretion of GP63 from both the WT and AgpiS 
cell lines was apparently unaffected by the inhibitor BFA (Figure 4.16, B). WT cells 
secreted a low level of the 65s and 63s isoforms, whilst the AgpiS cell line secreted a 
high level of the 65s isofoim
The experiment was repeated with WT cells grown in SOpg ml"' BFA (Data not 
shown). Growth of cells in an increased concentration of the inhibitor still had no 
discernible effect on the processing of GP63. It is possible that GP63 processing occurs 
pre-Golgi and that BFA treatment would not influence the processing of GP63, but 
would have an effect on the trafficking of the protein to the cell surface. To test this 
possibility, WT cells were grown in BFA and subsequently treated with PI-PLC to 
check if labelled protein could be cleaved from the cell surface. Whilst PI-PLC 
treatment did not work efficiently, a small amount of GP63 could be detected from both
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treated and untreated cells. It was concluded that BFA does not influence the 
intracellular processing, trafficking or secretion of GP63 in L. mexicana.
4.5 Discussion
Previous studies have shown that GP63 is GPI-anchored (Schneider et al., 1990) and 
N-glycosylated (Button et al., 1989; McGwire and Chang, 1996). The protein is 
activated intracellularly by the removal of the pro-region (Macdonald et al., 1995; 
McGwire and Chang, 1996) and trafficked to the cell surface via the flagellar pocket 
(Overath et al., 1997; Wei se et al., 2000). This study has examined in detail the 
intracellular processing of GP63 in WT cells, and compared this with the situation in 
cells with a defect in GPI-anchor addition. Pulse-chase labelling experiments 
demonstrated that in WT cells GP63 undergoes a series of intracellular processing steps 
to reach its mature 63kDa GPI-anchored form (63c). One major and one minor 
intermediate form were identified during the intracellular processing from the 65c to 
the 63c form. In contrast within the AgpiS and AgpiS[pXgpiS^^^^^] cell lines the 65c 
GP63 isoform undergoes no detectable form of modification, as assessed by size 
change, instead the 65kDa precursor is secreted from the cell. Loss of GPI8 activity, 
and the associated loss of GPI anchor addition therefore effects the intracellular 
processing of GP63.
TX-114 and NaCOa fractionation demonstrated that GP63 had a different intracellular 
distribution within WT cells lines when compared with cells lacking a functional GPI8. 
Within WT cells GP63 partitioned exclusively into the membrane associated phase. 
Within the AgpiS cell line GP63 partitions into the soluble phase as determined by TX- 
114 fractionation, whilst subsequent to NaCOa extraction the majority of the protein 
partitions into the soluble phase though some remains within the membrane associated 
fraction. The difference in the intracellular distribution of GP63 in the AgpiS cells 
subsequent to the different extraction methods may reflect the stringency of TX-114 
compared to NaCOa extraction. TX-114 partitions GPI-anchored proteins and 
embedded membrane proteins, from soluble proteins whilst the NaC03 method is less 
stringent and may also partition membrane-associated proteins into the membrane 
fraction. This may include GP63 associated with the membrane via the small C- 
terminal hydrophobic domain, suggesting a subset of the GP63 population remains
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membrane-associated in the AgpiS cells. Both TX-114 and NaCOa fractionation 
demonstrate a large proportion of GP63 remains within the soluble fraction of the 
AgpiS cells, differing from the situation in WT cells whereby GP63 remains 
exclusively in the membrane fraction. Differences in the intracellular distribution of 
GP63 between the WT and AgpiS cell lines, and the secretion of high levels of the 
protein into the medium of the AgpiS cells indicate that lack of GPI8 activity affects the 
trafficking of GP63. It therefore appears that prevention of GPI-anchor addition effects 
both the further processing and trafficking of GP63. This implies that the GPI-anchor 
has an important role on the forward transport of the protein.
Prior to this study the precise details of the processing of GP63 in WT cells had not 
been examined. However the finding that in WT L. mexicana the major GPI-anchored 
protein is processed from a 65kDa GPI-anchored precursor, through intermediate forms 
to reach a 63kDa mature forni is also supported by similar recently published work.
A study of L. mexicana GP63 has identified 3 GP63 isoforms (PI, P2 and P3) by pulse- 
chase labelling and TX-lOO fractionation (Ralton et al., 2002). PI and P2 were 
recovered in the first 30 minutes of the chase period, P3 was detected after the first 30 
minutes of chase. Biotin labelling demonstrated that PI remained in the internal 
membranes, whilst P3 was found predominantly on the surface, though a small 
proportion remained internally. The PI isoform is thought to be a GPI-anchored pro­
form, whilst P3 is described as the major GPI-anchored isoform of GP63 (Ralton et a l, 
2002). Work on L. chagasi identified 2 processing foims of GP63 of 66kDa, and 63kDa 
(Yao et a l, 2002). These were initially speculated to be isoforms of GP63 from two 
separate genes. An L. donovani attenuated cell line was used, which expressed only a 
low amount of GP63. Pulse-chase labelling of this L. donovani GP63 deficient cell line 
transfected with a single copy of L. chagasi GP63, and immune-precipitation with a L. 
chagasi GP63 specific antibody demonstrated a 66kDa pre-cursor was processed to a 
mature 63kDa form. This result was repeated when genes for any of the 3 different 
forms of L. chagasi GP63 {MSPSl, MSPS2, and MSPL) were expressed in the cell line. 
PI-PLC and N-glycanase treatment demonstrated that both forms of GP63 were GPI- 
anchored and N-glycosylated. It was speculated that the processing event was due to 
the removal of the pro-region (Yao et a l, 2002).
113
Chapter 4
Processing of GP63 in a GPI biosynthesis mutant has also recently been examined. An 
L. mexicana cell line, DIGl, with a defect in the addition of aI-6  linked mannose to the 
glycan backbone common to both GIPLs and GPI anchors has recently been isolated 
(Naderer and McConville, 2002). The processing of GP63 was analysed in this cell line 
and it was shown that an isoform described as a non-GPI-anchored preproform of GP63 
was secreted from the cell, and was the same molecular mass as the protein secreted 
from AgpiS cells (Naderer and McConville, 2002). The Un of secretion of this GP63 
isoform was 120 minutes, the same as that found for secretion of GP63 from the AgpiS 
cell line (Figure 4.4).
A detailed analysis of the processing of GP63 indicated that all WT isoforms of GP63 
identified in this study were GPI-anchored (Figure 4.7). The removal of the C-tenninal 
GPI signal and GPI anchor addition do not account for any of the WT processing 
intermediates identified. No unanchored forms were detectable by the methods used 
and the immature 65c precursor detectable at time 0 minutes of chase was GPI- 
anchored. This demonstrates that GPI anchor addition occurs rapidly following 
translation and translocation of the protein into the ER. GPI anchor addition is known 
to occur rapidly and it has previously been shown that GPI anchors are added to 
awaiting VSG proteins within 2 minutes of the proteins translation (Bangs et a l, 1985; 
Ferguson et a l, 1986).
Treatment of cells with tunicamycin, or treatment of cell lysates with PNGaseF 
demonstrated that the 65c isoform present at time 0 was N-glycosylated (see figures 4.9 
and 4.10). The finding that the first identifiable form of GP63 in WT cells is both GPI- 
anchored and N-glycosylated shows that addition of N-glycans is also rapid. The close 
association of the GPIT complex and the translation machinery is suggested by several 
recent studies. Immune-fluorescence microscopy demonstrated that in T. brucei GPI8 
co-localised with QM, a 60S ribosomal protein (Lillico et a l, 2002). This indicates a 
close association of the GPIT with the rough ER. Mutational experiments using a wheat 
geim translation system supplemented with mammalian microsomes examined the 
processing of a GPI-anchored protein with a 43 amino acid extension at the C-terminal 
end (Vidugiriene et a l, 2001). Proteolysis was used to isolate pro tease-protected 
proteins, deemed to be membrane translocated, and suggested that the ribosome-bound
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C-teiTninally extended protein became GPI-anchored. This implies that GPIT can 
access ribosome bound proteins, and is positioned close to the translocon in 
mammalian cells. However it was also possible that the protein was cleaved from the 
ribosome by proteolysis prior to anchor addition, and the results were therefore 
inconclusive (Vidugiriene et al., 2001). Attempts to co-purify the S. cerevisiae GPIT 
complex with Sec61p, a component of the yeast translocon, or Wpbl, a component of 
the yeast OST, were unsuccessful (Fraering et al., 2001). There is no direct evidence 
that GPIT associates with either the OST or the translocon, however the rapidity of 
anchor addition subsequent to translocation and glycosylation and the proximity of 
GPIT to the translocon and translational machinery strongly indicate that this is likely.
Treatment with tunicamycin or PNGase F showed that all detected cellular isoforms of 
GP63 from WT and AgpiS cells were N-glycosylated. The secreted foiTn of GP63 was 
also confirmed to be N-glycosylated by ConA precipitation. This demonstrates that 
GPI-anchor addition is not required for the N-glycosylation of GP63. In WT cells 
treated with tunicamycin only 2 major (63ct and 60ct) and one minor isoforms of GP63 
were identified, compared to the 4 isoforms of GP63 (65c, 64c 63c and the fourth 
minor intermediate between 65 and 64kDa) identified in WT cells grown under normal 
conditions. This suggested that at least one of the processing intermediates identified 
under normal conditions was due to the processing of N-glycans. However this 
hypothesis was not confirmed by PNGaseF treatment, as the 4 WT isoforms of GP63 
each underwent a size shift and 4 deglycosylated GP63 isofonus were still detected 
(63cp, 62cp, 61cp, and 60cp). If N-glycans were processed during the trafficking of 
GP63, PNGaseF treatment would be expected to result in the resolution of 2 of the 
detected isofonus into a single sized protein. The loss of N-glycosylation affected the 
onward processing of GP63 in tunicamycin treated cells. PNGaseF treatment examined 
the N-glycosylation state of isoforms that had been processed normally in untreated 
cells. The different isoforms of GP63 identified in WT cells may not be caused by the 
processing of N-glycans, as originally hypothesised subsequent to examining the results 
from tunicamycin treatment, however the presence of the N-glycans may be important 
for the coiTect processing of GP63 (N-glycan mediated processing).
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Loss of N-glycosylation by tunicamycin treatment effects the level of GP63 secretion. 
This result is particularly clear in the AgpiS cell line where the level of secretion of 
non-GPI-anchored GP63 is dramatically reduced (Figure 4.9, panel B). Therefore loss 
of N-glycosylation effects both the intracellular processing of GP63 in WT cells, and 
secretion of GP63 from the cell, with particular effect on the non-GPI-anchored GP63 
isoform in the AgpiS cell line.
In other systems treatment of cells with tunicamycin has been shown to affect the 
secretion of proteins. The mammalian zinc metalloproteinase, meprin A, consists of 2 
subunits; meprin a  has 10 potential N-glycosylation sites and is secreted if not 
associated with meprin P, an integral membrane protein. Individual point mutation of 
any of the potential N-linked glycosylation sites of meprin a  did not prevent its 
secretion from Madin-Darby canine kidney (MDCK) cells, however mutation of all 10 
sites resulted in retention of the protein in the cell, and no secretion (Kadowaki et aU,
2000). Treatment of MDCK cells with tunicamycin resulted in the decrease in both the 
biosynthesis and secretion of the meprin a  subunit. N-linked glycosylation was 
required for secretion of the protein from MDCK cells, and it was speculated that this 
was due to its requirement in the conect folding of the protein (Kadowaki et al., 2000).
It has also been suggested that N-linked glycans act directly as a signal for protein 
trafficking. The introduction of N-linked glycosylation sites into the non-glycosylated 
mammalian proteins, occludin and ERGIC-53, was examined (Gut et al., 1998). 
Occludin, is a polytopic membrane protein, and ERGIC-53 a membrane protein that 
cycles between the ER and Golgi. These proteins were mutated and expressed in 
MDCK cells and Chinese hamster ovary cells (CHO). It was shown in the absence of 
any other targeting signal the introduction of N-linked glycans resulted in cell surface 
expression. In the absence of N-glycans both chimeras accumulated within the Golgi 
(Gut et al., 1998). N-linked glycans have multiple functions, including the coiTect 
folding and sorting of proteins in the ER through interaction with the calnexin- 
calreticulin pathway, and thus mediate ER-to Golgi transport (Helenius and Aebi,
2001). In the absence of other signals they appear to act as a signal for secretion and 
trafficking. It therefore seems possible that in the AgpiS cell line N-glycans are required 
for the secretion of GP63 from the cell. It would be interesting to examine the fate of
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GP63 within the AgpiS tunicamycin treated cells. The loss of secretion suggests that 
the protein is retained or degraded intracellularly. Immune-fluorescence microscopy 
may determine where this degradation occurs. In WT cells N-glycans are not required 
for the trafficking of GPI-anchored GP63 to the cell surface. It is possible that the GPI 
anchor plays an active role in directing trafficking, and this point will be discussed later 
in this chapter.
Previous studies have examined the effects of loss of N-glycosylation on GP63 in WT 
cell lines. L. major promastigotes were grown in medium containing tunicamycin 
(Funk et ah, 1994). Biotin labelling and PI-PLC treatment was used to demonstrate that 
non-glycosylated GP63 was GPI-anchored on the cell surface. This protein was also 
shown to be active. Endo-F treatment of PI-PLC cleaved GP63 from both L. major and 
L. mexicana was used to demonstrate that N-glycosylation is not necessary for GP63 
activity (Funk et a l, 1994). Removal of N-glycosylation by site directed mutagenesis at 
any or all of the 3 N-glycosylation sites identified in L. major GP63, resulted in lower 
levels of cellular GP63 (McGwire and Chang, 1996). This was not due to secretion 
from the cell, and it was suggested that N-glycans may contribute to the intracellular 
stability of GP63. All mutant forms of deglycosylated GP63 showed azocasein or 
gelatinolytic activity, and it was suggested that the activity of the deglycosylated 
mutants increased compared to WT GP63 (McGwire and Chang, 1996). An L. 
donovani GP63 deficient strain expressing L. chagasi GP63 from a plasmid, was grown 
in medium containing tunicamycin (Yao et a l, 2002). 2 isoforms of GP63 were 
detected in cells grown under normal conditions, and 2 GP63 isoforms of decreased 
size were identified from tunicamycin treated cells. Similarly treatment of cell lysate 
with N-glycanase demonstrated that the 2 detectable GP63 isoforms were both N- 
glycosylated (Yao et a l, 2002). These studies showed that, similar to this study, in the 
cell lines examined all detectable isoforms of GP63 are N-glycosylated. They also 
demonstrated that in the absence of N-glycans GP63 is processed and GPI-anchored on 
the cell surface in an active form.
A recent study has also examined the secretion of non-glycosylated GP63 (McGwire et 
al, 2002). Expression from a plasmid of either WT and or a non-glycosylated mutant 
form of GP63 in a L. amazonenesis GP63 deficient cell line showed that GP63 was
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secreted into the medium (McGwire et a l, 2002). Both the re-expressed WT and 
deglycosylated forms were released into the medium at similar levels and with the same 
kinetics, and it was concluded that N-glycosylation does not effect the extracellular 
release of GP63 (McGwire et a l, 2002). The study did not address the intracellular 
processing of the non-glycosylated GP63, neither did it examine the secretion of non- 
glycosylated, non-GPI-anchored GP63. It would be interesting to express a mutant 
form of GP63 which is neither N-glycosylated, nor GPI-anchored using the L. 
amazonensis system as this would allow direct comparison with AgpiS cells grown in 
tunicamycin.
PNGase F treatment of pulse-chase labelled cell lysates, resulted in the separation of 
the 65c isoform present after time 0 minutes of chase in both WT and AgpiS cells, into 
a 63kDa and a 62kDa doublet (Figure 4.10). This suggests that the unprocessed 65kDa 
protein may consist of 2 isoforms of GP63. In the WT cells both isoforms appear to be 
processed to the 63c isoform, whilst in the AgpiS cell line both isofotms remain 
unprocessed. However treatment of cells with tunicamycin did not produce a similar 
result, this was most clearly seen in the AgpiS cell line where only a single 63ct isoform 
could be detected subsequent to treatment with tunicamycin (Figure 4.9). In a recent 
study 3 isoforms of GP63 were detected during pulse-chase labelling of WT L. 
mexicana. It was suggested that the 64kDa (P2) isoform was comprised of 2 subsets of 
GP63, a processed form of the 65kDa profomi, and a second major pro-form of GP63, 
(Ralton et a l, 2002). Pulse-chase labelling experiments were peifonned on the L. 
mexicana DIG2 mutant cell line, which has a defect in both GIPL and GPI-anchor 
biosynthesis and secretes unanchored GP63 (Naderer and McConville, 2002). Two 
different sized isoforms of GP63 were synthesised, as detected by SDS-PAGE. A large 
proportion of GP63 was secreted, however immune-fluorescence microscopy also 
suggested that a sub-population of GP63 was retained within the ER where it was 
thought to be degraded. It was suggested that the two isoforms of GP63 had differing 
fates within the mutant cell line (Naderer and McConville, 2002).
In this study 20% less GP63 was detected in the AgpiS cell line compared to WT, as 
assessed by the total levels of GP63 present in the medium and cellular fractions 
(Figure 4.6). It is possible that this difference was due to the intracellular degradation of
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a sub-population of GP63 in the AgpiS cell line. Northern blotting experiments would 
allow an assessment of the levels of GP63 expression in both WT and AgpiS cells.
Activation of GP63 occurs intracellularly by the removal of the pro-region. Expression 
of GP63 with a mutation at the anchor addition site using a baculovirus expression 
system suggested that the unanchored secreted form of GP63 was inactive, (Macdonald 
et al., 1995). Expression of GP63 mutated at the GPI anchor addition site from a vector 
in the L. amazonensis ‘GP63 deficient’ strain, suggested that the secreted protein had 
gelatinolytic activity, and was therefore thought to be active (McGwire and Chang, 
1996). Though the ‘GP63 deficient’ cell line expresses WT GP63 at reduced levels 
(Kink and Chang, 1988). This study demonstrated that GP63 secreted from the WT cell 
line is active, though it was not investigated if this activity corresponds to only one or 
both of the two isoforms known to be secreted from these cells. It is not clear from the 
work presented in this thesis whether GP63 secreted from the L. mexicana AgpiS cell 
line is active. The difficulty in detecting active GP63 in the medium of the AgpiS cell 
line suggests that non-GPI-anchored GP63 is not activated during processing. However 
to conclusively demonstrate this an alternate approach is required. The AgpiS cell line 
does provide a useful tool for examining the activation of non-GPI-anchored GP63 
without a background of fully processed WT protein.
Treatment of inactive secreted GP63 with HgCL, resulted in the identification of 
several different intermediates of GP63 as the protein underwent proteolytic 
degradation as it was activated (McMaster et al., 1994). It is possible that pro-region 
cleavage is not a single event, and may therefore account for more than one of the 
processing intermediates detected in the WT cell line.
It is interesting that the inhibitor Brefeldin A had no effect on the processing or
secretion of GP63 (Figure 4.16). BFA is an inhibitor of guanine nucleotide exchange
factors (GEFs), which stimulate the activation of ARF proteins, which in turn regulate
the formation of COPI vesicles, required for retrograde transport from the Golgi to the
ER (Chardin and McCormick, 1999). In mammalian cells and mutant yeast cells with a
permeable cell wall, treatment with BFA causes the collapse of the Golgi complex, and
inhibits secretion (Peyroche et al., 1999). Treatment of T. cruzi epimastigotes has also
been shown to effect the ultrastructure of the Golgi by causing an increase in the
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number and size of cistemae (Engel et ah, 1998). However it was not clear if retrograde 
protein trafficking had been inhibited in these cells. In another study on L. mexicana 
treatment of promastigotes with BFA, ilimaquinone, or monensin, all of which inhibit 
vesicular transport in other eukaryotes, had no effect on the rate of transport of GP63 or 
GIPLs, confirming the results found in this study (Ralton et ah, 2002). In yeast and 
mammalian cells BFA inhibits only a small sub-population of the GEF proteins 
(Chardin and McCoiTnick, 1999; Peyroche et ah, 1999). It therefore seems possible that 
homologues to these specific GEF proteins differ, or are absent in Leishmania. Such 
differences in vesicular trafficking components between mammalian and protozoa 
could provide important leads in the search for new drug targets.
Examination of the secretion of GP63 provided several interesting results. Firstly WT 
cells secreted two forms of GP63, which during pulse-chase labelling experiments 
appeared in the medium at different time points (Figure 4.3, panel C). TX-114 
fractionation partitioned the 65s from into the soluble fraction, whilst the 63s form 
partitioned into the membrane associated fraction. Subsequent to PI-PLC treatment, the 
63s form could be identified within the soluble fractionation (Figure 4.15). This 
suggested that the 65s foim was secreted without a GPI anchor and the 63s form was 
released with a GPI anchor. I originally thought that the 63s foim was released into the 
medium from the cell surface by cleavage of the GPI anchor, the mechanisms for the 
release of GP63 from the cell surface with an intact anchor are not clear. Ethanol amine 
labelling followed by immune-precipitation of GP63 from the medium, or use of the 
CRD antibody subsequent to PI-PLC treatment of the secreted samples, would provide 
a clearer indication as to whether the 63s form is released into the medium with an 
intact anchor. The CRD antibody could also be used to assess if either of the 63s, or 65s 
isoforms had contained a GPI-anchor, which had subsequently been removed prior to 
secretion. Analysis of the intracellular fractionation of GP63 in WT cells suggested that 
a small proportion of GP63 was present in the soluble fraction, and the quantity was 
directly comparable to the level of GP63 secreted (Figure 4.5).
Analysis of the AgpiS cell line demonstrated that the level of secretion of GP63 from 
these cells was far higher than from the WT cell line. Indeed secretion of GP63 from 
WT cells was only 13% of that from AgpiS (Figure 4.4). Pulse-chase labelling
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experiments indicated that the Agpf&secreted isoform of GP63 could be detected in the 
medium at the 20 minute time point, the same time at which the 65s isoform from WT 
cells was first detected. To compare in more detail the secretion of GP63 in AgpiS cells 
with trafficking within WT cells, it would be useful to calculate the time it takes to 
traffic GPI-anchored GP63 to the surface of WT cells. It would also be interesting to 
compare both cell surface trafficking in WT cells, and secretion forai AgpiS cells with 
the timing with which both the 65s, and 63s isoforms are released into the medium of 
WT cells. Preliminai’y attempts to biotin label pulse-chase labelled cells were 
unsuccessful, and due to time constraints it was not possible to continue this work, 
however this seems an interesting area for further investigation.
Collectively these results suggest that within WT L. mexicana GP63 is trafficked via 
two separate pathways, or different compartments within the same pathway (Figure
4.16). GPI-anchored GP63 is trafficked via a classical pathway whereby GP63 is N- 
glycosylated, GPI-anchored and then undergoes further modification during transport to 
the cell surface. Unanchored GP63 is trafficked via a direct secretion pathway whereby 
non-GPI-anchored GP63 is rapidly N-glycosylated and secreted from the cell without 
subsequent modification. The AgpiS cells utilise the second pathway; all GP63 is N- 
glycosylated and transported from the cell. The GPI-anchor therefore appears to be 
important in directing proteins into the first pathway. The inhibition of secretion from 
the AgpiS cells in the presence of tunicamycin suggests that N-glycans may play a role 
in the entry of proteins into the direct secretion pathway.
Work on L. chagasi has also identified a secreted foim of GP63 from WT cells (Yao et 
a l, 2002). Only a single 63kDa form was identified, and this protein was not 
recognised by the CRD antibody suggesting it was not released from the cell surface by 
cleavage of the GPI anchor. The 63kDa protein could be fractionated into both 
membrane associated and soluble forms. The absence of cytosolic proteins in the 
medium suggested the protein was not released due to cell lysis. It was speculated that 
GP63 was released as both a soluble foim in micelles, and also in membrane-bound 
vesicles (Yao et al., 2002). GP63 has also been demonstrated to be secreted from both 
laboratory strains, and clinical isolates of L. amazonensis, demonstrating that the 
extracellular release of GP63 occurs in a WT setting (McGwire et al., 2002). Labelling
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experiments of L. amazonensis with both [S^ ]^ cysteine/ methionine and biotin, 
suggested that the extra-cellular release of GP63 was from two separate pools, which 
each secreted GP63 with differing kinetics (McGwire et aL, 2002). Use of either the 
CRD antibody or ethanolamine labelling suggested the released form of GP63 was not 
GPI-anchored. This results differs from those found in this study on L. mexicana WT 
cells, or work on L. chagasi WT cells (Yao et aL, 2002), and may reflect differences 
between Leishmania species. The L. mexicana DIGl cell line has also been shown to 
secrete high levels of GP63 from the cell (Naderer and McConville, 2002). Collectively 
this work demonstrates that different GP63 isoforms are secreted at a low level from 
WT cells, whilst loss of anchoring leads to a high level of secretion. The secretion of 
WT GP63 from promastigote cells may have a biological significance. It is possible 
that the extracellular release of the protease aids invasion of host cells. It has been 
suggested that secreted GP63 plays a role in the degradation of the extra cellular matrix 
after inoculation into the host by the sandfly (McGwire et aL, 2002). It is also possible 
that the secreted protein aids the evasion of complement mediated lysis, similar to the 
function of membrane anchored GP63 (Brittingham and Mosser, 1996).
The fate of misprocessed GPI-anchored proteins has been examined within other 
systems. In mammalian cells a reporter protein with a mutation at the site of GPI 
anchor addition (hGHDAF28) was shown to be retained and degraded within a pre- 
Golgi compaitment (Moran and Caras, 1992; Field et aL, 1994). The use of yeast cells 
deficient in GPI anchor biosynthesis due to inositol starvation, demonstrated that GPI- 
anchored proteins were incorporated into ER transport vesicles and GPI-anchor 
attachment was a requirement for this to occur (Doering and Schekman, 1996). It is 
thought that non-GPI-anchored proteins are prevented from entering the secretory 
pathway, to avoid competition with con'ectly processed proteins. The precise 
mechanism for the ER retention and subsequent degradation of non-GPI-anchored 
proteins is not known. It is possible that the misprocessed proteins enter the calnexin/ 
calreticulin system which modulates the forward trafficking of glycoproteins (Parodi, 
2000; Ellgaard and Helenius, 2001), or are directed from the ER via the translocon pore 
for cytoplasmic degradation (Wiertz et aL, 1996; Wilbourn et aL, 1998; Ali et aL, 
2000). Mutation of a single cysteine residue present within the C-terminal GPI signal of 
the reporter protein hGHDAF28, (also mutated at the site of GPI anchor addition
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preventing GPI anchor addition), resulted in the secretion of the fusion protein instead 
of ER retention (Wilbourn et aL, 1998). It was therefore suggested that ER quality 
control mechanisms actively retain non-GPI-anchored proteins.
Expression of VSG in procyclic T. brucei demonstrated that mutation of the VSG 
anchor addition site resulted in the ER retention of the protein, and extracellular release 
with highly reduced kinetics (McDowell et aL, 1998). Studies in bloodstream form T. 
brucei expressed mutated forais of VSG-221 against a VSG-117 (WT) background. 
Truncation of VSG-221 to delete the entire C-terminal signal sequence, resulted in 
retention of the protein in the ER as determined by immune-fluorescence, and co­
localisation with the ER protein BiP (Bohme and Cross, 2002). The mutated VSG was 
determined to be coiTcctly folded and dimerised. Replacement of the C-terminal signal 
with a transmembrane domain did not produce cell surface expression, instead the 
protein was retained intracellularly close to the flagellar pocket in possible pre- 
lysosomal compartments (Bohme and Cross, 2002). Expression of GPI-PLC in T. cruzi 
resulted in the depletion of GPI proteins from the cell surface, and depletion of GPI 
protein interaiediates. A dominant negative effect resulted in a loss of a functional GPI- 
biosynthetic pathway (Garg et aL, 1997). Within these cells the fate of four different 
GPI-anchored proteins was examined, two were secreted into the medium and two were 
degraded intracellularly (Garg et aL, 1997). It was concluded that GPI-anchors were 
required for the correct surface expression of proteins, and the fate of the misprocessed 
GPI protein depended on the protein’s structure (Garg et aL, 1997; Bohme and Cross, 
2002). It has been speculated that the ER retention of non-GPI-anchored proteins may 
be due to sustained interaction with the GPIT complex (Garg et aL, 1997; Bohme and 
Cross, 2002).
The fate of non-GPI-anchored proteins was also investigated in the T. brucei mutant 
strain, GPIIO, defective in the addition of the third mannose to the GPI backbone 
(Nagamune et aL, 2000). In ‘GPI-sufficient’ cells EP procyclin (the major GPI- 
anchored protein of procyclic trypanosomes) was produced as 35, 40 and 50kDa 
peptides, and chased into a mature 50kDa form. A small amount of this mature form 
was secreted. In the GPI deficient cells, mature 50kDa procyclin was not produced. 
Several smaller peptides were produced, and smaller peptides were also detected in the
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medium. It was concluded that non-GPI-anchored EP procyclins were secreted into the 
medium, and degraded, and loss of GPI anchoring affected the processing of the protein 
(Nagamune et aL, 2000).
These studies collectively suggest that two parallel processes may affect the fate of 
GPI-anchored proteins. The first is the active retention of misprocessed proteins within 
the ER, the second is the active requirement for a GPI anchor for forward transport. It is 
possible that Leishmania and Trypanosomes lack the complex quality control 
mechanisms developed in higher eukaryotes for the intracellular retention and 
degradation of misprocessed proteins, though homologues to calnexin have been 
identified in L. donovani and T. cruzi (Joshi et aL, 1996; Labriola et aL, 1999).
GPI-anchors have recently been associated with the trafficking of proteins via 
interactions with lipid microdomains, liquid-ordered regions enriched in cholesterol and 
sphingolipids, termed lipid rafts (Simons and Ikonen, 1997; Muniz and Riezman, 2000; 
Ikonen, 2001). This suggests a process in which the GPI-anchor is directly required for 
the forward transport of proteins.
Studies of mammalian cells demonstrate that GPI-anchored proteins become insoluble 
to detergent extraction during trafficking through the secretory pathway and form 
detergent resistance membranes (DRMs), enriched in sterols, sphingolipids, 
glycosphingolipids and GPI-anchored proteins (Brown and Rose, 1992). This 
incorporation of GPI-anchored proteins into lipid rafts in the Golgi of mammalian cells 
(Brown and Rose, 1992; Simons and Ikonen, 1997). The depletion of ceramide or 
cholesterol in MDCK cells specifically affects the sorting and trafficking of GPI- 
anchored proteins to the cell surface. This suggests that the association of GPI- 
anchored proteins with lipid rafts is required for the delivery of proteins to the cell 
membrane (Mays et aL, 1995; Hannan and Edidin, 1996). It has also been shown that 
though a GPI-anchor is required to mediate raft association within MDCK cells, it is 
not sufficient for the correct targeting of a protein to the cells apical surface (Benting et 
a L ,1999)
The specific association of GPI-anchored proteins with lipid rafts, and their 
requirement in the delivery of these proteins to the plasma membrane has also been
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demonstrated in yeast. Yeast cells depleted in ceramide by growth in the inhibitor 
myrocin, showed a rapid reduction in GPI-protein transport, whilst the maturation and 
transport of both soluble and transmembrane proteins was unaffected (Horvath et aL,
1994). Similarly a ceramide bio-synthesis deficient cell line was unable to transport the 
GPI-protein Gas Ip to the Golgi, but secretion of a soluble protein was not abolished. 
(Stitterlin et aL, 1997; Bagnat et aL, 2000). DRMs were shown to be present in the 
yeast ER, suggesting a difference in the location of raft formation in mammalian and 
yeast cells, and demonstrating that GPI-proteins are sorted from other proteins at an 
early stage of the secretory pathway (Muniz and Riezman, 2000; Bagnat et aL, 2000).
In r. brucei a novel bloodstream stage alanine-rich protein (BARP), predicted to be 
GPI-anchored, localised in a punctate pattern on the cell surface (Nolan et aL, 2000). 
This protein could be fractionated into a detergent insoluble, glycolipid-enriched 
fraction by cold TritonX-100 extraction, while the predominant GPI-anchored protein 
VSG did not. It was suggested that this was the first example of lipid-microdomains in 
protozoa (Nolan et aL, 2000).
DRMs have also been isolated from L. major, and are enriched in characteristic 
eukaryotic lipid raft components; inositol phosphorylceramide (fPC), sterol 
(ergosterol), and GPI-anchored molecules (both GP63, and LPG) (Denny et aL, 2001). 
GP63 is rapidly incorporated into DRMs suggesting that rafts may form in the ER of 
Leishmania as in yeast (Denny et aL, 2001). In L. mexicana both GIPLs and GP63 have 
been demonstrated to associate into TX-lOO insoluble membranes (Ralton et aL, 2002). 
These insoluble membranes have similar characteristics to DRMs from other 
eukaryotes, and are enriched in IPG (the major sphingolipid of L. mexicana), but 
depleted in glycerophospholipids, and cellular proteins. Pulse-chase labelling, and TX- 
lOO fractionation demonstrated that the major isoform of GP63, was both transported to 
the cell surface, and incorporated into DRMs with similar kinetics, and that GP63 was 
incorporated into DRMs in a late secretory compartment in L. mexicana. This is 
different from the results from the L. major study whereby it was suggested that DRM 
incorporation occuired in an early secretory compartment (Denny et aL, 2001).
Low temperatures prevent the transport vesicles which bud from the ER from fusing
with the Golgi, and therefore blocks secretory transport. In T, brucei the transport of
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VSG from the Golgi to the flagellar pocket is inhibited at low temperatures (Duszenko 
et aL, 1988), similarly in mammalian cells the transport of free GPIs to the cell surface 
is inhibited at 15°C (Baumann et aL, 2000). In L. mexicana GP63 and GIPL 
incorporation into DRMs was inhibited at low temperatures, and it is suggested that this 
is evidence for a vesicular transport mechanism (Ralton et aL, 2002). It was also 
demonstrated in L. mexicana that in the presence of the sphingolipid biosynthesis 
inhibitor, myrocin, sphingosine and ceramide synthesis were completely inhibited. 
However GP63 surface transport, and GP63 and GIPL incorporation into DRMs was 
not inhibited. This is in contrast to the situation in other eukaryotes where the transport 
of GPI-anchored proteins requires the ongoing synthesis of sphingolipids and 
ceramides (Ralton et aL, 2002).
It therefore seems that GPI anchors play an important role in the forward transport of 
proteins in both higher eukaryotes, and protozoa, providing an interesting area for 
further study. Variations in this process between mammalian cells, yeast and protozoa 
have already been detected. Continued study using the AgpiS cell line would provide an 
interesting control in the study of trafficking of GPI-anchored proteins within 
Leishmania, It would be interesting to use ergosterol inhibitors to prevent raft 
formation in the AgpiS cell line, and compare the processing and trafficking of GP63 in 
these cells with the situation in WT cells.
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Figure 4.1: Characteristic domains of GP63, a GPI-anchored zinc metalloproteinase.
GPI-anchored proteins have 4 characteristic domains; an N-Terminal ER signal peptide, 
mature peptide and C-terminal hydrophobic tail. The co-site adjacent to the hydrophobic 
tail is the point of GPI anchor addition. Metalloproteinases are characterised by a pro- 
region and zinc-binding domain. GP63s from a number of Leishmania species are 
predicted to have 3 N-glycosylation sites.
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Figure 4.2: Amino Acid sequence alignment of Leishmania GP63 homologues.
The predicted protein sequence of a L. mexicana GPI-anchored GP63 (L.mex), 
aligned with L. major (L.maj) accession number P08148, and L. amazonensis 
(L.ama) accession number L46798 GP63s. The alignment was performed using 
Align X (InforMax. Inc). Identical residues are shaded pink, conserved and similar 
residues are shaded grey. Weakly similar residues are shown in blue.
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Figure 4,3: Analysis of the intracellular processing of GP63 by pulse chase 
labelling.
WT, AgpiS and AgpiS{pXAgpiS^'^^^^} cells were grown to mid log phase, and 
labelled in medium containing ^^S-ExpreSS for 12 minutes, washed 3 times and 
resuspended in an equivalent volume of growth medium. The chase time was for a 
period of up to 300 minutes. Equivalent samples of cells and medium were collected 
at suitable time points.
Panel A) Cell samples were partioned into soluble (S) and membrane-bound (M) 
fractions by TX-114 extraction.
Panel B) Cell samples were partitioned into soluble and membrane-bound fractions 
by NaCOg extiaction.
Panel C) Medium samples.
All samples were immune-precipitated with an a-GP63 antibody (L3.8), 
electrophoresed on a 12% SDS-PAGE gel and scanned with a phosphor-imager. 
Secreted (s) and cellular (c) GP63 are indicated.
130
A
Time
(mins) 0 20 40 80 180
S M S M S M S M S M
WT mm IMP # # #
^gpi8 ###- - ■ ■
AgpiS
[pXgp/S^2‘“ ]
64c63c
B
Time
(mins) 0
WT
^gpi8
20 40 80 180
S M S M S M S M S M . 65c g:64c 63c
-65c
Time(mins) Q 20 40 80 180
— 65s— 63sWT
—65s
65s^gpiS
131
6000000
5000000
4000000
^  3000000
<  2000000
1000000
0 50 100 150 200 250 300 350
WT
AgpiS
T im e  (M ins)
Figure 4.4: Kinetics of GP63 secretion from the cell.
The comparative levels of GP63 secreted into the medium from WT ( • )  and 
AgpiS (A) cells during a 300-minutes pulse-chase experiment were measured 
using the phosphor-imager and quantified using the Image Quant programme 
(Molecular Dynamics). This data is from a single experiment, and is representative 
of a number of repeated experiments. The experiment was repeated 4 times to 180 
minutes, and twice to 300 minutes.
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Figure 4.5: Comparative distribution of GP63 within WT and AgpiS cells over a 
300 minute chase period.
Cells were pulse-chase labelled and treated as previously described. The level of 
membrane associated (♦ ) ,  cell soluble (■) and secreted (A) GP63 was measured 
and quantified using the Typhoon phosphorimager, and Image Quant programme. 
Panel A shows the distibution of GP63 in WT cells. Panel B shows the distribution 
of GP63 in AgpiS cells. The data is from one experiment, and the levels of GP63 
within and between both cell lines is directly comparable. This data is representative 
of a number of repeated experiments. The experiment was repeated 4 times to 180 
minutes, and twice to 300 minutes.
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Figure 4.6: Total GP63 expression within WT and ^ p i8  cells.
Graph of relative GP63 expression from WT ( • )  and (A) cells. The figures
were calculated from the combined fractions collected during a 300 minute pulse- 
chase labelling experiment. This data is representative of a number of repeated 
experiments. The experiment was repeated 4 times to 180 minutes, and twice to 300 
minutes.
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Figure 4.7: PI-PLC treatment of cells.
WT promastigotes were pulse chase labelled with ^^S-ExpreSS for a period up to 180 
minutes. The cells were lysed and treated with or without PI-PLC prior to Triton X- 
114 fractionation into soluble (S) and membrane-associated (M) fractions, immune- 
precipitated with an a-GP63 antibody (L3.8) and electrophoresed on a 12% PAGE 
gel. The gel was visualised with a phosphor-imager.
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Figure 4.8: Glycosylation demonstrated by Con A precipitation.
Proteins were precipitated using ConA sepharose beads from either medium or cell 
lysates in two separate experiments and electrophoresed on a 12% SDS gel. 
Equivalent WT and Agpi8 samples were loaded from either the medium (Lanes 3 
and 4) or cell lysate (Lanes 5 and 6) ConA precipitation experiments, allowing 
direct comparison between the two cell lines. Untreated cell lysate material was 
loaded as a control (Lanes 1 and 2). The gel was electroblotted and GP63 detected 
by western blotting using a GP63 antibody.
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Figure 4.9: Tunicamycin treatment of cells.
Cells were grown in the presence or absence of 5 pg ml ' tunicamycin for 5 hours. 
Cells were labelled with ^^S-ExpreSS for 12 minutes and then chased in cold 
medium for a period up to 180 minutes. Samples were taken for analysis at 
appropriate time points.
Panel A) Cell samples were TX-114 fractionated, immune-precipitated with a GP63 
antibody, and electrophoresed on a 12% SDS gel. Only the membrane fractions from 
the WT cells, and the soluble fractions from the AgpiS cell line are shown here, as 
these were the fractions which contained detectable GP63. The different sized forms 
present when cells were grown in the presence of tunicamycin are indicated (ct).
Panel B) Medium fractions were immune-precipitated with an antiGP63 antibody 
and electrophoresed on a 12% SDS PAGE gel.
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Figure 4.10: PNGase F treatment of WT and AgpiS isoforms of GP63.
WT and AgpiS promastigotes were labelled with ^^S-ExpreSS for 12 minutes and 
then chased in cold medium for a period up to 180 minutes. Samples were collected 
at appropriate time points, TX-114 fractionated, and immune-prec ip itated with an 
aGP63 antibody. For each sample half was treated with PNGaseF, and half mock 
treated. The membrane fractions from WT cells, and the soluble fractions from the 
AgpiS cells are shown here.
The different sized isoforms present subsequent to PNGaseF treatment are indicated 
(cp).
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Figure 4.11: Comparison of the gelatinolytic activity of GP63 from cell lysate 
material.
WT and AgpiS cells were grown to late log phase. Differing cell equivalents were 
loaded on a 10% acrylamide 0.1% gelatin gel; 5x10^ cell equivalents lanes 1, 3, 6, 
and 8; 2x10^ cell equivalents lanes 2, 4, and 7; and 1x10  ^ cell equivalents lane 5. 
Subsequent to electrophoresis, the gel was cut in 2 and one section electroblotted 
and GP63 detected by western blotting. The other section was treated for 
gelatinolytic activity.
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Figure 4.12: Gelatinolytic activity of proteins precipitated with ConA from 
the medium of WT and AgpiS cells.
WT and AgpiS cells were grown to late log phase in medium containing 5% PCS. 
The medium from 5x10* cells was collected, concentrated and ConA 
precipitated.
Panel A) WT cell lysate from 1x10  ^ cell equivalents, and ConA precipitated 
samples from the medium of an estimated 1x10* cells were electrophoresed by 
12% SDS-PAGE, electroblotted and GP63 detected by western blotting.
Panel B) WT cell lysate from 1x10  ^ cell equivalents, and ConA precipitated 
samples from the medium of an estimated 2x10* cells were electrophoresed on a 
10% SDS-PAGE gel containing 0.1% gelatin. The gel was treated for 
gelatinolytic activity by incubating in O.IM Na Acetate, ImM DTT at 37°C 
overnight.
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Figure 4.13: Detection and gelatinolytic activity of proteins precipitated with 
ConA from WT and AgpiS cells grown in the absence of FCS.
Cells were grown to late log phase in medium containing 5% FCS. 1.7x10* WT 
cells and 3.4x10* AgpiS cells were washed and grown in 5mls of HOMEM in the 
absence of FCS for 6 hours. Medium and cell samples were ConA precipitated.
Panel A) Detection of gelatinolytic activity. 3x10^ WT and 6x10^ AgpiS cell 
equivalents from both medium and cell were ConA precipitated and samples 
electophoresed on a 10% SDS-PAGE gel containing 0.1% gelatin. The gel was 
treated for gelatinolytic activity by incubating in 50mM Tris-HCl pH8.00 at 37°C 
overnight.
Panel B) Detection of GP63. 3x10^ WT and 6x10^ AgpiS cell equivalents from 
both medium and cells were ConA precipitated, and samples electophoresed by 
12% SDS-PAGE, electroblotted and GP63 detected by western blotting.
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Figure 4.14: Activation of secreted GP63 with HgClj.
Panel A) WT and AgpiS cells were grown to late log phase, washed, and 
resuspended in medium lacking FCS for 4 hours. The medium samples weres 
collected, pre-cleared and ConA precipitated. The eluted samples were then 
treated with or without 2pM HgCl2 at 3TC  for 1 hour. WT lysate from 1x10^ cell 
equivalents (Lane 1), and the medium from an estimated 6x10^ cell equivalents 
(Lanes 2-5) were loaded on a 10% SDS PAGE gel containing 0.1% gelatin. 
Subsequent to electi’ophoresis the gel was washed in 2.5% TX-100, and treated for 
gelatinolytic activity by incubation in 50mM Tris HCl pHS.OO at 37°C overnight.
Panel B) WT and AgpiS cells were grown to late log phase, washed, and 
resuspended in medium lacking FCS for 4 hours. The medium samples were 
collected, pre-cleared and ConA precipitated. WT lysate from 5x10*^  cell 
equivalents (Lanes 3, 6 and 9), and the medium from an estimated 2x10* cell 
equivalents (WT lanes 2, 5 and 8, AgpiS lanes 1, 4, and 7) were loaded on a 10% 
SDS PAGE gels containing 0.1% gelatin. Subsequent to electrophoresis the gels 
were washed in 2.5% TX-100, and treated for gelatinolytic activity by incubation 
in 50mM Tris HCl pH 8.00 at 37°C overnight. In addition one gel (Lanes 4-6) was 
also incubated with 20mM 1-10 phenantliroline, and a second gel (Lanes 7-9) with 
4pM HgClg, during the final wash and incubation steps. (Note this picture was 
taken with inverted contrast).
The proteins predicted to be GP63 are indicated .
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Figure 4.15: Analysis of the secreted forms of GP63.
WT cells were grown to mid log phase and 1x10* cells were metabolically labelled 
with ^^S-ExpreSS for 6 hours. The medium was collected, pre-cleared and the 
samples split into 2 and treated with or without PI-PLC for 1 hour prior to TX-114 
fractionation. Soluble (S), and membrane-associated (M) fractions were and 
immune-precipitated with a GP63 antibody (L3.8).
Samples were electrophoresed on a 12% SDS-PAGE gel and visualised using a 
phosphor imager. The 65s and 63s forms of GP63 are indicated.
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Figure 4.16: Brefeldin A Treatment of cells.
Cells were grown to mid log phase and treated with lOpg ml'* Brefeldin A (BFA) 
for 4 hours prior to pulse chase labelling. WT and AgpiS promastigotes were 
labelled with ^^S-ExpreSS for 12 minutes and then chased in cold medium for a 
period up to 180 minutes. Samples were collected at appropriate time points.
Panel A) Cells were lysed, immune-prec ip itated with an aGP63 antibody (L3.8), 
and electrophoresed on a 12% SDS-PAGE gel.
Panel B) Samples of medium were pre-cleared, immune-precipitated with an 
aGP63 antibody (L3.8), and electrophoresed on a 12% SDS-PAGE gel.
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Figure 4.17; Model of GP63 processing in WT and AgpiS cells.
In WT cells the majority of GP63 is N-glycosylated and G PI-anchored rapidly in the 
ER to give a 65kDa form. N-glycan processing (not defined in this model) and pro­
domain removal give a mature, active 63kDa isoform that is transported to the the cell 
surface. In WT cells some GP63 is N-glycosylated and secreted from the cell without 
further modification. In AgpiS all GP63 destined for secretion is N-glycosylated and 
transported from the cell without further modification.
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Identification of GPI biosynthesis and trafficking components
5.1 Introduction
GPI anchor biosynthesis has been well characterised in mammalian cell lines 
(described in section 1.4). However, in Leishmania sp. only GPI8, the catalytic subunit 
of GPIT, has been identified. It seems likely that other members of the GPIT complex 
exist, mimicking the situation found in yeast and mammalian cells. The production of 
the AgpiS cell line demonstrated that GPI anchoring is not essential in L. mexicana 
(Hilley et aL, 2000) as it is in other organisms such as yeast (Hamburger et aL, 1995; 
Benghezal et aL, 1996), suggesting that L. mexicana promastigotes are a suitable model 
organism in which to study GPI anchor biosynthesis by the production of null mutants. 
GPI anchors are also speculated to have some involvement in the trafficking of proteins 
(Muniz and Riezman, 2000). This chapter describes two approaches taken to identify 
novel genes involved in the GPIT complex, GPI biosynthesis or the trafficking of GPI- 
anchored proteins in L. mexicana.
5.2 Epitope tagging of GPI8
Detection of GPI8 has previously only been possible from cell lines re-expressing GPI8 
from an episome by immune-precipitation of labelled proteins with the R492 
polyclonal GPI8 antibody. GPI8 was not detected in WT cells by this method, possibly 
due to the low level of expression of the protein in these cells, as discussed in chapter 3. 
A previous study produced a GPI8-green fluorescent protein (GFP) fusion protein, 
expressed from an episome in the AgpiS cell line (Hilley, 1999). It was suggested that 
this fusion protein was only partially able to rescue GPIT activity, as western blotting 
with a GP63 antibody detected only a 50kDa protein within the Ag/?/5[pXGP7S-GFP] 
cell lysate, compared to the 63kDa protein present in WT cell lysate. It was suggested 
that the size of the GFP component of the GPI8-GFP fusion protein may effect the 
correct functioning of the GPI8 protein, with respect to complex formation, and 
interaction with other proteins (Hilley, 1999).
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It was thought that the production of a tagged GPI8 protein would provide a tool with 
which to examine the protein, and associated complex members in greater detail. 
Tagging GPI8 with a small epitope would produce a fully functional and easily 
detectable form of the protein. This would allow intracellular localisation of GPI8 by 
immunofluorescence, and co-immune-precipitation of GPI8 with other members of the 
GPIT complex, and identification of these proteins.
The TY epitope is a short 10 amino acid peptide from the Ty-1 virus-like particle, an 
immunologically well-characterised protein found in S. cerevisiae (Brookman et aL,
1995). The TY epitope has been successfully developed in T. brucei as a means of 
tagging proteins (Bastin et aL, 1996). The epitope was readily detected by two 
monoclonal antibodies, BB2 and TYG-5, in immunofluorescence, immune- 
precipitation and western blotting analysis (Brookman et aL, 1995). The antibodies 
were produced using hybridoma cell lines (Brookman et aL, 1995).
5,2.1 Production of TY tagged GPI8
The original intent of this study was the production of a cell line with GPI8-TY 
integrated into the GPI8 locus, as this would allow the analysis of the cells expressing 
the protein at WT levels, rather than examining GPI8 in cells over-expressing the 
protein from an episome. Initially, production of an episomally expressed TY tagged 
GPI8 was planned. This would allow the assessment of a suitable position within the 
protein to detect the epitope and maintain a functional GPI8.
Two TY tagged forms of GPI8 were constructed using the pXGPIS expressing episome
(pGL269) (Hilley et aL, 2000). The restriction enzyme sites Notl and Ndel were
identified as unique sites within the plasmid, and were present within the GPI8 ORF. A
Kyte-Doolittle plot of GPI8 hydrophobicity demonstrated both restriction enzyme sites
were located in hydrophilic regions of the encoded protein, and were therefore suitable
positions to insert an epitope tag (Figure 5.1, panel A). Neither enzyme site was within
the region of the ORF encoding for the active site histidine or cysteine residues, and
insertion of an epitope tag at either position was not predicted to affect GPI8 activity.
The Notl restriction site was present in the GPI8 ORF close to the region which
encoded for the cleavage point of the predicted N-terminal signal sequence thought to
target GPI8 to the ER (Figure 5,1 Panel A and B).
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Two sets of oligonucleotide pairs were designed (Table 5.1). When annealed, each pair 
produced a small DNA fragment, which encoded for the TY epitope in frame with 
GPI8, with appropriate overhangs to allow insertion into either the Notl or Ndel 
restriction enzyme sites.
Name Sequence Restriction 
enzyme site
TY
EPITOPE
E V H T N Q D P L D  
GAG GTC CAT ACT AAC CAG GAT CCA CTT GAC 
CTC CAG GTA TCA TTG GTC CTA GGT GAA CTG
OL532
OL533
5' 3 ' G GCC GAG GTC CAT ACT AAC CAG GAT CCA CTT GAC GCCTC CAG GTA TGA TTG GTC CTA GGT GAA CTG CGC CGG 
3 ' 5'
Notl
OL534 
OL53 5
5' 3 ' T ATG GAG GTC CAT ACT AAC CAG GAT CCA CTT GAC CA
AC CTC CAG GTA TGA TTG GTC CTA GGT GAA CTG GTA T 
3 ' 5' Ndel
Table 5.1: Oligonucleotides used in the production of 2 forms of GPI 8 tagged vrith
the TY epitope.
The DNA fragments encoding the TY epitope were prepared by mixing 12pg each of 
the appropriate oligonucleotides, incubating at 96°C, and then slowly cooling to 55°C 
to allow annealing. The fragments were ligated into the pGL269 plasmid, which had 
previously been prepared by digestion with either the Notl or Ndel restriction enzymes. 
Colonies containing plasmids with the correctly orientated insert were identified by 
colony PGR, using the primers OL533 and OL460 for insertion at the Notl site, and 
OL535 and OL459 for insertion at the Ndel site, and named pGL452 and pGL453 
respectively. Plasmids were sequenced to verify that only a single insertion had 
occuiTed at each site, and that the GPI8 ORF remained in frame. The plasmids pGL452 
and pGL453 were transfected into the AgpiS cell line to produce the cell lines 
AgpiS[pXgf and Agp(S[pXgpî8-TY“ ' ‘].
5.2.2 Analysis of TY tagged GPI8
The cell lines Agpi8[pXgpi8-TY™] and AgpiS[pXgp;8-TY'^*'] were assessed for GPI8 
activity by examining the effect on the GPI anchoring of GP63. Cell lysate material 
from 10^  cell equivalents was electrophoresed by 12% SDS-PAGE, electroblotted and
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GP63 detected by western blotting (Figure 5.2, panel A). GP63 was detected in the cell 
lysate material from the WT and Agpi8[pXGPI8] cell lines, and absent from the AgpiS 
cell line as shown previously. GP63 was also present in cell lysate material from the 
AgpiS[pXgpiS-TY^^‘^ ] cell line, but absent from the cell lysate material from the 
AgpiSipXgpiS-TY^"^^^] cell line. This indicated GPI8-TY^"'* was active whilst GPI8- 
inactive.
The TY epitope in the GPIS-TY^ *^ *^ mutant was inserted into the protein close to the 
predicted point of cleavage of the ER signal (Figure 5.1, panel B). This insertion was 
designed such that in the translated protein removal of the ER signal was not predicted 
to be effected, and subsequent to the removal of this signal the TY epitope would be 
positioned close to the N-terminus of the GPI8 protein. In contrast the GPIS-TY^ *^ *^ 
expressing cell line had the epitope inserted internally within the protein. Though it was 
not predicted to interfere with the active site residues of GPI8, it is possible that the 10 
residue peptide has affected the tertiary structure of the protein, possibly disrupting the 
formation of the GPIT complex, or binding to the GPI-protein thus preventing 
transamidase activity. In contrast the Notl site within the GPI8 ORF therefore provides 
an ideal position for tagging the GPI8 protein, as it does not appear to affect the 
function of the GPIT.
The cell lines AgpiS[pXgpiS-TY^^^^], and AgpiSipXgpiS-TY^^^^^] were tested to confirm 
that the epitope tagged GPI8 was recognisable using the TY antibody BB2 (Brookman 
et aL, 1995). Cell extracts from WT, AgpiS AgpiS[pXGPIS], AgpiS[pXgpiS-TY^^\ 
and AgpiS[pXgpiS-TY^^^^] were electrophoresed on a 12% SDS PAGE gel, 
electroblotted and GPI8-TY detected by western blotting with the BB2 antibody used at 
a dilution of 1:10 (Figure 5.2, panel B). GPI8 has a predicted size of 42kDa. 2 proteins 
of 43 and 42kDa appeared as a doublet on the gel, and were detected only in the cell 
lysates of cell lines expressing the TY tagged foi*m of GPI8 (Lanes 4 and 5). No 
proteins of this size were detected in the WT, or AgpiS cells, or in the cell line re­
expressing GPI8 from an episome (Lane 2). This suggested that the protein detected 
was GPI8-TY, and this protein was present as 2 isoforms. Insertion of the TY-Tag at 
either the Notl or Ndel sites in the GPI8 ORF resulted in an epitope tagged GPI8 
protein recognisable by the BB2 antibody.
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Whilst the TY-tagging of GPI8 appeared to be successful the western blot showed that 
the BB2 antibody also detected an abundant smaller sized protein. This protein was 
present in all cell lines tested, including the AgpiS cell line, and so is likely to be a 
cross-reacting protein. The protein was detected at higher levels than GPI8-TY. In an 
attempt to prevent the detection of the cross-reacting protein the BB2 antibody was 
used at higher dilutions. Whilst this resulted in the detection of a lower level of 
contaminating protein it also resulted in the loss of detection of GPI8-TY. A high 
stringency wash was introduced in an attempt to prevent the cross-reaction. TBS was 
used in place of PBS usually used in western blot detection. Western blots were washed 
in TBS, 0.1% Tween after incubation with the primary antibody. The blot was 
subsequently washed with lOmM Tris, 0.5M NaCl, 0.5% Tween pH 7.6, and then 
washed again in TBS, 0.1% Tween. This method had no effect on the level of detection 
of the contaminating protein. Attempts to further purify the antibody by growth of the 
hybridoma cell line in Serum Free and Protein Free Hybridoma Medium (Sigma), or 
purification using a protein G column, failed to either increase the concentration of the 
antibody or prevent the detection of the cross-reacting protein. The presence of a cross­
reacting protein has not been reported in other studies on T. brucei (Bastin et aL, 1996), 
and in this study where T. brucei cell lysate was used as a control no cross 
contamination was detected. It was concluded that the BB2 antibody detected a cross­
reacting protein at high levels in L. mexicana cell lysates.
5.3 Production of GPI-anchored GFP
The identification of novel genes involved in GPI anchor biosynthesis and the 
trafficking of GPI-anchored proteins, requires the development of a novel method to 
mutate and screen a large number of genes. Therefore a model system was designed to 
allow the production and assessment of a large number of mutant cell lines. The general 
approach was to subject Leishmania to mutagenesis, screen for mutants lacking in GPI- 
anchored surface proteins, and complement these mutants using an L. mexicana cosmid 
library. As L. mexicana is a diploid organism, 2 random mutation events are required to 
produce recessive mutants. The frequency of recovery of null mutants after chemical 
mutagenesis is estimated to be 10'  ^ (Gueiros-Filho and Beverley, 1996). The method 
used would therefore require the efficient screening of a high number of cells for the 
loss of GPI-anchored proteins.
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The green fluorescent protein (GFP) from Aequorea victoria is commonly used as a 
marker for gene expression in eukaryotic cells (Chalfie et aL, 1994). Expression of 
GFP, enhanced GFP, and a GFP tagged protein from the pXG episome in L. major and 
L. donavani demonstrated that the protein was a suitable marker for use in Leishmania 
(Ha et aL, 1996). Use of fluorescence activated cell sorting (FACS) demonstrated that 
separation of GFP expressing cells from non-GFP expressing cells in a mixed 
population was possible (Ha et aL, 1996). It was therefore thought that the construction 
and use of a GPI-anchored GFP expressing episome in L. mexicana would allow the 
rapid detection of GPI biosynthesis mutants by FACS analysis.
It was predicted that a GP63-GFP fusion protein with both the N-terminal signal 
peptide and the C-terminal GPI anchor attachment domain from GP63, would be GPI- 
anchored and then trafficked to the cell surface. Cells with a GPI-anchored GFP could 
be isolated from cells with no surface expressed GFP by FACS. Subsequent to 
chemical mutagenesis, cells with a deficiency in any gene involved in the GPI 
biosynthesis or trafficking pathways, would not coiTectly process and traffick GPI-GFP 
to the surface, and could be isolated by FACS. Similarly those cells in which GPI- 
anchoring was rescued by complementation with the cosmid library, would regain 
surface anchored GFP, again making them identifiable by FACS. Rescued cell lines 
would be produced, and the cosmids isolated to allow the identification of the novel 
genes (See figure 5.3). Use of GFP and FACS analysis would therefore allow the 
processing of high numbers of live cells at each stage of the analysis.
5.3.1 Production of GPI-GFP constructs
GPI-anchored proteins have two domains essential for GPI anchor addition, the N- 
terminal ER signal and C-teiTninal GPI anchor addition site. GP63 also has a 
characteristic pro-domain that is cleaved during the trafficking of the protein. A recent 
study examined the intracellular trafficking of T. brucei cathepsin L-Iike cysteine 
protease in both T. brucei and L. mexicana (Huete-Pérez et aL, 1999). This 
demonstrated that the pro-domain, required to maintain the cysteine protease in an 
inactive foi*m, was required to traffic a pro-domain-GFP fusion protein to the lysosome/ 
endosome. It was shown that this was due to a 9 amino acid motif present in the pro­
domain, thought to be required to direct the trafficking of the cathepsin L-like protein
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through the golgi (Huete-Pérez et a l, 1999). It seemed possible that the GP63 pro­
region may be required for the correct trafficking of the GP63 to the surface.
Two separate constructs were designed to produce GPI-GFP fusion proteins. The two 
proteins varied at the N-terminus. Both fusion proteins had the GP63 ER-signal, 
however GFP*^ ’’* contained only a short section (15 residues) of the GP63 pro-region. 
The other protein, ProGFP^^\ contained the entire GP63 pro-region and a short section 
(18 residues) of the N-terminal end of the GP63 mature peptide fused to the N-terminus 
of GFP (Figure 5.4).
A number of previous studies have converted non-GPI-anchored proteins to GPI- 
anchored molecules by addition of the GPI-attachment site, hydrophilic spacer and 
hydrophobic domain from GPI-anchored molecules (Micanovic et aL, 1990; Moran and 
Caras, 1991). However in one study the non-GPI-anchored yeast protein prepro-a- 
factor (ppaf) failed to become GPI-anchored when the co site, hydrophilic spacer, and 
hydrophobic domain from the GPI-anchored yeast protein Gas Ip was added to ppaf to 
produce a fusion protein. GPI anchor addition did occur when a second fusion protein 
incoiporating a further 20 amino acids N-terminal of the Gas Ip O) site was produced 
(Doering and Schekman, 1997). The reason for this was unclear, however both GFP- 
GPI fusion proteins for expression in L. mexicana were designed such that the C- 
teiminal end of GFP was fused to an additional 43 residues of the mature peptide of L. 
mexicana GP63, prior to the (o site, hydrophilic spacer and hydrophobic tail.
The 2 GFP-GPI expressing episomes were constructed in several stages (Figure 5.5). 
Initially the 5’ and 3’ regions of the GP63 ORF were cloned by PCR from the plasmid 
pGL454, which contains a cDNA of the C2 type GP63 (GPI-anchored) cloned into 
pBlueScript (Medina-Acosta et aL 1993). The primers used for the cloning of the 5’ 
region of GP63 incorporated a Smal site into the forward primer (OL 763), and an 
EcoRI site into the reverse primers (OL739 and OL741). The primers used for cloning 
the 3’ region of GP63 incorporated a Hmdlll site into the forward primer (OL765), and 
a BaniYa site into the reverse primer (OL764).
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GFP was cloned by PCR from a commercial vector (pEGFP-Cl, Cion tech, renamed 
pGL312) containing enhanced GFP (eGFP). Enhanced GFP is a modified form of the 
WT protein, which is brighter and has an excitation and emission spectra similar to that 
of FITC (Cormack et aL, 1996). The forward primer (OL740) incorporated an 
additional EcoBl site. The reverse primer (OL613) spanned the region of the multiple 
cloning site at the 3’ end of the GFP ORF.
Purpose Primername
Sequence
Added restriction enzyme sites are indicated
5’GP63 ORF. 
Forward
OL763 CCC GGG ATG TCC GTC GAC AGC AGC AGC Xmal
5’GP63 ORF 
Reverse (ER signal)
OL739 GAA TTC CGC GTC GTG GTG GAT GCA GCG GTG Ecom
5’ GP63 ORF. 
Reverse (ER signal 
and pro-region)
OL741 GAA TTC GGT GAG GTC TTC GGC GGA GAC £coRl
3’GP63 ORF 
Forward
OL765 GAA GCT TGC ACG CCG GGC CTC AGO TTT Hindm
3’ GP63 Reverse. 
Downstream of 
ORF
OL764 CGG ATCC GAC AGC ACC AGT CCT ACC BamHI
GFP ORF. 
Forward
OL740 GAA TTC GTG AGC AAG GGC GAG GAG CTG EcoRl
GFP ORF. 
Reverse
OL613 CGC GGT ACC GTC GAC TGC
Table 5.2; Primers used In the production of the episomes pGL586, and pGL587, 
encoding the fusion proteins GFP^ *** and ProGFP *^** respectively.
PCR reactions used Pfu polymerase, for increased proof reading ability. Subsequent to 
PCR the reactions were heated to 96°C for 30 minutes, and then lU  of Taq polymerase, 
20pM ATP added and the reactions incubated at 72°C for 2 min. This incoiporated an 
additional adenosine overhang to the PCR products to allow direct cloning into the 
commercial vector pGEMT (Promega). The plasmids were named pGL540 (GP63 ER 
signal, and pro-region), pGL541 (GP63 ER signal), pGL542 (GFP ORF), and pGL556 
(GP63 C-terminal). Plasmids were checked for insert orientation by restriction digests, 
and sequenced using the SP6 and T7 primers to check that no mutations had been 
incorporated by PCR.
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The plasmid pGL542 was digested with the enzyme EcoRI to release the GFP ORF, 
and the GFP EcoRI fragment was cloned into the EcoRI site of both pGL540 and 
pGL541, to produce plasmids pGL558 and pGL557 respectively. Insertion of the GFP 
EcoRl fragment in the correct orientation was verified by restriction digestion. The 
plasmid pGL556 was digested with the restriction enzymes //m dlll and Pstl to release 
the 3’ fragment of the GP63 ORF, and this fragment was ligated into the plasmids 
pGL558 and pGL557 at the Hindlll and EcoRI sites, to create plasmids pGL576 and 
pGL575 respectively.
The final step of the cloning was restriction digestion of the plasmids pGL576 and 
pGL575 with the enzymes Smal and BamlAi and ligation into the Smal and BamHl sites 
of the pXG episome, to produce the episomes pGL587 and pGL586. The pXG episome 
is a Leishmania expression vector with high expression levels (Ha et aL, 1996). The 
episomes pGL586 and pGL587 were shown, by both restriction digestion and 
sequencing, to contain no mutations, and the predicted proteins from the sequence 
correlated with the fusion proteins as originally designed. The episomes pGL586 and 
pGL587 were transfected into WT L. mexicana to generate the cell lines 
WT[pXGGFP°'’'] and WT[pXGProGFP°"] respectively. The episomes were also 
transfected into the AgpiS cell line for comparison generating the cell lines 
Agpi5[pXGProGFP^^*] and Ag/7?5[pXGGFP^^*]. The episome pXG-GFP+ (renamed 
pGL104, a gift from Dr Steve Beverley, Washington University Medical School), was 
transfected into WT cells generating the cell line WT[pXGFP]. The plasmid contains 
the GFP coding region, inserted into the Smal site of the pXG episome (Ha et aL,
1996).
5.3.2 Analysis of GFP-GPI expressing cell lines
Live cells were examined directly by fluorescence microscopy to assess GFP 
expression. Cells were grown to mid log phase, washed 3 times and resuspended in 
PBS. NaNs was added to a concentration of 0.005% to prevent excessive movement of 
the live cells, and cells were examined by fluorescence microscopy on a Zeiss 
microscope (Figure 5.6).
WT cells showed a low level of background fluorescence (Panel A). In contrast the
positive control WT[pXGFP] showed a high level of fluorescence which appeared
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cytosolic in its distribution (Panel B), as has been described previously when the 
plasmid was expressed in L. major (Ha et aL, 1996). A mixed population of cells was 
present with regards to the level of GFP expression (Compare aiTowed cells in Panel 
B), and in some cases individual cells did not appear to express GFP at all. All cultures 
were grown in the presence of G418, therefore the episome would be expected to be 
present in all cells.
WT cells expressing the GFP°^^ fusion protein showed a different distribution of 
fluorescence compared to those expressing GFP (Panel C). The protein was not located 
on the cell surface, but instead remained intracellularly, in an extranuclear pattern. The 
protein was not distributed evenly throughout the cytoplasm but instead appeared in a 
distinct pattern consistent with an ER location. A similar location was also found in the 
ProGFP^^' expressing cell line (Panel D). Analysis of the Agp/5[pXGProGFP‘^ *^] cell 
line showed a showed a high level of fluorescence, with a similar pattern of distribution 
(Panel F). The Agpi8[pXGGFP^^^] cell line did not show fluorescence at a level 
comparable with the other GFP expressing cell lines (Panel E). The intensity was at a 
level similar to WT cells and was therefore indistinguishable from background 
fluorescence. GFP expression could not be detected in this cell line by fluorescence 
microscopy. The three cell lines expressing detectable GFP^^* or ProGFP*^^* also 
showed high variability in the level of fluorescence detectable in individual cells (See 
cells indicated by arrows in figure 5.6).
The four cell lines were examined for GFP expression by western blotting. Cells were 
grown to mid log phase, and 10  ^ cell equivalents were electrophoresed by 12% SDS- 
PAGE, electroblotted, and GFP detected using a mouse monoclonal GFP antibody 
(Clonetech-JL8) at a dilution of 1:1000 (Figure 5.7). No protein was detected in either 
the WT or AgpiS cell lysate material (Lanes 1 and 2), whilst a protein of approximately 
72kDa was detected in cell lysate material from the WT[pXGP/5-GFP] cell line (Lane 
7). This was the estimated size of the GPI8-GFP fusion protein and suggested that the 
antibody was detecting GFP. Protein was detected in the cell lysate material from the 
WT[pXGGFP“’’‘], WT[pXGPioGFP°'’'] and Agp/S[pXGProGFP°'’'] cell lines (Lanes 4- 
6), suggesting that these cell lines were expressing a form of GFP. The predicted size of 
QppGPi \yas approximately 35-42kDa, dependent on whether processing events such as
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the removal of the ER signal and or the GPI attachment signal occuned. The estimated 
size of ProGFP*^^  ^ was 49-35kDa, dependent on the removal of the ER signal, pro­
region and GPI-attachment signal. Whilst proteins within this range were present in 
each of the cell lines, it was not clear which of the detected proteins represented the 
GFP fusion proteins. It would be anticipated that the ProGFP*^^* protein would be of a 
larger size than GFP^^* unless pro-region removal had occurred. Removal of the pro­
region of GP63 occurs by an unknown mechanism during the trafficking of GP63, 
possibly by enzymes localised in a membrane trafficking pathway (Macdonald et aL, 
1995). In the absence of the trafficking of the GFP fusion proteins to the cell surface, it 
might be predicted that this process would not occur. However there was no difference 
in the size of the detected protein in the cell lysates expressing the 2 different fusion 
proteins (compare lanes 5 and 6). No protein of the predicted size, 35-42kDa, was 
detected in the Agpi^[pXGGFP°^'] cell line (Lane 3). This result was consistent with 
the results from the fluorescence microscopy, where GFP expression was not detected. 
This suggested that the fusion protein GFP^^* was not expressed in these cells, and the 
episomal expression of GFP^^  ^ was lost. It was also possible that the GFP°^^ protein 
was degraded or rapidly secreted from the Agp/5[pXGGFP^*’*]cell line. A protein of 
size 26kDa was present in each of the 5 cell lysates expressing GFP fusion proteins 
(Lanes 3 to 7). It is possible that the multiple proteins detected represent different 
isoforms or degradation products of ProGFP^^^ and GFP°^\ the fusion proteins having 
undergone a variety of processing or degradation events within the cell.
Over a period of weeks the WT and AgpiS transfected cell lines lost GFP^^  ^ or 
ProGFP^^^ expression, as determined by western blotting and fluorescence microscopy. 
Growth of the original stabilates in increasing concentrations of the antibiotic G418 
failed to prevent this loss of expression. Expression of GFP^^* and ProGFP^*"* from an 
episome appeared to be unstable.
The results from the fluorescence microscopy indicated that the GFP-GPI fusion 
proteins failed to reach the surface of WT cells. The pattern of intracellular 
fluorescence suggested that the proteins were targeted to the ER. However it was not 
clear if the proteins received a GPI anchor, and failed to be trafficked from the ER or if
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the proteins did not receive an anchor. TX-114 fractionation and PI-PLC treatment 
were used in an attempt to address this question.
Cells were grown to mid log phase and 10  ^ cells were washed in PBS, pelleted, and 
resuspended in 300pl of TX-114 buffer but in the absence of TX-114, and the addition 
of 0.05% TX-lOO and incubated at room temperature for 30 minutes to lyse the cells. 
Samples were pre-cleared by centrifugation and the supernatant transferred to a fresh 
tube. Each sample was divided in two and 2pl of PI-PLC was added to one of each pair. 
All samples were incubated at 37°C for 1 hour, and pre-condensed TX-114 added to a 
final concentration of 0.5%. All samples were TX-114 fractionated as described 
previously (Section 2.5.8). Subsequent to fractionation lOjxl of 4 x SDS loading buffer 
was added to the 30pl of membrane fraction. The soluble fraction was concentrated to 
60pl using a Microcon spin column (Amicon), and 20pl of SDS loading buffer added. 
Samples were boiled and comparable amounts of membrane and soluble fractions were 
electrophoresed on 12% SDS-PAGE gels. Gels were electroblotted, and then western 
blotted using either a GP63 monoclonal antibody at a dilution of 1:50 (Figure 5.8, panel 
A), or the Clontech JL-8 GFP antibody at a dilution of 1:1000 (Panel B, and C).
Western blotting of the WT[pXGGFP°"] and WT[pXGProGFP°'''] cell lines with a 
GP63 antibody demonstrated that the PI-PLC treatment and TX-114 fractionation 
worked efficiently (Figure 5.8, panel A). GP63 was detected in both cell lines, and the 
protein was detected in the membrane fraction with no PI-PLC treatment, and was 
present in the soluble fraction subsequent to treatment.
Western blotting using the JL8 GFP antibody (Panel B and C) failed to detect any 
protein using the SuperSignal west pico chemiluminescent detection kit (Pierce). 
However using the SuperSignal west femto maximum sensitivity detection kit (Pierce), 
which has increased sensitivity, did detect some protein. A similar pattern of proteins 
was present in each of the 4 cell lines. A protein of approximately 63 kDa was detected 
in all fractions of each cell line. The predicted size of GFP°*"^  was 35-42kDa, and the 
predicted size of ProGFP*^ *** was 49-35kDa, the size of the 63 kDA protein suggested it 
was a cross-reacting protein. A repeat of the experiment using WT cells would confirm 
this. A protein of an estimated 30kDa was detected in the soluble fraction of each cell
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line, and proteins within the predicted size range of ProGFP^^^ were detected in the 
AgpiS[pXGProGFP‘^ ^^ ], minus PI-PLC, soluble cell fractions. However, no protein was 
detected which was judged to be GPI-anchored, as assessed by partitioning into the 
detergent fraction, and movement to the soluble fraction subsequent to PI-PLC 
treatment. This suggested that the GFP fusion proteins were not GPI-anchored. 
However the technical problems in detecting the GPI-GFP, made this experiment 
inconclusive. The difficulty in detecting the GFP fusion proteins by this method, may 
have been due to the degradation of the proteins within the cells, though this prediction 
is inconsistent with the GFP fluorescence seen in live cells by microscopy. 
Alternatively the JL8 antibody may unsuitable for detecting GFP proteins by western 
blotting. A more sensitive method may be the use of the antibody in immune- 
precipitation experiments, as GPI8-GFP has previously been detected by this method 
(see figure 3.2).
5.4 Discussion
The TY tagging of GPI8 was successful, however, a cross-reacting protein was detected 
at high levels in L. mexicana cell lysates using the BB2 antibody. This cross-reaction 
was not detected in previous work on TY-tagged proteins expressed in T. brucei 
(Brookman et aL, 1995), or Leishmania (K. Gull, personal communication). The low 
level of WT GPI8 expression and the presence of the cross-reacting protein prevented 
the use of the TY-tagged protein for the co-immune-precipitation of other GPTT- 
complex members from L. mexicana using the BB2 antibody. A second TY antibody, 
TYG-5, has been produced (Brookman et a l, 1995). This antibody may not detect the 
same cross-reacting protein in L. mexicana cell lysates, and would therefore make a 
viable alternative to the BB2 antibody. The TY-tagging of GPI8 has allowed the 
identification of GPI8 by western blotting, which was previously not possible. This 
suggested two different isofoims of GPI8 were present within the cell lysate. The Notl 
restriction site has also been identified as a suitable position for tagging GPI8 without 
inactivating the protein. GPI8-TY^^^  ^was shown to be active, as GP63 was present in 
the cell lysate material of the Agpi8[pXgpi8-TY^^^^] cell line. The tagging of GPI8 with 
alternative epitopes inserted at the Notl site would provide a method to allow the 
further analysis of L. mexicana GPI8 in the future. A recent study analysed the cross­
reactivity of commercially available antibodies to commonly used epitope tags with
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Leishmania cell lysates (Traub-Cseko et al., 1998). This demonstrated that anti-c-myc 
cross-reacted with a 17kDa protein, and anti-FLAG with a 36kDa protein in L. 
mexicana lysates. A suitable alternate tag might be the HA epitope, a 9 amino acid 
peptide present on the human influenza virus hemaglutinin protein (Wilson et at., 
1984). The HA antibody has been used to successfully detect a HA-tagged form of 
dolichol-phosphate-mannose synthase (DPMS) in L. mexicana (Mullin et al., 2001). 
GPIS-TY^ '^^* was an inactive protein. It might be interesting to express this protein in 
WT cells to examine any possible dominant negative effect, and observe if this differed 
from that seen when the active site mutant GPI8^^^^^ was expressed in WT cells.
Neither of the fusion proteins GFP^^* or ProGFP^^* became GPI-anchored on the cell 
surface as anticipated. Fluorescence microscopy indicated that the fusion proteins 
remained intracellularly with a pattern of fluorescence indicative of an ER location. 
This distribution was similar to that seen when a GFP construct was expressed with an 
N-terminal signal sequence and a T. brucei ER retention signal in L. mexicana (Ilgoutz 
et al., 1999a). Expression of a GFP-tagged forni of the Leishmania LPG3 protein in L. 
donovani also showed a similar pattern of fluorescence (Descoteaux et al., 2002). 
LPG3 is a homologue of the mammalian ER chaperone GRP94. LPG3-GFP co­
localised with BiP, a known ER protein, confirming the protein’s ER location. Co­
localisation studies with known ER proteins, such as the Leishmania ER marker LM39 
(Wallis et al., 1994) or the moleculai* chaperone BiP (Bangs et al., 1993) would 
confirm the ER location of the GFP fusion proteins used in this study. TX-114 
fractionation experiments also suggested that the proteins failed to receive a GPI 
anchor, as all detected proteins which might be ProGFP*^ *’’, or GFP°^\ were detected 
only in the soluble fraction. The pattern of fluorescence was similar in both WT and 
AgpiS cells expressing the constructs, suggesting that the presence or absence of a 
functional GPIT complex had no effect on the intracellular distribution of the fusion 
proteins within the cells.
The reason for the failure to produce GPI-anchored GFP using this system is unclear. 
GPI-anchored GFP fusion proteins have been successfully used in mammalian systems. 
A GPI-anchored GFP incorporating the ER signal (residues 1-25), and the N-teiminal 
domain (residues 67-102, with the o) site at residue 77) of the GPI-anchored receptor
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protein CD59, was shown to be anchored to the surface of CHO cells and the mouse T 
cell line, EL4 (Hiscox et al., 2002). A fusion protein described as a ‘minimal GPI-GFP 
fusion protein’ was successfully expressed on the plasma membrane of a variety of 
mammalian cell lines (Cos, HeLa, NRK and MDKC) (Nichols et al., 2001). The GPI- 
GFP behaved in an identical manner to the endogenous mammalian GPI-anchored 
protein CD59, though a second endogenous GPI-anchored protein, the folate receptor, 
had a different distribution suggesting that the trafficking of some GPI-anchored 
proteins may be mediated by additional sorting signals (Nichols et a l, 2001). The 
transferrin receptor (TfR) of T. brucei is GPI-anchored. It is expressed in bloodstream 
foim cells and is localised to the flagellar pocket. The different surface location of this 
protein, compared to VSG, suggests that some sorting or retention mechanism exists to 
specifically retain TfR within the flagellar pocket (MuBmann et a l, 2003). Analysis of 
the intracellular trafficking of VSG by studying the distribution of the protein within T. 
brucei suggested that the enrichment or sorting of the GPI-anchored protein occurs in 
several intracellular compartments (Grunfelder et a l, 2002). Therefore a variety of 
signals may be required to coiTectly target GPI-anchored proteins to the cell surface.
The expression of GFP and GFP fusion proteins has also been used in successfully in 
Leishmania. Similar to the findings in this study, the expression of GFP in L. major and 
L. mexicana has previously been shown to result in a cytoplasmic distribution (Ha et 
a l, 1996; Huete-Pérez et a l, 1999). The construction of different GFP fusion proteins 
has also allowed GFP to be targeted to different intracellulai' organelles. A fusion 
protein incoiporating the T. brucei cathepsin L like pro-domain with GFP was 
successfully used to examine the function of the pro-domain in the trafficking of 
cysteine proteases (Huete-Pérez et a l, 1999). A GFP-DPMS (GFP linked dolichol- 
phosphate mannose synthase) construct has been used as a marker for DPM linked GPI 
biosynthesis reactions in L. mexicana. GFP-DPMS was demonstrated to localise to a 
multivesicular tubule (MVT), initially thought to be a sub-domain of the ER, but now 
regarded as an early lysosome (Ilgoutz et a l, 1999a; Mullin et a l, 2001).
The failure to produce GPI-anchored forms of either GFP, or the mammalian protein 
PLAP in T. brucei was speculated to be due to the low levels of expression and rapid 
degradation of alien proteins in this system (Bohme and Cross, 2002). The levels of
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expression of the fusion proteins seen in the present study appeared initially high, as the 
proteins were readily detectable by microscopy. However this level of expression 
appeared to be unstable and was lost over a period of weeks, even under continued drug 
selection to maintain the presence of the episome. In contrast, the cell line expressing 
GFP from an episome maintained GFP in a cytosolic location. The loss of expression of 
QPpGPi ProGFP^^' may have been a result of the retention of these proteins 
intracellularly within the ER, where the build up of a large quantity of alien protein 
may have been detrimental to the cells. There would be selection for cells not 
expressing this protein.
A recent study produced a GPI-anchored GFP expressed in L. major promastigotes 
(Ghedin et al., 2001). An episome was constructed containing GFP flanked by an N- 
terminal signal peptide, from the Leishmania donovani surface enzyme 
3’nucleotidase/nuclease (Trf3’NT/NU), and the C-terminal GPI signal from L. chagasi 
GP63. This protein was termed 3 ’ SP: : GFP: iGPl'^^^ .^ The GFP used was amplified from 
the eGFP plasmid from Clontech. Confocal microscopy suggested that this protein was 
expressed on the cell surface of L. major promastigotes, and was present in the flagellar 
pocket. Increased episomal expression resulted in the chimera accumulating in a small 
intracellular compartment (Ghedin et al., 2001).
It is not clear why the 3’SP::GFP::GPI°^^^ chimera would become successfully GPI- 
anchored (Ghedin et a l, 2001) whilst the GFP^^  ^ and ProGFP^^^ fusion proteins 
produced in this study failed to do so. Both studies utilised the C-terminal end of GPI- 
anchored foims of GP63. Though in this study the final 69 amino acids of the C- 
terminal end of the protein were used, while in the previous study only the final 30 
amino acid were used. This study also incorporated the GP63 signal peptide and pro­
region, whilst the earlier study utilised the signal peptide from a transmembrane 
protein. It is possible that GP63 pro-region on the ProGFP°^^ protein acted as an ER 
retention signal, although this seems unlikely as both ProGFP^^^ and GFP '^*’^ were 
retained in the ER, suggesting that the pro-region was not the cause of ER retention.
Previous studies have demonstrated that the requirements for GPI anchor addition are
an N-temiinal signal to target the protein to the ER lumen (Caras and Weddell, 1989), a
C-terminal hydrophobic domain (Caras et al., 1989), spacer region and a domain of
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small amino acids around the (O site (Gerber et a l, 1992; Nuoffer et al., 1993; 
Kodukula et al., 1995). These requirements are discussed fully in section 1.4.8. The 
constructed fusion proteins had each of these elements, and it was predicted that these 
proteins would become GPI-anchored in L. mexicana. The putative ER location of the 
protein indicated the N-terminal signal had successfully targeted the fusion proteins to 
the ER. Therefore it seems that the failure in GPI-anchor addition occuned within the 
ER. A previous study suggested that there may be different requirements at the anchor 
addition site between species (Moran and Caras, 1994), however the constructs were 
based on GP63, a protein native to L. mexicana. There appears to be no obvious reason 
why anchor addition should not occur. A recent study has suggested that there is some 
variability in anchor addition requirements between individual proteins (Aceto et al., 
1999). The comparison of the C-terminus of two individual GPI-anchored proteins 
when fused to the same mature domain, indicated that individual proteins may have 
unique requirements for anchor addition (Aceto et a l, 1999). It is possible that an 
additional signal exists in GP63 that is required for GPI anchor addition in L. mexicana, 
and this was not incorporated into the GFP-GPI fusion constructs. In mammalian cells 
proteins destined to be GPI-anchored directly associate with GPI8 during anchor 
addition (Spurway et al., 2001; Vidugiriene et al., 2001), and photo cross-linking 
studies indicate the proteins may also associate with GAAl another member of the 
G Prr complex (Vidugiriene et al., 2001). The function of this association is not clear, 
however it is possible that the GFP constructs were not recognised by other, as yet 
unidentified components of the GPFT complex in L. mexicana, either due to misfolding 
or because the appropriate binding sites were not incorporated into the constructs. This 
lack of association may have prevented GPI-anchor addition.
It is interesting that failure to produce a GPI-anchored protein did not result in the 
secretion of the GFP-fusion proteins from the cell, as was found when GP63 failed to 
become GPI-anchored in the ÉsgpiS cell line. Instead the proteins appeared to be 
retained in the ER. This may be due to the lack of appropriate signals on the protein, or 
may be that the protein was identified to be misfolded. In higher eukaryotes misfolded 
glycoproteins are retained in the ER by the calnexin calreticulin system, and 
subsequently targeted for proteasome degradation (Paiodi, 2000; Ellgaard and 
Helenius, 2001). Whilst little is known about the secretory pathway in trypanosomatids,
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calreticulin homologues have been identified in L. donovani (Joshi et al., 1996) and T. 
cruzi (Labriola et al., 1999), suggesting a similar system exists in these cells. It is 
possible that and ProGFP^^^ are retained in the ER by this system.
The GPI-anchored GFP fusion proteins were unsuitable for their intended use as a 
method of screening for GPI biosynthesis or trafficking mutants. However production 
and manipulation of further GFP-GP63 fusion constructs may provide a means to study 
the trafficking of GPI-anchored proteins in Leishmania, and identify the domains 
required to allow anchor addition and exit from the ER. In T. brucei RNA interference 
(RNAi) has been successfully used to be produce functional ‘knockdowns’ of specific 
proteins (Ngô et al., 1998). More recently the introduction of a RNAi genomic library 
into T. brucei was used to identify genes affecting EP-procyclin expression or 
modification (Moms et al., 2002). However a similar approach may not be possible in 
Leishmania, as the parasite appears to lack the RNAi pathway (Beverley, 2003). A 
recent study has developed a L. mexicana cell line with a modified surface coat suitable 
for screening for GPI and GIPL biosynthesis mutants (Naderer and McConville, 2002). 
The production of the cell line, lslpg2\pX NEO GPIPLC], which lacked both LPG and 
GPI-anchored proteins from the cell surface, allowed the selection of biosynthesis 
mutants by growth on Con A. ConA is toxic to the cells as it binds to the mannose 
residues present in GIPLs and GPI anchors, causing the agglutination of the cells. 
Selection of GIPL and GPI anchor mutants by this method was not previously possible 
as the LPG coat masks the GIPL, and GPI anchors. Using this screening method a 
mutant cell line, DIGl, was identified. Analysis of the GPI and GIPL intermediates 
established that these cells were deficient at the point of otl-6mannose addition to the 
common GPI and GIPL core (Naderer and McConville, 2002).
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Figure 5.1; Epitope tagging of the GPI8 protein 
Panel A) Hydrophobicity plot of L. mexicana GPI8
Hydrophobicity plot of GPI8 using the Kyte-Doolittle algorithim. Scores greater 
than zero are hydrophobic, scores less than zero are hydrophilic. The predicted 
endoplasmic reticulum signal direction sequence from residues 1-31, and the 
positions of the active site residues H I74 and C216 are indicated. The position on 
the conesponding DNA sequnece of the restriction enzyme sites Notl (Amino acid 
residues 32/33) andAWel (Amino acid residues 256/257) are shown.
Panel B) Predicted amino acid sequence of TY tagged forms of GPI8
The predicted amino acid sequence of the epitope tagged proteins GPI8-TY^^^  ^and 
GPI8“TY^ '^ ^^  are shown. The TY epitiope is shaded blue and active site residues 
shaded pink. An arrow indicates the predicted cleavage point of the ER signal 
sequence.
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Figure 5.2: Analysis of epitope tagged forms of GPI8
Panel A) Analysis of GP63 expression in cell lines expressing TY tagged forms 
ofGPI8.
Cell lysates were prepared from the cell lines WT, Agpi8[pXGPI8], Agpi8, 
Agpi8[pXgpi8-TY^"‘% and Agpi8[pXgpi8~TY^^^^]. 1x10  ^cell equivalents per lane 
were electrophoresed by 12% SDS-PAGE, electroblotted, and exposed to a L. 
major GP63 monoclonal antibody at a dilution of 1:50. The GP63 protein is 
indicated.
Panel B) Analysis of GPI8-TY expression by western blotting with the BB2 
antibody.
Cell lysates were prepared from the cell lines WT, Agpi8{pXGP18\ Agpi8, 
Agpi8[pXgpi8-TY’^ '^ ‘% and Agpi8[pXgpi8-TY^^^^]. 1x10  ^cell equivalents per lane 
were electrophoresed by 12% SDS-PAGE and electroblotted. GPI8-Ty was 
detected by exposure to the BB2 monoclonal antibody at a dilution of 1:10. The 
GPI8-TY protein is indicated.
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Figure 5.3: Schematic of the method designed for the identification of GPI 
biosynethesis and trafficking genes in L. mexicana
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Figure 5.4: Schematic diagram of the GFP-GPI anchored fusion proteins 
ProGFP^***and GFP^P:
The GFP fusion proteins incorporate domains from the GPI anchored protein GP63 
fused to the N and C terminals of GFP. The models for the proteins ProGFP^^I and 
GFpGPi are shown, alongside GP63. The key includes a table indicating the number 
of amino acid residues incorporated from each region.
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Figure 5.5: Schematic of the method used to clone episomally expressed GFP- 
GPI fusion proteins.
The plasmids pGL587 and pGL586 contain the ORFs coding for the GPI- 
anchored fusion proteins GFP^^  ^ and ProGFP^^\ and were produced by multiple 
cloning steps as described in detail in the text.
Relevant restriction enzyme sites are indicated, as are the positions of relevant 
oligonucleotides.
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Figure 5.6: Fluorescence microscopy of GFP expressing cell lines.
Live cells were treated with 0.005% NaN^ to inhibit movement and examined by 
fluorescence microscopy using a Zeiss microscope. Filter settings were as those 
used for FITC labelled cells. Images were captured using a Hamamatsu digital 
camera, and visualised using Openlab (Improvision).
Arrows indicate cells for comparison which have variable levels of fluorescence.
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Figure 5.7: Analysis of GFP expression in cell lines expressing GPI-anchored 
GFP.
Cell lysates were prepared from the cell lines WT, AgpiS, Agp/5[pXGGFP‘^ '’*], 
Agpz( [^pXGProGFpGPi], WT[pXGGFP^P‘], WT[pXGProGFP«P‘], and 
Agp/5[pXGP/5-GFP]. These were subjected to SDS-PAGE and electrophoresed at 
1x10  ^ cell equivalents per lane, and electroblotted. The blot was exposed to a JL-8 
GFP monoclonal antibody (Clontech), at a dilution of 1:1000. The 72 kDa GPI8-GFP 
fusion protein is indicated.
177
Figure 5.8: Analysis of GPI-anchored proteins by PI-PLC treatment and 
TritonX-114 extraction of GFP expressing cell lines.
10» cells were pelleted from the cell lines WT[pXGGFpQPi], WTpXGProGFPG^], 
Agp/5[pXGGFP^Pi], and Agpz^[pXGProGFPGM].
Cells were lysed and tieated with or without PI-PLC prior to Triton X-114 
fractionation into soluble (S) and membrane-associated (M) fractions. Samples 
were subjected to 12% SDS-PAGE and electroblotted.
Panel A) The blot was exposed to a L. major GP63 monoclonal antibody at a 
dilution of 1:50. The 63kDa GP63 protein is indicated.
Panel B and C) The blots were exposed to the Clontech JL-8 GFP monoclonal 
antibody at a dilution of 1:1000. The arrows indicate possible GFP proteins and 
associated degradation products.
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Discussion
The aims of this work were the continuation of the characterisation of GPI8, the 
identification of novel proteins associated with GPI biosynthesis or trafficking, and the 
analysis of the trafficking of GPI, and non-GPI-anchored protein in L. mexicana.
The catalytic active sites of L. mexicana GPI8 were identified as C216 and H174. This 
result is fully consistent with the situation in the yeast and mammalian homologues, 
where the active sites were identified as C199 and H157, and Cys206 and H164 
respectively (Meyer et al., 2000; Ohishi et al., 2000). This demonstrates the high level 
of conservation at the position of the catalytic dyad within the GPI8 subfamily of the 
C l3 cysteine proteases. The GPI8 of L. mexicana was also demonstrated to be part of a 
lai'ger complex, again consistent with the situation in higher eukaryotes. This suggests 
that a high level of similarity exists between the GPIT complexes in higher eukaryotes 
and trypanosomatids. However important differences also exist, such as the soluble 
nature of the L. mexicana and T. brucei GPI8 (Hilley et al., 2000; Shanna et al., 2000), 
compared to the yeast and mammalian homologues which have a transmembrane 
domain.
The GPI8 amino acid residue C94 was identified as functionally important, and the 
protein GPIS^ "^^  ^ demonstrated to be dysfunctional with respect to GP63 GPI-anchor 
addition. The homologous mutation in the human GPI8 also results in a decrease in 
transamidase activity (Ohishi et al., 2000). It is possible that this residue has some 
catalytic activity, other than involvement with the transamidation mechanism. 
Alternatively the residue may be required for maintenance of tertiary structure of the 
GPI8 protein or the GPIT complex. The latter is possible as the residue is conserved 
amongst the GPI8 subfamily (but not the C l3 subfamily) and may form a disulphide 
bond with another member of the GPIT complex. Similaiiy epitope tagging of GPI8 at 
a position C-terminal of the identified active site residues also resulted in an inactive 
GPTT complex. The reason for this was not clear but it is possible that insertion of the 9 
amino acid peptide resulted in confoimational changes to the GPI8 protein. Co­
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precipitation experiments with cell lines expressing GPI8-TY^^^^ or a tagged form of 
Gp i8^^ '^ °, and comparison with cell lines expressing either the inactive or the fully 
functional GPI8 would be interesting.
Photo cross-linking experiments have previously demonstrated that GPI8 interacts 
directly with the pro-protein (Spurway et aL, 2001; Vidugiriene et aL, 2001), but it is 
not known how other members of the GPIT complex interact. As both L. mexicana and 
T. brucei GPI8 lack a transmembrane domain common in higher eukaryotes it is likely 
that interaction with other GPIT complex members allows the GPI8 protein to associate 
with the ER membrane. It would therefore be interesting to examine in-depth the 
protein-protein interactions of the different GPIT complex members. It is also possible 
that the GPTT complex of trypanosomatids has a different complexity from that of 
higher eukaryotes with a different number of members, or the proteins involved having 
differing roles.
The identification of other GPIT complex members seems an obvious and interesting 
area for further research. The presence in the L. major genome database of a putative 
GAAI homologue (Eisenhaber et al., 2001), provides a suitable starting point for 
further analysis. The present difficulties associated with the detection of GPI8 in WT 
cells is thought to be due to the low level of expression of the protein. However, 
isolation of a second complex member and production of antibodies against this may 
provide different results. The detection of the complex intracellularly by immune- 
fluorescence or direct immune-precipitation of the complex would allow the 
comparison of the GPIT complex of higher and lower eukaryotes.
The novel method devised for screening for GPI biosynthesis and trafficking mutants
was unsuccessful. Technical difficulties, associated with variations in GFP fluorescence
in different cells within a single population, suggested that the method would not be
suitable for a protracted screening process. The failure to produce a GFP GPI-anchored
on the cell surface suggests that the signals required for anchor addition and trafficking
are complex. Other recent studies in trypanosomatids reported similar difficulties in
producing GPI-anchored GFP (Bohme and Cross, 2002). The report that a successful
GPI-anchored GFP chimera was produced utilising the signal attachment sequences
from GP63 (Ghedin et al., 2001), as attempted in this study, only serves to underline
181
Chapter 6
the complexities involved in GPI-anchor addition. The failure to produce surface 
anchored GFP in this study may be explained by the fact that the trafficking of GPI- 
anchored proteins is complex, and may be mediated by a variety of unidentified 
trafficking and sorting signals (Nichols et ah, 2001). Similarly the precise requirements 
for the signals for GPI anchor attachment appear to be different for individual proteins 
(Aceto et aL, 1999), and it is possible that this is associated with the signals required to 
mediate the interaction with the GPIT complex.
It is interesting that the fate of the GFP, in both WT and the AgpiS cells, was different 
from that of unanchored GP63 in the AgpiS cell line. The unanchored GFP was retained 
within the ER, whilst the majority of un anchored GP63 was secreted. It is possible that 
the GFP was retained, due to a failure to remove the ER signal. This would have 
interesting implications for the workings of translocation machinery. Proteins are 
predicted to have their ER signal removed by the transiocon machinery as they pass 
through the translocon pore, and thus would not be expected to be affected by a non­
native protein sequence C-terminal to the cleavage point. Alternatively the failure to 
secrete GFP from the cells, could suggest that unanchored GP63 contains signals which 
specifically direct its transport from the cell.
In mammalian cells, the use of GFP chimeras and confocal microscopy coupled with 
photobleaching techniques have provided exciting methods to directly analyse the 
processes and dynamics of vesicular transport within live cells (Lippincott-Schwartz et 
ah, 2000). In L. mexicana the multi-vesicular tubule, a novel compartment has been 
identified using a GFP-DPMS chimera (Ilgoutz et al., 1999a; Mullin et al., 2001). The 
sorting of VSG has been examined in T. brucei by fluorescence microscopy, 
biotinylation and electron microscopy, and has been concluded to occur in multiple 
membrane compartments (Grunfelder et al., 2002). The production of a GFP chimera 
associated with the complete GP63 protein would allow the direct study and 
comparison of the trafficking pathways in both WT and AgpiS cells, using similar 
methods, and would provide an interesting comparison of the trafficking of a GPI- 
anchored versus non-anchored protein.
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Some differences exist in the secretory trafficking pathway between mammalian and 
trypanosomatids. EM microscopy suggests that the ERGIC identified in mammalian 
cells and the ER to Golgi transport in L. mexicana differ, as does the ultrastructure of 
the TGN compared with the trans-Golgi of L. mexicana (Weise et al., 2000). This study 
identified that the inhibitor Brefeldin A, associated with disruption of the Golgi 
apparatus in yeast and mammalian cells, had no discernible affect in L. mexicana. 
These differences suggest that the continued study of trafficking in these organisms 
may provide potential new drug targets.
Detailed comparison of the trafficking of GP63 in the WT and AgpiS cell lines 
demonstrated that in WT cells GP63 is trafficked to the cell surface, and during this 
trafficking the nascent protein is processed through two identifiable intermediate forms. 
In the AgpiS cell line the nascent protein is N-glycosylated and secreted directly from 
the cell with no further processing. The abolition of GPI anchor addition therefore 
effects both the trafficking and processing of GP63 in L. mexicana. Loss of N- 
glycosylation inhibited the secretion of GP63 in the AgpiS cell line. In other systems 
loss of GPI anchoring resulted in the retention of the protein within the ER, and it is 
thought that the GPI anchor itself may be an important signal in the onward trafficking 
of proteins (Field et al., 1994; Doering and Schekman, 1997). It has also been reported 
that in the absence of other targeting signals N-glycans can act as signals for protein 
trafficking (Gut et al., 1998). In this study neither the loss of GPI-anchor addition nor 
the loss of N-glycosylation resulted in the intracellular retention of GP63. However, 
loss of both GPI-anchor addition and N-glycosylation inhibited secretion of the nascent 
form of GP63 into the medium. This indicates that in the absence of a GPI anchor, N- 
glyeans are important in directing the trafficking of GP63 from the cell.
In this system, it seems that a small proportion of the nascent non-anchored GP63 is 
secreted from the WT cells, and suggests that GP63 may be trafficked by two separate 
pathways in WT cells. The AgpiS cell line is able to utilise the second pathway in the 
absence of GPI anchoring. It is proposed that in WT cells two pathways exist for the 
trafficking of GP63 from the cell. Trafficking is either by a classical pathway whereby 
GP63 is N-glycosylated, GPI-anchored and then undergoes further modification during 
transport to the cell surface, or a direct secretion pathway whereby non-GPI-anchored
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GP63 is secreted rapidly from the cell without subsequent modification. It appears that 
the requirement for entry into the first pathway is the presence of a GPI anchor, whilst 
the alternate pathway appears to require both the absence of a GPI anchor and presence 
of N-glycans. GPI-anchoring in Leishmania does affect the forward trafficking of GPI- 
anchored proteins. However, this study does not address whether GPI anchors act 
directly as a signal for the forward transport of proteins, or if they play an active role in 
protein transport.
GPI-anchored proteins become insoluble to detergent extraction during trafficking 
through the secretory pathway forming detergent resistant membranes (DRMs). Lipid- 
microdomains occur in protozoa (Nolan et al., 2000; Denny et al., 2001; Ralton et al., 
2002). DRMs can be isolated from L. major, and aie enriched in characteristic 
eukaryotic lipid raft components; inositol phosphorylceramide, sterols such as 
ergosterol and GPI-anchored molecules (both GP63 and LPG). In L. major GP63 is 
rapidly incorporated into DRMs suggesting that rafts may form in the ER of 
Leishmania as in yeast (Denny et al., 2001). Studies in L. mexicana suggested that 
GP63 was incorporated into DRMs with slow kinetics, suggesting incorporation in a 
late secretory compartment and indicating a discrepancy with the situation in L. major 
(Ralton et al., 2002).
Lipid rafts appear to be extremely relevant to the forwaid trafficking of GPI proteins in 
Leishmania. Continued investigation into this process would be extremely interesting, 
such as the use of ergosterol inhibitors to inhibit the formation of lipid rafts. Study of 
the AgpiS cell line would continue to provide useful insights into the trafficking of GPI 
proteins in Leishmania.
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